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ABSTRACT
Enzymic phosphate monoester hydrolysis by inositol monophosphatase from bovine brain 
(EC 3.1.3.25) occurs via the direct displacement of phosphate by water rather than by a two 
step mechanism Involving a phosphorylated enzyme Intermediate. The catalytic process is 
believed to Involve two Mg2+ ions, one of which Is burled and acts as a Lewis acid and 
phosphate coordination site. The second metal ion appears to coordinate to the alkyl 
phosphate bridging oxygen, the ‘catalytic’ hydroxyl group (C-60H of D-lns 1-P) and to the 
nucleophile, water or hydroxide. Mechanistic differences have been identified between the 
hydrolysis of inositol phosphate and nucleoside 2’-monophosphate substrates In that 
although phosphate-oxygen ligand exchange with the solvent is facile In the presence of 
inositol, no such exchange occurs in the presence of adenosine. The minimum structural 
requirements of a substrate have been demonstrated via synthesis of ethane 1,2-diol 
monophosphate which shows enzyme activity (Vmax ca. 12% that of Vmax for Ins 1-P, Km = 
0.7 mM and Ki = 1.0 mM). Elaboration of the free hydroxyl group to produce (S,R)-, (S)- and 
(R)-pentane 1,2,5-triol 2-phosphate gave inhibitors of contrasting potency ((S)- pentane 1,2,5- 
triol 2-phosphate Ki = 0.12 mM, (R)-pentane 1,2,5-triol 2-phosphate, Ki = 3.8 mM) as expected 
from the structural requirements for hydrolysis to occur. The proposed mechanism of 
adenosine 2’-monophosphate hydrolysis involving the N3-atom of the adenine moiety has 
been discounted through spectroscopic analysis of enzymic Incubations of new nucleoside 
substrates (Uridine 2’-monophosphate; Vmax 230% that of Vmax for 2’-AMP, Km = 4.0 mM 
and 5,6-dihydrouridine 2’-monophosphate; Vmax 70% that of Vmax for 2’-AMP, Km = 1.4 mM), 
which showed no intermediate phosphates, with only the substrate and final enzymic product 
(uridine) detected. Ethane 1,2-diol phosphate has been further elaborated to produce 2- 
methoxyethanol phosphate, diethylene glycol phosphate, pentane 1,5-diol phosphate, 
diethylene glycol cyclic phosphate and pentane 1,5-diol cyclic phosphate (Ki values range 
between 3 & 8 mM). Inhibition is attributed to interaction of the substrate with the second Mg2+ 
ion, and displacement of the catalytic water (hydroxide) molecule. The fact that the cyclic 
phosphate diesters are not hydrolysed to phosphate monoesters by the enzyme demonstrates 
that the attacking nucleophile is not positioned on the first (buried) Mg2+ ion. The mechanistic 
difference of nucleoside 2’-monophosphate hydrolyses is attributeded to the ribofuranosyl 
oxygen acting as a surrogate for the catalytic hydroxyl group of inositol 1-phosphate. 
Modelling studies have shown that this results In 2’-AMP adopting an unfavourable 
conformation which is stabilised by the second (catalytic) Mg2+ ion. The absence of the 
phosphate moiety in adenosine prevents this conformation being achieved at the active site, 
accounting for the lack of inhibitory activity of adenosine, and the absence of phosphate- 
oxygen ligand exchange in the presence of adenosine. The proposed mechanism is 
consistent with all published kinetic data, and the substrate dependency of lithium inhibition.
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CHAPTER ONE 
INTRODUCTION
1. INTRODUCTION:
In brain cells, myo-inositol 1,4,5-trisphosphate, a hydrolysis product of 
phosphatidylinositol 4,5-bisphosphate, acts as a second messenger by 
stimulating calcium release from intracellular stores. The enzymic hydrolysis of 
phosphatidylinositol 4,5-bisphosphate (by phosphatidylinositol lipase 0) is 
initiated on activation of an extracellular receptor by various agents such as 
hormones and neurotransmitters (first messengers), myo-lnositol second 
messenger metabolism occurs by stepwise enzymic dephosphorylations 
catalysed by specific phosphatase enzymes. The final dephosphorylation step 
involved in the metabolic pathway is mediated by the lithium sensitive enzyme 
myo-inositol monophosphatase. Since brain cells can not take up inositol, 
inhibition of myo-inositol monophosphatase by lithium depletes levels of free 
inositol, and prevents phosphoinositide biosynthesis. It is thought that this 
mechanism explains how lithium exerts its effect in the treatment of manic 
depression.
1.1 The inositols.
Inositol is a cyclohexanehexol, of which there are nine isomeric forms; 
alio -(1 ), (+)chiro -(2), {-)chlro -(3), cis -(4), epi -(5), muco -(6), myo -(7), neo - 
(8) and schyllo -(9).^ (Figure 1.1.1) myo-lnositol (7), the only isomer of great 
importance with respect to receptor signalling, is an achiral molecule, 
possessing a plane of symmetry through C-2 and C-5^ with chirality being 
introduced into the molecule as a result of unsymmetrical substitution (e.g. 
inositol 1-phosphate). It also has a single axial hydroxyl group at C2. The 
natural existence of its phosphoric esters has been known for many years, with 
the hexakisphosphate being a major constituent of plant seed (in the form of 
phytic acid), its function generally assigned the role of a phosphorus/ energy 
store.^ The primary function of the inositol phosphates however (most 
importantly inositol 1,4,5-trisphosphate), is to act as intracellular messengers. 
The majority of human inositol intake is dietary (mainly from plants), however 
myo-inositol is biosynthesised in plants and mammals. The biosynthesis of 
inositol occurs via the myo-inositol 1 -phosphate synthase catalysed 
isomérisation of D-glucose 6-phosphate (10) to L-myo-inositol 1-phosphate 
(15), and subsequent phosphate ester hydrolysis by myo-inositol
1
monophosphatase, myo-lnositol 1-phosphate synthase has been purified from 
bovine^ and rat®>® testis, yeast^ «® and a number of plant species^*'*® and the 
mechanism of isomérisation has been studied in depth.
OH
aHo -(1) (+)ctnro -(2)
OH
{-)chiro-(3)
cis -(4) ep/-{5) muco -{6)
OH
OH
myo -(7)
OH
OH
neo “(8)
OH
HQ PHpHHQ HQ
HO'OH HO 'OH 'OHHO
PH
OH
schyllo -(9)
Figure 1.1.1. The stereochemistry of the inositols.
The enzyme is a complex one in that it combines the activities of an
NAD"*" dependent oxidoreductase with an aldolase.^^ Initial opening of the
hemiacetal ring (10) followed by NAD+ mediated oxidation of the 5-hydroxyl 
group (via abstraction of the 5 hydrogen) gives the putative 5-keto-glucose 6- 
phosphate (12). Stereospecific deprotonation followed by stereospecific ring 
closure forms L-myo-lnosose 2,1-phosphate (14) which is reduced (NADH) to 
L- myo-inositol 1-phosphate (15). Evidence for the formation of myo-inosose
2,1-phosphate (14) has been found in the reduction of a testis synthase 
catalysed reaction mixture with [^Hl-NaBH^, which allows both myo- and 
scyllo- tritiated inositol 1-phosphate to be isolated. All of the intermediates in
.OHho;HO.
OH(10 )
HO
HO
OH
(11 )
HOHO
(12)
^A/v/W A/'enz
»/w\f\/v»enz
B:'
»AAAAA/»enz
HQHO
OH
(14)
HQHO ' - '3-OH
OH
(15)
OH
Scheme 1.1.1. Mechanism of inositol 1-phosphate synthase.
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the catalytic pathway are reported to be tightly bound,"*® however the first three 
steps of the pathway were shown to be reversible, by demonstrating the 
incorporation of deuterium (from the [^H]-H2 0  incubation medium) into the 6- 
position of glucose 6-phosphate (10). No overall reversibility of the 
isomérisation has been observed,^ suggesting that the cyclisation step is 
irreversib le. The hydrolysis of inositol 1-phosphate by inositol 
monophosphatase will be discussed in more detail elsewhere. The mechanism
of catalysis of inositol phosphate synthase is shown in scheme 1.1.1.
1.2 Intercellular signalling.
Cells respond when a variety of extracellular ligands (hormones, growth 
factors or neurotransmitters) interact with receptors on the outer surface of the 
plasma membrane. Such Interactions result in a cascade of biochemical 
processes causing a change in the cell behaviour, for example, the secretion of 
a specific enzyme or in the case of muscle cells, physical contraction. The 
signalling mechanisms known to be coupled to the activation of plasma 
membrane receptors fall into three main categories.^® The first class of 
receptors either contain, or are closely linked to an ion channel which spans the 
plasma membrane. Stimulation of these receptors leads to a change in the 
ability of the ion channel to allow Ions for which it is specific to pass across the 
cell membrane, resulting in a change in the Intracellular concentration of that 
ion. The second class of signalling mechanism involves a receptor that is 
actually a membrane spanning protein (a tyrosine kinase). The tyrosine kinase 
receptors have sites on the outer surface which recognise agonists, and active 
sites on the inner surface within the cell. The binding of an agonist to these 
enzymes results in the phosphorylation of tyrosine residues on target proteins 
within the cell. This type of signalling mechanism is used by many growth 
factors and hormones such as insulin. The third class of receptors are coupled 
to a class of glycoproteins called ‘G-proteins’, by which agonist binding causes
a response within the cell."*®*"*^  Receptor activation causes the associated 
trimeric G-protein (consisting of an a-, a p- and a y- subunit) to release 
guanosine 5’-diphosphate and bind guanosine 5’-triphosphate. The GTP-G- 
protein complex then dissociates into two separate units, an a-GTP unit and a 
P,y- unit, and it is the a-GTP subunit which is involved in the activation of the
4
enzyme to which the receptor Is coupled. The bound GTP is then hydrolysed by 
the GTP’ase activity of the a-subunit, and the resulting a-GDP complex 
recombines with the p.y- unit, allowing the cycle to continue again on agonist 
binding (Scheme 1.2.1).
The two main examples of G-protein linked receptors are the activation of 
adenylate cyclase and the activation of phosphatidylinositol lipase C. In both 
cases, the products of enzyme activation are known as second messengers, 
ultimately leading to a response within the cell. In the first example, (yielding 
adenosine 3’,5’-cyclic monophosphate from adenosine S’-triphosphate’*®-'*®) 
cAMP acts by stimulating a specific protein kinase which in turn phosphorylates
specific target proteins within the cell leading to overall response.^®-^® This 
system has been the subject of much research, and unlike the second example, 
has been very well understood for many years.
I I agonist
GD
Receptor
ITP
G-protein
.GDP
nucleoside exchang
GD GT
1enzymeactivation
Scheme 1.2.1, G-protein signal transduction.
Hokin and Hokin's discovery in 1953 that acetylcholine and 
carbamoylcholine stimulated the turnover of phosphate into the total 
phospholipid of slices of pancreas^® (shown by the ®^P-incorporation from 
[®2p]-|norganic phosphate into the phospholipid) was the first indication that 
phosphatidyl Inositol was metabolised on stimulation of the muscarinic 
cholinergic receptors of cells.
Q  Agonist
I,
eceptor R1
GTP
GDP-*^
G - Protein
Ptdlns Ptdlns(4,5)P2
(Ins (1,3.4,5)P4-
DG +
) lns(1,4,5)P3
Inositol
y ^ ^ E n d o i
t
Receptor R2.
Endoplasmic reticulum.
Ptdlns = Phosphatidyl Inositol.
PIG = Phosphatidyl inositol lipase 0. DG = Diacylglycerol.
Scheme 1.2,2. The inositol cycle. 
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Since this discovery, It has become apparent that a large number of 
agonists can stimulate an increase in the metabolism of membrane 
phosphoinositides, for example, noradrenaline,^® histamine,2i v a s o p r e s s in ^ ^  
and angiotensin.^® Although the change in phosphoinositide metabolism is 
always specific for one particular receptor class such as the a-adrenergic
receptor, the H^-histaminergic receptor or the -vasopressin receptor.^® In 
1975, Michel! noted that receptors which stimulated phosphoinositide turnover 
also activated calcium dependent processes within the cell.^® It is now known 
that the G-protein controlled hydrolysis of the phospholipid phosphatidylinositol
4,5-bisphosphate releases the two second messengers inositol 1,4,5- 
trisphosphate and diacyl g ly c e ro l.2 7  Inositol 1,4,5-trisphosphate diffuses into the 
cytosol and releases calcium from an intracellular storage site via a second 
receptor on the endoplasmic retlculum.^®»^® Diacyl glycerol activates a calcium 
and phospholipid requiring kinase enzyme (protein kinase which is
responsible for the phosphorylation of certain regulatory proteins. It can also be 
hydrolysed by diacyl glycerol lipase®^ resulting in the release arachidonic 
acid®2-®® which is involved in the biosynthesis of prostaglandins. The formation 
of these second messengers is summarised in scheme 1.2.2.
1 . 3  The Inositol cycle and Its Inhibition by lithium.
Chemical messengers acting within a cell must not only be synthesised 
rapidly, but also metabolised rapidly to ensure fast cellular response and fast 
return to the cell's prestimulated state.®  ^The pathway involved in the synthesis 
and metabolism of diacyl glycerol and the inositol phosphate second 
messengers is known as the inositol cycle, from which the majority of enzymes 
have been isolated and characterised. Diacyl glycerol can be phosphorylated 
by diacyl glycerol kinase to form phosphatidic acid which in turn is converted 
into OMP-phosphatidate, and recycled into the phospholipid via recombination 
with inositol®®. The breakdown of inositol 1,4,5-trisphosphate occurs through 
the sequential loss of phosphate groups by the action of certain phosphatase 
enzymes, initially by inositol 5-phosphatase to form the inactive inositol 1,4- 
bisphosphate.®®'®^ The fact that inositol 1,4-bisphosphate is inactive suggests 
that this enzyme is responsible for the termination of the calcium mobilising
signal. The bisphosphate Is further dephosphorylated by inositol 1-phosphatase 
and inositol monophosphatase to form free inositol, which reacts with the diacyl 
glycerol derivative CMP-phosphatidate. An additional metabolic pathway 
involves phosphorylation of the inositol 1,4,5-trisphosphate second messenger, 
to form inositol 1,3,4,6-tetrakisphosphate. The tetrakisphosphate is again 
sequentially dephosphorylated ultimately leading to myo-inositol (Scheme 
1.3.1).
« In®3 kinaseIns (1,4,5)P3   Ins (1,3,4,5)P4
ins
5-P ’ase
Ins (1,4)P2
Ins1-P*ase
Ins5-P'ase
Ins (1,3,4)P3
Ins1-P'ase
Ins (3,4)Pg 
Ins4-P’ase
Ins
4=P'ase
Ins (1,3)Pg 
Ins
3-P'ase
Ins 4P Ins 1PIns 3P
IMP'ase
IMP'ase IMP'asaOH
pH
HOHO OHHO
m y o in o s ito l
IMP'ase = Inositol monophosphatase
Scheme 1.3.1, The fate of the second messenger Ins 1,4,5-P^.
Irvine etal first noticed that two different isomers of inositol trisphosphate 
and also inositol 1,3,4,5-tetrakisphosphate were present in stimulated rat
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cortical slices.^® The further phosphorylation step is known to be catalysed by 
the specific 3-kinase enzyme.^® Although not fully understood, inositol 1,3,4,5- 
tetrakisphosphate has been shown to possess second messenger activity, but 
is active only in the presence of inositol 1,4,5-trisphosphate. This 
tetrakisphosphate is thought to be responsible for the activation of calcium 
mobilisation between different intracellular storage sites and also for the entry of
calcium ions into the cell.^® Inositol 1,3,4,5- tetrakisphosphate is also believed 
to be hydrolysed by the same enzyme (lns(1,4,5)P3-5-phosphatase) that causes 
Ins 1,4,5-Pg deactivation through specific déphosphorylation.^^ Other higher 
phosphates that have been identified include inositol 1,3,4,6- 
t e t r a k l s p h o s p h a t e ^ 2  and inositol 1,3,4,5,6-pentakisphosphate, but their 
functions in mammals remain unclear.
One important feature of the inositol cycle is that the enzyme inositol 
monophosphatase is the only enzyme capable of regenerating inositol. 
Inhibition of inositol monophosphatase within the cell should therefore result in 
the partial or complete failure of the inositol cycle. Lithium is one such agent 
which blocks inositol formation through inhibition the monophophatase (in an
uncompetitive manner at low lithium concentration).^^ The inhibitory action of 
lithium was first discovered in 1971 when Allison et al. noted that there was a 
considerable reduction in the concentration of inositol in the brains of lithium 
treated rats^^ (this attributed to inositol monophosphatase inhibition), it has 
since been shown that the reduction in the level of inositol in the cytosol is 
accompanied by decreased levels of the inositol phosphate second 
messengers.”^® An increase in the levels of CMP-phosphatidate,4® the species 
requiring inositol to reform phosphatidylinositol 4,5-bisphosphate has also been 
observed. The mode of action of lithium as an inhibitor has been of 
considerable academic and industrial interest over the last twenty years as 
lithium is widely used (usually as its citrate or carbonate salt) in the treatment of 
manic depression, a disease affecting approximately 1% of the world 
population. Although lithium exhibits properties as a therapeutic agent, a 
greater understanding of the mechanism of inhibition is essential to allow the 
design of new drugs, as a number of problems are associated with lithium 
therapy. To achieve the desired therapeutic effect, a plasma concentration of 
between 0.5 mM and 1.2 mM lithium is required, however serious side effects
occur at plasma concentrations of, or greater than, 2 mM. A plasma 
concentration of 3 mM can be fatai so strict monitoring of piasma lithium levels 
is necessary on initiation of lithium therapy. Also prolonged lithium therapy 
(periods in the region of 2-3 years) result in histological changes in the kidneys 
which may impair renal function.
The concentrations of inositol cycle components in the brain together 
with the uncompetitive nature of lithium on inositol monophosphatase and the 
fact that Inositol is unable to cross the blood brain barrier suggest that the 
inositol cycle and the accompanied signalling processes are the therapeutic 
target for lithium. Note that lithium has little effect on ceils in the periphery which 
has relatively free access to plasma inositol.
1.4 inositol monophosphatase; Physiology and Biochemistry.
inositol monophosphatase and the inositol cycle have been studied in a 
variety of tissue types from various sources but the most concentrated research
has been conducted with bovine®®»®'* and rat brain enzymes.®^ The enzyme 
has been purified from its natural sources and the gene cloned into 
Escherichia co//.®^ inositol monophosphatase has been shown to be a 
homodimer of molecular weight 58,000 Daltons with the optimum pH for 
substrate hydrolysis being 7.8. It also requires magnesium cations for activity, 
but other metal ions are known to bind to the enzyme. These metal ions include
calcium, manganese, cobalt, copper and zinc.®®»®^  Zinc has been shown to 
support activity (around 20% that of magnesium) and cobait also acts as a poor 
surrogate for magnesium (3.5 mM cobalt supports around 10% of the activity 
attainable with 3 mM magnesium with (+/-) ins 1-P as the substrate).®® Other 
metal ions gave at best 5% activity with (+/-) Ins 1-P as the substrate. A variety of 
natural substrates exist for the enzyme. In addition to both enantiomers of 
inositol 1- and inositol 4-phosphate, the enzyme is also capable of hydrolysing 
2'-AMP, 2'-GMP, a-glycerophosphate and p-glycerophosphate.
Fluoride anions have been shown to inhibit the enzyme®® in a manner 
which appears to be substrate dependent (competitive with respect to glycerol
2-phosphate, noncompetitive with respect to (+/-) Ins 1-P, and uncompetitive 
with respect to magnesium), it has been suggested that this substrate 
dependency arises because the enzyme bound fluoride can prevent glycerol 2-
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phosphate from binding to the enzyme, but not inositol 1-phosphate due to it 
forming more specific interactions at the active site.®®
The order of product release has been determined by examination of the 
product inhibition properties of the components associated with hydrolysis. 
Inorganic phosphate is a competitive inhibitor for (+/-) ins 1-P (K; 0.5 mM at pH 
7.8) and is the last product to debind. The Kj for phosphate inhibition decreases 
by a factor of approximately 25 from 8.0 mM at pH 6.5 to 0.3 mM (at pH 8.0), 
showing that the phosphate dianion binds more tightly to the enzyme at high 
pH. Inositol displays non-competitive inhibitor activity at high inositol
concentrations (Kj apparent^  250 mM at pH 6.5, and 400 mM at pH 8.0 ^®) for the 
hydrolysis of (+/-) Ins 1-P, and is the first product to debind.
In the presence of saturating lithium, there is an initial rapid release of 
inositol followed by no further reaction occurring.®^ From these results, it was 
proposed that inositol monophosphatase catalysed phosphate ester hydrolysis 
by a ping pong mechanism (see section 1.6) and that inhibition by lithium
occurred after hydrolysis.®^ Much research has since been focussed on the 
mode of lithium inhibition of inositol monophosphatase, including a study on the 
different isotopes of lithium^® and their effects on the enzyme. As a result, it has 
been shown that phosphate increases the extent of lithium inhibition, a result of 
consequence in Wvo.®® Phosphate release from the enzyme after hydrolysis of 
a substrate is believed to be rate limiting for inositol monophosphates, and 
lithium has also been proposed to bind selectively to the site vacated by
magnesium in binding to a non-covalent E.Pi c o m p le x ,T h is  proposed 
mechanism is in accord with the initial rapid release of inositol observed in early 
studies of the hydrolysis mechanism.
A chemical modifier for arginine residues (phenyl glyoxal) has been 
shown to inactivate inositol monophosphatase.®® The modified arginine residue 
has not been isolated. However, it has been shown that one arginine residue is 
modified in each subunit. It was thought unlikely that this residue is involved in 
the mechanism of hydrolysis as phosphoarginine residues have only previously 
been isolated from phosphoproteins, e.g. rat myelin basic protein,®^ where their 
role is not associated with any catalytic function. It is more likely that this residue 
has a substrate binding role.
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1.5 Enzyme catalysed phosphoryl transfer.
Phosphoryl transfer reactions in biological systems are crucially 
important processes linked to energy transduction, metabolic regulation and a 
wide variety of signal transduction pathways.®®»®® Simple non-enzymic 
phosphoryl transfer reactions can occur by two main types of mechanism, 
associative (Sn2 (P)) and dissociative (8^1 (P)).®® (Scheme 1.5.1)
Ro­ llrOH O ROH + O O R'O—p— a Dissociative
RO— J^—O' 
OH
O
RO— Pç-OR'
HO O'
ROH + R '0“-“ P— 0 ' Associative 
OH
Scheme 1.5.1. Dissociative and associative mechanisms 
of phosphoryl group transfer.
Evidence suggests that both dissociative {via the metaphosphate 
intermediate)®^ and in-line associative mechanisms®® can occur in aqueous 
non-enzymic hydrolyses of phosphate monoesters, but enzyme catalysed 
phosphoryl transfer reactions are believed to proceed via the in-line 
associative mechanism.®®
There are a number of different types of enzymic phosphoryl transfer 
reactions which depend on the level of substitution at the phosphorus centre 
and the nature of the enzyme in question. Many of these enzymes show an 
absolute requirement for a divalent metal ion (usually magnesium or zinc) to 
show catalytic activity. Metal ion coordination to a phosphate ester can 
neutralise negative charge on the phosphate group making it more susceptible
to nucleophilic attack, stabilise the leaving group (RO"), and with additional 
coordination to the acceptor molecule, orientate the reacting species in such a 
way as to make the reaction effectively intramolecular. The metal ion can also 
be involved in a more general role, in the stabilisation of the enzyme structure.
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Enzymic phosphoryi transfer via in-line displacements is known to occur in one 
of three ways; a) a single step displacement by water, b) by a double 
displacement utilising an enzyme bound nucleophile forming a phosphorylated 
enzyme intermediate and c) by a double displacement utilising an adjacent 
hydroxyl group forming a cyclic diester intermediate (Scheme 1.5.2).
Three main categories of enzyme exist for the turnover of phosphate 
monoester substrates: phosphatase enzymes, where the phosphoryl donor is a 
phosphate monoester and the acceptor molecule Is water; kinase enzymes, 
where the phosphoryl donor is a nucleoside triphosphate and the acceptor is 
some agent other than water; and the mutase enzymes where the phosphoryl 
acceptor is another functional group on the donor molecule itself. Other classes 
of phosphoryl transfer enzymes include those which process phosphate 
diesters (e.g. nucleases, phospholipases and phosphodiesterases) and those 
other than phosphokinases which utilise nucleoside triphosphates as 
substrates (e.g. ATP’ases and nucleotidyl cyclases) . Mechanistically, enzymes 
involved in processing phosphate monoesters fall into categories a) and b) 
(Scheme 1.5.2). The formation of cyclic phosphate diester intermediates 
(Scheme 1 .5 .2 , c)) is a phenomenon associated with phosphate diester 
hydrolysis of nucleotides for example by ribonuclease, which catalyses the 
hydrolysis of RNA in the 3’->5’ direction, giving the 3' monophosphate of the 
nucleotide.®^
In the case of phosphatase enzymes, the double displacement 
mechanism (ping pong, scheme 1.5.2 b)) is by far the most common. The 
phosphatase enzyme that has received the most attention over the past forty 
years with regard to both characterisation and mechanistic determination is that
of alkaline phosphatase from £. co//,®®»®® which involves the obligatory 
formation of a phosphoenzyme intermediate. This phosphatase is non-specific, 
suggesting its role may be to supply phosphate from phosphate esters under 
conditions of phosphate deprivation,®^ however other functions such as 
phosphate transport have also been suggested for this enzyme.®® It is known 
that a maximum rate of synthesis of the enzyme occurs when phosphate 
concentrations within a cell become low enough to limit cell growth.®® The 
evidence for the bi bi ping pong mechanism in alkaline phosphatase is 
unquestionable.®® The enzyme has been shown to catalyse trans-
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phosphorylation between alcohols (the alcohol being an alternative phosphoryl 
group acceptor to water, which is able to react with the phosphorylated enzyme 
intermediate), and catalyses ^^0 -exchange between water and inorganic 
phosphate in the absence of any other acceptor molecule (where E-P forms as
OR
Enz
O-HO o
Enz
a) Single step displacement mechanism.
Nu : HO
O'
Enz
b) Doubie dispiacement mechanism via enzyme bound nucleophiie.
R'O R'O R'O
Enz EnzEnz
c) Double displacement mechanism via cyclic phosphate diester.
Scheme 1.5,2. The mechanisms of enzymic phosphoryl transfer reactions.
a result of the reverse hydrolysis reaction and is subsequently hydrolysed by 
[ l8o]_water, see section 1.7). The phosphoenzyme intermediate has also been 
isolated from incubations with enzyme and inorganic phosphate and with
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enzyme and substrate at low pH, and the initial transfer of the phosphoryl group 
has been shown to be to a serine residue at the active site/^ Stereochemical 
analysis at the phosphorus centre (see section 1.7) shows overall retention of 
configuration, again indicating a two step mechanism. Acid phosphatase 
(another non-specific phosphatase) and giucose 6 -phosphatase have also 
been shown to operate by this type of mechanism. Here, the phosphorylated 
enzyme intermediates are phosphorylated on histidine residues In each 
c a s e . ^^«^2 Both alkaline and acid phosphatase show similar values 
regardless of the substrate which indicates that the breakdown of the E-P 
complex is rate limiting. The alternative single step displacement mechanism is 
extremely rare for phosphatase enzymes, however examples have been 
reported. Subsequent to our own proposals, Knowles et al. have very recently 
shown that purple acid phosphatase (a diiron phosphatase) catalyses a direct 
phosphoryl group transfer to water. This conclusion was based on the analysis 
of the stereochemical course of the reaction with respect to the phosphorus
centre.^3
Evidence suggesting the involvement of a phosphorylated intermediate 
is not always as clear cut as in the case for alkaline phosphatase, and 
experimental data has been misinterpreted in some cases. The phosphokinase 
enzyme hexokinase, which is the initial enzyme involved in the sequence of 
reactions converting glucose Into pyruvate with the concomitant production of 
ATP (glycolysis) operates by a random addition of substrates (glucose and ATP) 
to the enzyme with single step transfer of the phosphoryl group occurring after 
the formation of a ternary complex (Scheme 1.5.3).^^ initial experimentation did 
however suggest the formation of a phosphorylated enzyme intermediate, with 
slow isotopic exchange being observed between ATP and ADP in the absence 
of glucose.^5 Such exchange has since been shown to occur due to the 
presence of cosubstrates and cosubstrate analogues such as water (the 
exchange reaction occurs at a rate about 10^ times slower than the normal 
reaction).
In the third class of enzymes which involves catalysis of a phosphoryi 
transfer within the same molecule (the phosphomutases), the process generally 
involves phosphorylated enzyme intermediates. In the case of 
phosphoglucomutase, the enzyme responsible for the conversion of giucose 1-
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phosphate to glucose 6 -phosphate, an active site serine residue has been 
identified as the enzyme bound nucleophile/^
Enz
HO
OH O —T P f” O F? —— O P ““ O Ad
OH
HO OH
Scheme 1.5.3. Mechanism of hexokinase.
1.6 Stereochemical course of phosphoryl transfer reactions at the 
phosphorus centre.
Enzyme catalysed phosphoryl transfer reactions tend to be complex and 
kinetic data can often be misinterpreted. With regard to mechanistic 
determination of such reactions, much information can be obtained from studies 
involving the determination of the stereochemical course of the reaction at the
phosphorus centre.^^ The stereochemical course of such a reaction can only be 
observed if the reaction involves a chiral starting material (with respect to 
phosphorus) leading to a chiral product (with respect to phosphorus), therefore, 
a substrate chiral at phosphorus must be produced. Sophisticated methods 
have been developed to analyse both substrates and products of such enzymic 
reactions.
0
1
R"0 ‘^  I  "'"'/OR 
OR'
chiral.
0
jj
1
OR'
prochirai
oIIp
R"D'^ ^ ""/O' 
O'
"""«/O'
r
pro-pro-prochiral
I
O'
pro-prochi ral
Figure 1.6.1. The stereochemical environment of phosphorus centres.
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The different types of phosphoryl transfer reactions involving P-O bond 
cleavage and the stereochemical environment of both substrates and products 
are summarised in schemes 1.6.1 and 1.6.2. The production of chiral phosphate 
esters involves, in many cases, the incorporation of two or more of the stable 
isotopes of oxygen, and and sulfur to produce phosphorothioate
analogues, providing products of assessable stereochemical character. Many 
enzymes have been shown to accept phosphorothioate analogues as 
s u b s t r a t e s , o f t e n  accompanied by significant reductions in rates of 
reaction, for example, inositol monophosphatase.^o The reduction in rate
ROPO2OR’ (prochirai) ^5= ^  ROPOgOR" (prochirai) (A)
ROPO2OR’ (prochirai) ROPO3 (pro-prochiral) (B)
ROPO3 (pro-prochiral) R'0 P0 3  (pro-prochiral) (C)
ROPO3 (pro-prochiral) PO4 (pro-pro-prochiral) (D)
PO4 (pro-pro-prochiral) ^^5= ^  PO4 (pro-pro-prochiral) (E)
Scheme 1.6.2. Stereochemical environment of reactions at a phosphorus
centre.
is probably due to the difference in size between sulfur and oxygen. The non­
specific ping pong phosphatase enzyme alkaline phosphatase (which shows a 
wide range of substrate specificity for many phosphate monoesters with only 
minor changes in 's not capable of hydrolysing phosphorothioates.®"*
Since the size difference between isotopes of a particular atom is 
extremely small (even in the most extreme case of H- and ^H-),an isotopicaiiy 
chiral substrate will bind to the enzyme in an identical manner to the non­
labelled substrate, and apart from possible rate changes arising from any
isotope effects (which are insignificant between and ®^0 -), will react in 
exactly the same way. Enzymic reactions belonging to type C (Scheme 1 .6.2) 
involving a pro-prochiral substrate leading to a pro-prochiral product as a result 
of phosphoryl group transfer to an acceptor molecule other than water 
(phosphokinase enzymes) have been studied in such stereochemical
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investigations,®® and a number of general methods for the production of chiral 
[I6oi7oi8o]-phosphate monoesters have been devised.®'^ (Scheme 1.6.3 
and 1.6.4.) The Lowe synthesis (Scheme 1.6.4) from (S)-mandeiic acid (31) 
offers a route to both enantiomers of the chirai thiophosphate esters through 
control of the POCI3 cyclisation.®^ The use of pyridine as a solvent gives solely 
the Sp enantiomer (23), as reversible ring opening of the phosphorochloridate 
intermediate leads to the production of the thermodynamic product. The use of 
two equivalents of pyridine leads solely to the Rp- enantiomer (the kinetic 
product). To date, all kinase enzymes have been shown to proceed with overall 
Inversion of configuration as a result of direct transfer of the phosphoryl group to 
an acceptor molecule, and no involvement of a phosphorylated enzyme 
intermediate. Methods of synthesis and analysis of analogous chiral 
[■i6oi7oi8o]-sulfate monoesters have also been developed for the study of 
both chemical and enzymic sulfuryl transfer reactions.®®"®®
MeNH
P^ O^Cig +
Hg, Pd/C
RO —
(20)
Scheme 1.63. Knowles synthesis of chiral [^^O^^O^^Ohphosphate monoesters.
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Phosphatase enzymes belong to type D (Scheme 1.6.2), and involve a pro- 
prochiral phosphate monoester leading to a pro-pro-prochiral product 
(inorganic phosphate), and In order to produce the product in a chi rally labelled 
form, all three stable isotopes of oxygen and sulfur must be incorporated. The
methods described for the production of [^ ®0 ^^0 ‘*^0 ]-phosphate monoesters 
can be manipulated to produce the analogous chiral 
phosphorothioate monoesters®'' (Scheme 1.6.5). incubation of the 
phosphorothioate monoester with the enzyme under investigation in a ^^O- 
enriched aqueous medium, allows the production of chiral inorganic 
thiophosphate.
Ph
H
COOH
(21)
H
PhLi
H
H
Ph
« .% -  N.BH,
(24)
h1 L
H+
' ■ v L o "
23 O
i
H (23)
ROH, pyr
18QXFoOR
(26)
Hg Pd/C 
— —- —*► RO“=““ P'>18q 
(20)
Scheme 1.6.4. Lowe synthesis of chiral [^^O^^O^^Ohphosphate monoesters.
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Scheme 1.6.5 Synthesis of chiral [^^0^^0]-phosphoroth ioate  |
monoesters. j
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In 1980, Tsai reported the first stereochemical study developed 
specifically for a phosphatase e n z y m e ® ^  (alkaline phosphatase from E.Co//was 
the first phosphatase to receive such study, however since alkaline 
phosphatase also catalyses transestérification, its stereochemical course had 
been elucidated via a method developed for kinase enzymes®^), in this study, it 
was shown that the hydrolysis of adenosine 5’-phosphorothioate to adenosine 
and inorganic thiophosphate catalysed by the snake venom 5’-nucleotidase (5’- 
ribonucleotide phosphohydrolase) occurred with overall inversion of 
configuration at phosphorus, indicating that the reaction did not involve the 
formation of a covalently bound phosphorylated intermediate. This result, 
although an unusual one for a phosphatase enzyme, agreed with previous 
experiments demonstrating the enzyme’s inability to catalyse 
transphosphorylation®^ (type C, Scheme 1 .6 .2 ) or phosphate-oxygen isotope 
exchange®^ (type E, Scheme 1.6.2). The synthesis of the chirai adenosine 5’- 
phosphorothioate involved a combination of two chemical steps to achieve 
label incorporation and two enzymic steps to give separately the two 
enantiomers,® '^®®'®® Hydrolysis catalysed by venom 5’-nucleotidase in a 
enriched aqueous medium gives the chiral product. Chiral analysis of the 
inorganic thiophosphate was achieved by a combination of enzymic and 
spectroscopic methods; firstly by coupling of the product to glyceraldehyde 3 -
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phosphate, followed by further kinase catalysed phosphoryi transfer reactions to 
uitimately give chiral adenosine 5’-[pS]-triphosphate which was analysed by 
®^P«NMR spectroscopy. Two important properties of and ^®0- are utilised 
in such analyses. Firstly, an atom directly bonded to a phosphorus atom 
will result in a slight shift of the ®‘*P-NMR signal to higher field compared with 
that observed for a atom directly bonded to phosphorus.®® The magnitude 
of this shift is related to the fractional change in the mass of the isotope, the 
number of ^®0 - atoms directly bonded to the phosphorus centre and also the 
bond order of the P-^®0 bond. For example, adenosine 5'-[^®0]- 
monophosphate has a shift of 0.020 +/- 0.0003 ppm to higher field, and 
inorganic phosphate has a shift of 0 .0 2 0  +/- 0.01 ppm to higher field for each 
^®0- atom incorporated.^®® The shift associated with a doubly bonded P-^®0
species is approximately twice that associated with a singly bonded P-‘*®0 
species. P-O-P Bridging species display smaller shifts as the effect is divided
between two phosphorus atoms.®^ A atom directly bonded to the 
phosphorus atom however, has a completely different effect. The effect of this 
isotope is to cause extensive line broadening of the ®^P-NiVIR signal due to 
quadrupolar relaxation.^®^'^®^ The magnitude of this line broadening is so 
great that the signal is effectively reduced to a noise level, meaning that only 
species containing ^®0- and ^®0-label will be visible by NMR spectroscopy.
it has been shown that the chiral phosphate methyl ester produced by the 
Lowe synthesis (Scheme 1.6.4) described above exhibited circular dichroism, 
whereas the unlabeiied methyl ester did not, giving a type of fingerprint for the 
chirai compound. Following this methodology, attempts have been made to 
obtain the circular dichroism spectrum of chiral inorganic thiophosphate to act 
as a possible method of enantiomeric analysis.®"^ Although inorganic 
thiophosphate absorbs strongly at 220-230 nm, the circular dichroism spectrum 
was not observable in this region. It is very unlikely that normal methods for 
determining configuration could distinguish between chiral phosphate esters or 
chiral inorganic thiophosphate with any great accuracy, and alternative non- 
enzymic methods of analysis have been developed.
The most elegant method of chirai inorganic thiophosphate analysis was 
developed by Lowe et aL 103-105 and involves the coupling of the hydrolysis
21
product (inorganic thiophosphate) to an enantiomerically pure derivative of (S)- 
mandelic acid (2 1 ) ((S)-2 -iodo-1 -phenylethanol (28))1®® (Scheme 1 .6 .6 ). 
Cyclisation of the coupled species followed by derivatisation as the methyl ester
with diazomethane gives the species to be analysed by high resolution 
NMR spectroscopy (Scheme 1.6.6). This method was successfully used to 
determine the stereochemical course of the activation of glutamate by glutamine 
synthase. 1®^
H
.OH
I O' (PhO)2PCI
(28)
s pC==.o - BugNIIO
H
Ph//,,,
(29)
H
O OMe
CHaNa
/ \  —  ^ / \
(30) (31)
Scheme 1,6,6 Chiral inorganic thiophosphate analysis species.
For the Sp- configuration of the alkylated thiophosphate (29b), there are six 
possible products formed on cyclisation (31g-l), three being c/s- and three 
being trans-. For the Rp- configuration of the alkylated thiophosphate (29a), 
there are an alternative six products (31a-e), differing from the above in their 
isotopic distribution only. No two products from the R- and S- configurations are 
the same (Scheme 1.6.7.). Theoretically, only two of the aforementioned 
species will be detectable for each enantiomer of inorganic thiophosphate, and 
can be easily distinguished from each other by ®ip-NMR. The analytical 
technique becomes slightly more complicated by the fact that [i^O]-water is not 
commercially available in an isotopicaiiy pure form. Therefore some species 
initially thought to be ®ip NMR invisible will actually contain a i®0-atom in the 
place of a i^O-atom and will give rise to a signal. Calculations based on the 
isotopic abundance of the reagents used in the synthesis and the pattern 
expected for each enantiomer allows a theoretical value to be determined for 
the intensity of each peak. Comparison between theoretical and experimental
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values have been shown to give excellent correlation, allowing the 
configuration of the thiophosphate to be determined.
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Scheme 1.6.7. Possible isotopic distribution products of the Lowe chiral 
inorganic thiophosphate analysis method.
1.7 Inositol monophosphatase catalysed phosphate-oxygen 
ligand exchange
Phosphatase enzymes like alkaline phosphatase and acid phosphatase, 
which operate via a substituted enzyme mechanism (ping pong mechanism) 
(see section 1.5) are able to catalyse the incorporation of 1®0-Iabel from [1®0]- 
water into inorganic phosphate by means of the reverse hydrolysis
23
r e a c t i o n ^ ( S c h e m e  1.7.1). Isotope incorporation occurs in the absence of 
an acceptor moiecuie (other than water), and implicates the involvement of a 
phosphoenzyme intermediate, since ^^O-enrichment can occur as the result of 
phosphoenzyme hydrolysis.
.. OHNu : Nu :OH
O'
EnzEnz Enz
Scheme 1.7,1. Enzyme catalysed phosphate-oxygen ligand exchange.
Inositol monophosphatase is unable to catalyse such a reaction in the 
absence of i n o s i t o l . I n  the presence of inositol, however, an exchange 
reaction does occur, and shows similar pH and metal ion dependencies to the 
physiological phosphate ester hydrolysis. The exchange reaction is also 
inhibited by the lithium cation.^^jo? The observation of inositol dependent 
exchange (K^ 190 mM, (saturating phosphate) 60% that of for (+/-) Ins 
1 -P hydrolysis) is inconsistent with a ping pong mechanism^^ as this would 
require inositol to bind to the enzyme before the water molecule derived from 
the enzyme phosphorylation (to form the proposed phosphorylated enzyme 
intermediate) is released. This would result in the formation of a ternary 
complex capable of binding both phosphoryl group acceptors simultaneously 
(Scheme 1.7.2).
Evidence suggests that the proposed ternary complex mechanism is of a 
non-substituted rather than a substituted nature, as attempts to detect a 
phosphorylated enzyme intermediate have failed.®®*''®^ Transestérification 
between 2'-AMP and [U^^C]-inositol and also between unlabelled inositol 1-
phosphate and [U^^C]-inositol have proved unsuccessful. Also, attempts to trap 
the proposed E-P complex by incubation of 2’-AMP with enzyme and 
subsequent quenching with lithium chloride showed no modified protein.
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Similar experiments using [^^P]-phosphate and (+/-) [^^S]-inositol 1 
phosphorothioate resulted in no radiolabelled protein being detected.
Enzyme
OII -O '  {E.InsO.HgOInsO— P.
O '
■*" Enzyme +
O
E.ROH.HOP} HO— P " ° '
'"o
+ InsOH
Scheme 1.7.2. Ternary complex mechanism.
1.8 The structure of human inositol monophosphatase
Recently, the structure of human inositol monophosphatase has been 
solved to 2.1 Â resolution, and has shown the enzyme to exist as a dimer of two 
identical subunits. Each subunit is folded into a five layered sandwich of three
pairs of a-helices and two p-sheets. The structural determination has been
determined with the lanthanide ion Gd^+ (a competitive inhibitor for 
magnesium) instead of the natural metal ion, and sulfate (a competitive inhibitor 
for the substrate) in place of the phosphate group."*®® If it is assumed that the 
position of the sulfate group in the crystal structure approximates that of the 
phosphate group of the substrate, and Gd®+ the position of magnesium, then it 
is evident that there are no amino acid residues at the active site with side 
chains that are correctly disposed to act as potential nucleophiles in a 
substituted enzyme m e c h a n i s m . A l t h o u g h  the exact position of the 
phosphate group of the substrate is not known, the only amino acid side chain 
positioned to act as an internal nucleophile is the hydroxyl group of Thr-95. 
While it is possible that this residue is a catalytic nucleophile, it is still relatively 
distant with a separation of 4 Â between the hydroxyl oxygen of Thr-95 and the 
sulfur atom of the sulfate group in the crystal structure. The position of the 
threonine residue makes the proposed role of the hydroxyl group unlikely, and it 
is more likely that Thr-95 is involved in magnesium binding to facilitate 
polarisation of the phosphate group of the substrate (Thr-95 mutants
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possessing alanine and serine residues have been shown to exhibit reductions 
in magnesium binding affinity). Examination of the amino acid residues with a 
single step displacement mechanism for the hydrolysis in mind reveals that the 
carboxylate group of Glu-70, at a distance of around 4.5 Â from the sulfur atom 
of the sulfate group, is positioned to possibly activate a water molecule. 
Although Glu-70 appears to be a metal ligand in the crystal structure, mutations 
replacing this residue with glutamine and aspartic acid result in 0 .0 1 % and 
0.06% activity respectively compared with the wild type, with no change in 
for the substrate or for magnes ium.G lu -70  could be less important in 
magnesium binding compared with that of Gd^+ (as in the crystal structure) due 
to the differences in coordination between the two metals. Figure 1 .8.1 shows 
the positions of some of the active site amino acid residues relative to Gd^+ and 
sulfate in the crystal structure of inositol monophosphatase.
His 217
Asp 93
O
Cys^lB
O' \ lie 92o -s .
O'
Glu 70
Figure 1.8.1 Active site amino acid residues of inositol monophosphatase 
(side chains w ith in  coordinating distance of the metal ion are indicated by
dashed lines).
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Chemical modifications of alternative amino acid residues at the active site 
have shown that the modification of Cys-218 (with N-ethyl maleimide)^ and of 
His-217 (with diethyl pyrocarbonate)"*^^ also result in the loss of catalytic 
activity. The use of site directed mutagenesis to replace Cys-218 with an 
alanine residue proved that this residue is not essential for catalysis to occur, 
suggesting that the chemical modification inhibits the enzyme by steric 
effects.^Similarly, replacement of His-217 with a glutamine residue gives full 
activity in the mutant enzyme, again suggesting that the chemical modification is 
responsible for the loss of activity."* “* ^
1.9 Deoxylnosito! 1-phosphate analogues.
Inositol monophosphatase shows a notable lack of substrate specificity in 
that it is able to catalyse the hydrolysis of both enantiomers of inositol 1- and 
inositol 4-phosphates as well as other polyol phosphates possessing a hydroxy! 
group a- to the phosphate group."* "*2 Inositol 1-phosphonate^"*'^ (32) shows no 
substrate activity or inhibitor activity, indicating that the alkyl phosphate bridging 
oxygen is essential for substrate binding.
OH
HO,
HO' OH
OH
(3 2)
OH
HQ
HO' OH
OH
OH
h o ^ ^ ^ â .,^ o p o 32-
HO'‘'''’^ V " ’’^ ^OH 
OH
(33a) (33 b)
Figure 1.9,1, Inositol 1-phosphate and phosphonate.
By use of deoxy analogues of inositol 1-phosphate, the importance of the 
five free hydroxyl groups has been determined."* (+)-2-Deoxyinositol 1 -
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p h o s p h a t e (34a) has been shown to be a substrate for the enzyme (K^ 1.3 
mM, 78% that of (+/-) Ins 1-P), whereas (-)-2-deoxyinosltol 1-phosphate 
(34b) is a good competitive inhibitor (Kj 50 jiM). These results, accompanied by 
the fact that (+/-)-6 -deoxyinositol 1-phosphate acts as a competitive inhibitor (K; 
-70 jj,M) and gives no detectable release of Inorganic phosphate on enzyme 
incubation suggests that the a-hydroxyl groups have discrete and different roles 
in inositol monophosphatase activity towards substrates. Substrate recognition 
by inositol monophosphatase requires a binding interaction from one of the a-
OH
HO,
HO OH
OH
Bindingsite
Mechanismsite
OH
OPOo2- HO
HO
OH
(34b)
Figure 1.9.2, a-Hydroxyl interactions w ith  inositol monophosphatase.
hydroxyl groups, with the second a-hydroxyl group being involved in the 
mechanism of phosphate ester hydrolysis. (+)-2-Deoxy Ins 1-P (34a) 
possesses the mechanistic hydroxyl group but not the binding hydroxyl group, 
resulting in its weak substrate activity and (-)-2-deoxy Ins 1-P (34b) possesses 
the binding hydroxyl group but not the mechanistic (or catalytic) hydroxyl group, 
resulting in its competitive inhibitor activity (Figure 1.9 .2 ). Other substrates like 
a-glycerophosphate and p-glycerophosphate have at least one hydroxyl group
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a -  to the phosphate group, fulfilling the structural requirements for hydrolysis to 
occur. Further investigation into the roles of the hydroxyl groups of the inositol 
ring through comparison of the three dimensional structures of the two 
enantiomers of inositol 1 -phosphate (33a & 33b) using molecular modelling 
techniques has shown good overlap between the phosphate group, both a- 
hydroxyl groups and the 4-hydroxyl group. Superimposition of the 3- and 5 - 
hydroxyl groups could not be achieved, suggesting that these groups are not of 
any great binding or catalytic significance. This prediction was confirmed 
through synthesis and incubation of c/s-3,5-dihydroxycyclohexane phosphate 
(2,4,6-trisdeoxyinositol 1-phosphate) (35), which shows no substrate or 
inhibitor activity.''^® ffans-4-Hydroxycyclohexane phosphate (36) does show 
some inhibitor activity, indicating that the 4-hydroxyl group is involved in 
binding. 2,3,5-Trisdeoxy- and 3,5,6-trisdeoxy- analogues of inositol 1- 
phosphate have also been synthesised, and exhibit the expected substrate and 
inhibitor properties.
HQ
OH
(35)
c s s -3,5-dihydroxy 
cyclohexane 1-phosphate
HO' a
pPOj
(36) 
trans -4-hydroxy 
cyclohexane 1-phosphate
OH
HO
1-(S)-phosphoryloxy-(2R, 4S) 
dihydroxy cyclohexane ((-)PDC)
a PPOgZ-
OH
(38)
1-(S)-phosphoryloxy-(2S, 4R) 
dihydroxy cyclohexane ((+)PDC)
Figure 1,9.3 Synthetic inhibitors and substrates of inositol 
m onophosphatase.
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1-(S)-Phosphoryloxy“(2R,4S)"dihydroxycyclohexane ((-)PDC) (37) which 
possesses the phosphate group and the two binding hydroxyl groups, but not 
the catalytic hydroxy group, has been shown to be an extremely potent 
competitive inhibitor of the enzyme (IC50 3 pM) whereas its enantiomer 
((+)PDC) (38) which possesses the catalytic hydroxyl group and a single
binding hydroxyi group behaves as a weak substrateJ^® The binding and 
catalytic sites of D-inositol 1-phosphate are summarised in figure 1.9.4.
i>OH
HQ
^HQ 'OH
OH
Binding 
Catalytic
Figure I S A ,  Binding and catalytic sites on D-myo-inositol 1-phosphate.
It is well known that inositol monophosphatase is able to hydrolyse 2 '- 
nucleoside phosphates, including adenosine 2 '-monophosphate (40)^^^ (K^ 
0.58 mM, Vf^ax 1 58 that of (+/-) Ins 1-P). The adenine group is known not to 
significantly reduce binding to the enzyme. Implying a tolerance of steric bulk 
near the active site. The use of molecular modelling techniques to compare the 
3-dimensional structures of the deoxyinositol phosphates (39) and 2'-AMP (40) 
have shown good overlap between the phosphate group and the two hydroxy 
groups ' *o f  each compound (Figure 1.9.5).
HQ
OH
HO.
(39)
N
OPO32- 
OH
# 0)
Figure  2 .9 .5 .  Comparison of inositol and adenosine functional groups.
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The deoxyanalogue (39) R=H (Figure 1.9.5) is an extremely efficient 
competitive inhibitor"*(no catalytic hydroxy group), which suggests that the 
adenine group may in some way be involved in the hydrolysis of 2’“AMP (See 
results and discussion section). The structural analysis indicates that the R 
group at the 6 -position of the cyclohexane ring would occupy the same 3- 
dimensional space as the adenine moiety in 2’-AMP (40). The synthesis and 
testing of a number of deoxyinositol phosphate analogues possessing steric
bulk at the 6 -position have been reported,^ the best of which inhibited with an 
IC50 value of 70 nM (41 d) These reports confirm that there is a substantial 
tolerance of steric bulk at the active site, with a substituent at the 6 -position 
providing significant extra binding affinity.
(41a) R = OH (KmO.025 mM, V^ax 0.61 that 
of (+/-) Ins1-P).” ^
OPO.
HQ
OH
(41b) R = H (ICso3nM)” ®
(410) R= (CH2)4CH3 (ICsoSjlM).’ ' ’’
(41d) R= o ^  (ICso/OnM).117
Figure 1.9.6 Side chain deoxyinositol phosphate inhibitors.
1.10 Non-phosphate inhibitors of inositol monophosphatase.
Although the deoxy analogues are potent specific inhibitors of inositol 
monophosphatase, their in vivo activity is compromised by their hydrolyses by 
non-specific phosphatase enzymes and also their lack of penetration into intact 
cells. Non-hydrolysable phosphonates have been shown to be devoid of 
substrate and inhibitory activity,"* "*3 however, through random screening, some 
bis phosphonic acids have been identified as inhibitors. Methylene bis 
phosphonic acid (42) (the simplest example) was inactive, however 
hydroxyethylidine-1,1 -bis phosphonic acid (43) was shown to be a reasonable 
competitive inhibitor (IC50 110 pM)."* "*8
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0 0HO. Il II/OH
XH3C OH 
(42) (43)
Figure 1.10.1. Bis-phosphonic acids.
Combination of the structural features of the deoxyinositol phosphate 
inhibitors and the bisphosphonic acid inhibitors resulted in the production of (+/- 
) 3,5,6-trisdeoxyinositol“1,1-bis phosphonic acid (44), a potent competitive 
inhibitor of inositol monophosphatase (IC50 4 pM)J
H3C P0 {0 H)2 
po(OH)2
(44)
Figure 1.10.2. 3,5,6 trisdeoxy ethylidene 1,1-bisphosphonic acid.
Substitution of the methyl group and the 0-cyclohexane diol ring in 
compound (44) gave rise to a number of competitive inhibitors of varying 
degrees of efficiency (Table 1.10.1). The best of these is compound (52) (iCgq 
0.08 pM), which is the most potent non-hydrolysable inhibitor of inositol 
monophosphatase reported to date,"*^® and is structurally almost completely 
unrelated to the natural substrate. The in v/Vo activity of these compounds as yet 
remains unknown.
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Table 1.10.1. Non-phosphate inhibitors of inositol monophosphatase.
P0(0H)2R1 O p2
P0(0H)2
Compound i f  ICgolpM)
(45) H CHa 1 1 0 " *
(46) H Rl 29™
(47) H Bn 38™
(48) H C I - O - v  23™
p i
(49) H  ^ Q61™
(50) H J  CHa 0 .3 3 ’ ®^
HO
(51) ( [ ^  Bn 05™
HO
(52) . 0.08
HO VI4 /ÎSSV) “^ Q "Cl
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One further inhibitor unrelated to the natural substrate is the fungal 
metabolite K-76 monocarboxylic acid (53) (Figure 1.10.3), which is reported to 
be a competitive inhibitor for the substrate D-lns 1-P (Kj 0.5 mM) . ’*20
HO CHO
COOH
HO. Me
HO
Mer Me
(53)
Figure 1.10.3. K-76 monocarboxylic acid.
1.11 The synthesis of inosltoi phosphates.
Interest in the inositol cycle and its specific enzymic transformations has 
presented the need for the natural substrates. Although they can be isolated 
from their natural sources, the ability to synthesise these compounds would 
result in the production of large amounts of the desired material, with the added 
advantage of being able to make minor chemical changes to investigate the 
enzymic processes more closely and at a mechanistic l e v e l . ^  21 Q y @  
commercial availability and low cost, the majority of inositol polyphosphate 
syntheses use the parent compound, inositol, as the Initial starting material. 
There are, nevertheless, a number of problems associated with such syntheses. 
Firstly, myo-inositol (7) is an achiral compound, which becomes chiral upon 
unsymmetrical substitution. Syntheses therefore often require a resolution step 
in order to obtain the naturally occurring and biologically important 
stereoisomer. To combat this problem, a number of syntheses have been 
developed using chiral starting materials other than inositol, for example (-)- 
quinic acid^22 and conduritol B.^23 |p addition, enzyme aided syntheses from 
achiral starting materials such as benzene have been d e v e l o p e d . ^24 second 
problem arises due to the fact that specific regioisomers are required to be 
useful in research, meaning a number of specific protection steps are usually 
required to achieve phosphorylation at the desired position(s). To achieve
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specific protection, one must exploit the differences in reactivity between the 
axial and equatorial hydroxyl groups and also the 1 ,2 -c/s- and 1 ,2 -frans- 
relationship between adjacent hydroxyl g r o u p s . ‘'25-129 yvith the hydroxyl 
groups all being secondary, further complications arise with efficient 
phosphorylation. The relative un reactivity of P(V) reagents for phosphorylation 
of secondary alcohols usually having large protection groups on adjacent 
carbon atoms has prompted the use of much more reactive phosphites and 
other P(lll) related reagents for phosphitylation.^^O The use of phosphitylating 
agents has an added advantage in that they offer routes to both the natural 
phosphate esters and also the phosphorothioate a n a l o g u e s . >^22 jhese 
have proved very useful in mechanistic investigations as they are often slower 
substrates and/ or inhibitors. The final problem is that of phosphoryl group 
migration and cyclic diester formation during deprotection (usually occurring 
under acidic conditions).
One synthesis of optically pure inositol 1 -phosphate from inositol which 
appears to break the ‘rules’ for efficient inositol phosphate synthesis has
however been r e p o r t e d ^ (Scheme 1.11.1). This three step synthesis does not
myo­
inositol OHHO
(7)
HOHO-
HO
(56)
D-myo-
  Inositol 1-
phosphate
(33a)
Scheme 1,11.1. Three step synthesis of D-myo~inositol 1-phosphate.
require complete protection of inositol (leaving a single hydroxyl group for 
phosphorylation), does not require any chromatographic resolution, uses a P(V) 
reagent for phosphorylation and involves an acidic final deprotection step. The
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initial ketal formation (with camphor dimethylacetal"*^^) is a precipitation driven 
equilibrium (performed in CHCI3 : CH3OH : HgO) which allows the isolation of 
the desired diastereoisomer (55) by simple filtration. (The use of this camphor 
monoacetal has been the subject of further investigation, with alternative 
enantiomerically pure inositol phosphates being produced after further 
protection stepsl35) Direct phosphorylation of the tetraol with 
dibenzylchlorophosphate results in the phosphate from reaction at C-1 OH (56) 
(reported to be the only component accumulating in any significant quantity). 
This selective phosphorylation of the polyol is possibly due to an a-effect. The 
strain involved in the five membered ring of the camphor ketal (55) results in a 
slight distortion of the inositol ring with C-1 OH not being completely equatorial, 
and the 0-2 substituent not being entirely axial. This results in the interaction of 
the two oxygens, making 0-1 OH slightly more nucleophilic than the other 
hydroxyl groups. Simple hydrogenation and acidic ketal deprotection gave no 
isomérisation or cyclic ester formation, and allowed the isolation of the target 
compound as the bis-cyclohexylammonium salt. This synthesis also offers 
equally straight forward access to L-myo-inositol 1-phosphate (33b) using the 
commercially available L-camphor.
A more common method of obtaining enantiomerically pure Inositol 
phosphates which does not rely on the fortune of selective crystallisation is that
pH  , ^OCamph GamphO,camphanic acid chloride 1
(RO)s (OR)s
chromatographic separation
KOH KOH
(RO)s (OR)s
enantiomerically pure protected 
inositols
Scheme 1.11.2. Camphanate diastereomeric resolution.
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of diastereomeric resolution of a suitably protected myo-inositol derivative. 
Systems that have been used Include the production of orthoesters of D- 
mannose, menthoxyacetates and camphanate esters (Scheme 1.11.2).^36 |p 
the production of these diastereoisomers, the considerable bulk of the 
multichiral centred esters makes the diastereomeric components significantly 
different to allow relatively simple separation.
A similar synthesis to that outlined above of racemic inositol 4-phosphate 
(61) (similar in the fact that specific phosphorylation can be achieved from a 
non-fully protected inositol derivative) has been performed using mono­
orthoformate inositol (58) which has hydroxyl groups at C-1 , 0-3 and 0-5
simultaneously p r o te c te d . ^ T h e  axial/ equatorial relationship usually 
associated with myo-inositol (7) is now reversed, which allows specific 4-OH 
alkylations, or in this case phosphorylation, through deprotonation of one of the 
axial hydroxyl groups with stabilisation of the resulting alkoxide by coordination 
of the metal ion (Scheme 1.11.1).
myo­
inositol
(7)
0 " " y ^ o
(58) HO
HO
O ^-Na+(59)
myo­
inositol 4- 
phosphateHO
HO (61)(60)
Scheme 1,11,3, Synthesis of racemic inositol 4-phosphate,
Phosphorylation is achieved with pentabenzylpyrophosphate, a reagent which 
has also been used with great efficiency in the polyphosphoryiation of inositol 
derivatives. Phosphorylation of the orthoformate (58) can occur on either of the 
axial hydroxyl to give, on deprotection, racemic inositol 4-phosphate (61 ) (since 
(■f) Ins 6 -P = (-) Ins 4-P).
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A relatively simple synthesis of an achiral inositol monophosphate not 
occurring in the inositol cycle (that of inositol 5-monophosphate (6 6 )) has been 
reported^^® employing a derivative of neo-inositol (5-amino-5-deoxy-neo- 
inosltol (62), obtained from the antibiotic hygromycin as the initial
starting material. The simplicity of this system arises because the hydroxyl 
group required for phosphorylation is only incorporated after full protection is 
complete. Protection as the penta-O-acetyl compound is followed by 
diazotisation and invertive hydrolysis giving the protected myo-inositol 
derivative for phosphorylation (64), (Scheme 1.11.4.). Although inositol 5- 
phosphate (6 6 ) is not involved in second messenger metabolism, it is of interest 
with regard to inositol monophosphatase, because it possesses an interesting 
1,4 phosphate-OH c/s-arrangement not present in inositol 1- and inositol 4- 
phosphate.
5-amlno-5-deoxy-neo-inositol
OAc OAc
AcO^ ^OAcAca OAc
Ag o OAc(62) —  A T
OH
(6 3 ) (64 )
OAc
*r nr nr  myoinositolI  J . 5-phosphate
AcO ''^^Y^'^O Ac (66)
0 P 0 (0 R )2
(65 )
Scheme 1.11.4. Synthesis of inositol 5-phosphate.
A popular solution to the problem of acquiring suitably protected myo­
inositol derivatives is the use of bis-ketals,^^^ usually from cyclohexanone"*^® or 
cyclohexanone p r e c u r s o r s , ^ w h i c h  yields a mixture of three different 
ketals that can be chromatographically separated or fractionally crystallised. 
(Scheme 1.11.5). Separation of the bis-ketal mixture immediately provides 
access to three inositol bis-phosphates (all be it in a racemic form), and further
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manipulation by the use of specific protecting groups aiiows the synthesis of 
more complex and more interesting inositol phosphates.
OEt
myo-inositol f
HQ
HQ
(67)
HQ
4"
(6 8 )
OH
(69)
Scheme 1.11.5. Bis-ketal isomers of inositol.
The mixture is also a readily available source of the most stable 1,2- 
monoketal, produced under mild hydrolysis conditions to remove the less stable 
and non specific ketal. The 1,2-monoketal (81) has recently been efficiently
resolved into its enantiomeric components by enzymic estérification."*^® This 
invoives the treatment of racemic 2,3-c/s-cyclohexyiidene myo-inositol in 
dioxane with the relevant enzyme (amano lipase C or amano lipase CES from 
Pseudomonas sp.) and acetic anhydr ide ,and  resuits in seiective acétylation 
at 0-1 of the L-enantiomer."*^® The acetyiated L-enantiomer and the non- 
acetylated D-enantiomer were easily separable by chromatography. D-myo­
inositol 1,4,5-tris phosphate has since been synthesised in 30% yieid from this
enzymicaliy resolved monoketal."*^8 D-myo-inositol 1,4,5-trisphosphate (80) 
has received much attention as a synthetic target over recent years due to its 
importance in ceii signalling. The first reported synthesis by Ozaki et a! "*^ ® 
aithough long and low yielding, incorporates protecting groups stiil used in
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more recent syntheses, namely benzyl protection and ally I protection.
Both groups show acid and base stabiiity and can be selectively removed in the 
presence of each other (see results and discussion section). Benzylation of the 
1,2;4,5 bis-ketai (6 8 ) foilowed by partial ketal hydrolysis of (70) gave the 
racemic 4,5-diol. Bis-aiiyiation followed by further ketal hydrolysis affords the 
1,2-bishydroxy compound (72), from which chromatographic diastereomeric 
resolution was achieved via chiral ester formation on the more reactive and less 
hindered equatorial hydroxyl group. Ester hydrolysis and selective allyiation, 
again on the equatorial hydroxyl group, followed by benzyl éthérification of the 
C2-OH group gave a fully protected inositol derivative possessing ally! groups 
at C-1 ,0-4 and 0-6 (75) (Scheme 1.1 1 .6 ).
0 --OeH^o
(68) (+/-)
■CrH6^10 O—OeH-io
BnQBnQHQ
"^OBn AllylQ'OH
AllylO
(70) (+ /") (71) (+ /” )
OH
p HBnQ
AllylQ PBn
AllylO
resolve
BnQ
AllylQ
OH
I J L  ^OMenth
(72) (+ /-)
AllylO
(73)
BnO OBn
pAllylBnQ
AllylQ 'OBn
AllylO
PHBnQ
HQ
OH
(74) (75)
Scheme 1.11.6, Synthesis if D-1,4,S-tris-O-benzyI inositol.
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Phosphorylation (using dianilidochlorophosphate), which occurred in low yieid, 
and deprotection gave the target compound (79). Numerous problems have 
been associated with such phosphorylations due to the lability of the 
phosphorus protecting groups and subsequent cyclic ester formation. Ozaki et 
al. have since reported that cyclisations of monophosphoryiated intermediates 
In the polyphosphoryiation of a 1,2-diol similar to that described above occurs 
preferentially to give the five membered cyclic phosphate instead of further 
phosphorylation leading to the bisphosphate^^^ (complex mixtures of mono 
and bis phosphate esters have been Isolated in alternative syntheses of 
polyphosphates using dianilidochlorophosphate^®^’’*®^ ).
H-ioCe"— o 
o{ 1  -OH
10^6
(69) (+ /-)
10^6
OBn
HioCg-— 0
(76) (+/")
resolve
pCamph pH
PBn HO
OH
(77)
(BnO)2 0 PO OBn
D-lns 1,4 ,5 -p3. 
(80)
OPO(OBn)2 
(7 9)
Scheme 1.11.7. Synthesis of D-myo-inositol 1,4,5-tris phosphate.
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A more recent synthesis of D-lns 1,4,5-Pg combines the aforementioned 
bis-ketalisation with simple benzyl protection and effective phosphorylation to
give the target compound in good y ie ld Is o la t io n  of the 1,2;5,6 bis-ketal (69) 
followed by partially selective monobenzylation^®® affords the racemic 3- 
benzyl-4-hydroxy derivative (Scheme 1.11.7) which was resolved following 
camphanate ester formation. Partial ketal hydrolysis followed by ester 
hydrolysis gave the required protected inositol derivative (78) in just four steps 
from the bis-ketal. Tetrabenzyl pyrophosphate phosphorylation was achieved in 
excellent yield (> 80%).'*4® Subsequent hydrogenation and ketal hydrolysis 
afforded the desired compound (80) (Scheme 1.11.7). The use of tetrabenzyl 
pyrophosphate appears to have eliminated the problems encountered in the 
earlier synthesis due to the relative inertness of the phosphate benzyl ester. A 
second advantage of this phosphate protecting group is that simultaneous 
phosphate benzyl ester and alkyl benzyl ether deprotection can be achieved in 
a 'one-po t' reaction, without the need for ted ious ion exchange 
chromatography.
The development of synthetic routes to protected myo-inositols and 
myo-inositol phosphates has allowed the production of a number of related 
compounds such as phosphorothioate,**®® phosphonate,**®^ sulfate"*®® and 
sulfonate^®® analogues. In the case of Inositol 1,4,5-trisphosphoro- 
thioate,**®®’**®** the analogue can fulfil the biological messenger function of the 
natural compound, however, is not accepted as a substrate for inositol 5- 
phosphatase. In many cases these analogues tend to be slow substrates and/ 
or competitive inhibitors of varying degrees of potency. They are useful tools to 
be employed in the accumulation of mechanistic information, both for the 
enzymes involved In the inositol cycle and in elucidating the mechanisms of 
signal transduction.
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2. RESULTS AND DISCUSSION
The aim of this project was to produce novel substrate analogues of 
inositol 1-phosphate (33), adenosine 2 ’-monophosphate (40) and glycerol 
phosphates, and by studying their behaviour as inhibitors and substrates for 
inositol monophosphatase, gain more information concerning the mode of 
action of the enzyme. By stereospecific incorporation of an ^^O-label into the 
phosphorothioate analogues of inositol 1-phosphate (33) and adenosine 2 - 
monophosphate (40) (Figure 2.1) the production of a substrate chiral at 
phosphorus (by means of isotopic substitution) was also investigated, with the 
aim of determining the stereochemical course of the phosphate ester hydrolysis 
at the phosphorus centre.
OH
HQ
OH
NH.
HO
(33)
Figure 2,1. D-Inositol 1-phosphate and 2 '-AM P.
Initial experimentation involved the production of the natural substrate, 
inositol 1-phosphate (33), which was required to determine the potency of 
synthetic inhibitors, and the production of the substrate analogue, inositol 1- 
phosphorothioate, with the aim of stereospecifically incorporating an oxygen 
label to produce Rp- and Sp-inositol 1 ^0]-phosphorothioate.
2.1 The synthesis of (+/-) Inos itol 1-phosphorothioate.
As described in section 1.11, the synthesis of specific isomers of inositol 
monophosphates requires a number of specific protection steps to ensure 
phosphorylation occurs in the correct position. Two syntheses of inositol 1- 
phosphorothioate have been r e p o r t e d , ’’32,162 one of which has potential in 
terms of stereospecifically Incorporating an oxygen label. The production of a 
penta-protected inositol derivative possessing a free hydroxyl group at the 1 -
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position was performed according to the method of Baker et Initial
formation of the mono-c/s-ketal (81 (section 1 .1 1 ), followed by 
tetrabenzylation and acidic ketal deprotection yields (+/-)-3,4,5,6-tetra-0-benzyl 
myo-inositol (83) in 52% yield from myoinositol (7) (Scheme 2 .1 .1). Specific 
allylation at the C-1 position was achieved via the formation of a stannylidene 
intermediate using dibutyl tin oxide under dehydrating c o n d i t i o n s . ^
OH
BnQHO,.OHHO,
BnQ DBnOH
OH
(7 )
OH
(81 )
OBn
(82)
OH
BnQ OH
>0B,
OBn
OH
JYI
(83)
OBn
BnQ
BnQ OBn
OBn
(85 )
BnQ
OBn
OBn
(84)
OBn
BnQ OH
BnQ OBn
OBn
( 86 )
Reagents; I) CqH  ^qO, PhOHQ, 65%; II) BnCI, KOH, 84%; III) AcOH. HgO, 82%;
Iv) a) Bu2SnO. PhH, b) Ally! bromide, 94%; v) BnBr, NaH, DMF, 93%; 
vl) a) (Ph3P)3RhOI. DABCO, EtOH, HgO; b) AcOH, H2O, 91%;
Scheme 2.1.1, Synthesis of 3A,5,6-tetra~0-benzvl m vo-inos ito l. 
Previously, a partial allylation reaction of a similarly protected compound had
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been used to protect the equatorial C-1 hydroxyl g r o u p T h i s  reaction, apart 
from being low yielding, was reported not to be completely regioselective. The 
use of dibutyl tin oxide followed by allyl bromide gave the desired product (84) 
in 94% yield after chromatography, with no 2 -Oallyl- or bis-O-allyl- protected 
inositol derivatives being detected. The reaction has previously been studied by 
ii9Sn NMR spectroscopy, and the Intermediates characterised by X-ray 
crystallography and mass spectrometry. In the solid phase, the stannylidene 
intermediate (87) (Figure 2.1.2), exists apparently as an infinite chain of dimeric 
units joined by weak Sn-0 bonds.
a
Bu
Bu
Bu
Bu
Sn
Bu
Bu
n
Solid phase structure (8 7) Solution phase structure (8  8)
Figure 2.1.2. Structure of stannylidene intermediate.
In the solution phase, the species is thought to exist as a single dimer (8 8 ) in 
which the two inositol oxygens are not equivalent. 0-2 OH Is thought to be 
coordinated to both tin atoms in the dimer (Scheme 2.1.3) and is relatively 
electron deficient, as well as being sterically hindered. 0-1 OH on the other 
hand is only two coordinate, and more electron rich (only being bonded to one 
tin atom in the dimer). It has been proposed that a combination of these factors 
together with the fact that the axial hydroxyl group is less nucleophilic than the
equatorial hydroxyl group, results in the preferential allylation of C-1 OH.'*®  ^
Having achieved selective equatorial allylation (Figure 2.1.3), the penta-O- 
protected inositol (84) was further benzylated using benzyl bromide and 
sodium hydride in THF or in DMF. Significant increases in rates of reaction have
been observed when DMF was used as a solvent in preference to THF.^^
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BnO, OBnOBn
OBn
OH OHBu- Sn- OBn,BnOi ,OH pAllyl
BnO
BnO' BnO'BuOBn OBnBnO'BnOOBn OBnOBn
(8 3) (89) (84)
Reagents; I) Bu2SnO, Benzene, (- HgO); II) Allyl bromide, 94%.
Scheme 2.1.3. C-1 O H  allylation via a stannylidene intermediate.
De-allylation to protduce the desired protected precursor to inositol 1- 
phosphorothioate (8 6 ) was achieved following the methodology of Corey and 
SuggsJG4 The use of catalytic amounts of both Wilkinson’s catalyst (tris 
triphenylphosphine rhodium (I) chloride) and DABCO in aqueous ethanol 
resulted in the isomérisation of the allyl ether (85) to the more 
thermodynamically stable enol ether (92) (Scheme 2.1.4).
OBn
Bn
Bn OBn
OBn
(Ph3P)3RhCI 
DABCO
Rh(PPh3)3 Rh(PPh3)3
OBn
(90)
(Ph3P)3RhCI
DABCO
J
Rh(PPb3)3 BnO'' " V  ''OBn 
OBn
(9 2 )
Scheme 2.1.4. Wilkinson's catalyst mediated deallylation.
46
The enol ether (92) is easily hydrolysed In aqueous acid to give the 
precursor to both Inositol 1 -phosphate and Inositol 1-phosphorothioate. 
Incorporation of the phosphorothioate functionality Is achieved using the 
phosphitylating agent N,N’-dllsopropyl(2-cyanoethyl)chlorophosphoramidlte, in 
Its racem ic form. Transestérification of (93) with an excess of 3- 
hydroxyproplonltrlle forms the bis-cyanoethyl phosphite which was oxidised 
with elemental sulfur In pyridine to afford the fully protected phosphorothioate 
(94) (Scheme 2.1.5).
OBn
' Y V ° h  ,  _
OOr. /  N
ii)
OBn
(86)
OBn
OBn
(93)
BnQ
BnO' OBn
OBn
OH
Hi)
HQ
HO OH
OH
■ O -
\ O
(94) (95)
Reagents: I) N’N-diisopropyl(2-cyanoethyl)chlorophosphoramidite, dlisopropylethyl
amine,THF; II) a) 1-Htetrazole, 3-hydroxyproplonltrile, CH3 CN,b)Sg, 
pyridine, 65%; Hi) a) NaOMe/ MeOH, b) Na/ NHg(|^ , THF, c) Amberilte IRA 
118(H)+, d) cyclohexylamine, H2 O, 58%.
Scheme 2.1.5. Synthesis of inositol 1-phosphorothioate.
De protection is achieved firstly by treatment with sodium methoxlde In methanol 
(removing the cyanoethyl groups by production of the volatile side-product 
acrylonltrlle), and secondly by a dissolving metal reduction (sodium metal In 
liquid ammonia) removing the benzyl ethers to produce pure Inositol 1- 
phosphorothloate (95). Ion exchange chromatography (Amberilte IRA 118 (H)+) 
and conversion to the bis-cyclohexylammonlum salt gives the desired product 
In 58% yield from (94). The use of substrates In the form of the ir bls- 
cyclohexylammonlum salts aids crystallisation, and hence purification, and also 
does not interfere In any way with the enzyme Incubation.
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Phosphltylation of a single enantiomer of 2,3,4,5,6-penta-O-benzyl myo~ 
inositol ([«dI +10.4», (c 0.3 in CHCI3), {lit.,'65 [ « j  +9 .1°, (c 0.3 in CHCig)}) with 
racemic N,N’-diisopropyl(2-cyanoethyl)chlorophosphoramidite and examination 
of the reaction intermediate (93) by thin layer chromatography revealed that the 
Inositol phosphoramidite was apparently present as an inseparable mixture of 
two diastereomers. Similarly, transestérification with benzyl alcohol instead of 
cyanoethyl alcohol (3-hydroxyproplonitrile) gave an inseparable mixture of 
diastereomers as judged by TLC. Diastereomeric resolution of such species
was investigated as a possible route to stereospecifically incorporate an ^^O- 
label (by use of [^ ®0 ]-cyanoethyl alcohol or [‘*®0 ]-benzyl alcohol) however in 
the case of inositol, this does not seem to be a valid possibility.
2.2 Synthesis of (+/-) inositol 1 «phosphate.
The production of inositol 1-phosphate (33) for use in the determination 
of enzyme activity and inhibitor potency of synthetic inhibitors was performed 
according to the method of Billington and involved the phosphorylation
of (8 6 ) with diphenylphosphorochloridate (Scheme 2 .2 .1).
OBn OBn nII _OPh
OPh
BnO, p H
OBn
BnO,
OBn
it)
(86) (96)
OH OOBn
OBnBnO, P  P>
OBn
OBn
OBn
III)
HO
OH
OH
; ^ o -
% -
(97) (33)
Reagents; I) (PhO)2 POC!, DMAP, Et^ N: CH2 Cl2 ,6 8 % II) NaH. BnOH,
THF, 63%. II) a) Na/NHg i^j, -78^,b) Amberilte IRA 118 (H)+, c) 
cyclohexylamine, H2 O, 69%.
Scheme 2.2.1. Synthesis of (+/-) inositol 1-phosphate.
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Transestérification with benzoxide, followed by sodium/ liquid ammonia 
reduction gave inositol 1-phosphate (33), which was converted to the bis- 
cyclohexylammonium salt as in the case of Inositol 1-phosphorothioate 
(Scheme 2 .2 .1) in 69% yield from (97).
For the purpose of following the enzymic reaction course of synthetic 
substrates with inositol monophosphatase by ^H-NMR spectroscopy, the 
amount of activity lost on lyophilisation of an enzyme solution was investigated. 
Inositol 1-phosphate was dissolved in deuteriated assay buffer (20 mM 
NH4 HCO3 and 2 mM MgClg 6 H2O in 2 H2O, pH 8.0) and a lyophilised enzyme 
sample redissolved in deuteriated assay buffer added. Incubation at 37 and 
analysis by f H-NMR spectroscopy revealed that the lyophilised protein was 
capable of completely processing the substrate. Parallel experiments 
comparing the initial rate of enzymic hydrolysis of inositol 1-phosphate using a 
normal and a freeze dried enzyme sample by the colormetric assay (see 
experimental section) showed that lyophilisation does not result in the loss of 
enzyme activity.
2.3 Adenosine as a substrate for inos itol monophosphatase.
As inositol 1-phosphorothioate is known to be a substrate for inositol 
monophosphatase,®^ it was hoped that this compound could be produced in a 
form chiral at the phosphorus centre In order to examine the stereochemical 
course of the phosphate ester hydrolysis. Diastereomeric resolution of a 
suitably protected inositol 1-phosphite or inositol 1-phosphoramidite could not 
be achieved, as determined by TLC analysis (see page 48), so the synthesis of 
a thiophosphate analogue of an alternative substrate for the enzyme, namely 2 - 
AMP (40), was investigated. In addition to the synthesis of the substrate 
analogue, the ab ility of adenosine to act as a substrate for inos itol 
monophosphatase with regard to oxygen-phosphate ligand exchange between 
the solvent and inorganic phosphate in an ‘•®0 -enriched aqueous medium was 
assessed. As inositol was known to act as a substrate for the exchange 
reaction, all incubations for probable but unknown substrates were run in 
parallel with identical incubations containing inositol In addition to controls 
containing no enzyme. In initial studies, [^®0]-water was added to an assay 
mixture (30 mM Tris MCI, 20 mM inorganic phosphate, 2 mM MgCl2 , 30 mM
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substrate (inositol or adenosine)), and aliquots removed periodically, 
quenching in liquid nitrogen. On lyophilisation, the inorganic phosphate was 
isolated by extraction into acidic methanol (2 %) and derivatised to the trimethyl 
ester by treatment with freshly prepared ethereal diazomethane. On 
evaporation of the solvent, the trimethyl phosphate samples were analysed by 
g.c. mass spectrometry using a 50% phenyl methyl silicone capillary column at 
an initial temperature of 60 °C. Surprisingly, in the incubations containing 
adenosine, no oxygen isotope incorporation into phosphate was observed. The 
experiments were repeated in duplicate with a higher atom % of (up
to a maximum of 45%) and extended incubation periods (up to 24 hours). Those 
containing inositol showed the expected parent ion at 140, and an additional 
signal at 142 assigned as (MeO)2 p^®OMe. The inositol incubation showed the 
expected isotope incorporation whereas no incorporation could be detected in 
incubations containing adenosine. Only the parent ion of trimethyl phosphate 
an 140 was observed, with no additional signals present as a result of oxygen 
isotope incorporation. Examination of the lower molecular weight fragments
(e.g. 1 1 0  (M^ “ MeO) shows multiple incorporations in the case of inositol with 
the adenosine case being identical to the control (Figures 2.3.1-2.3.4, pages 51 
& 52). This result suggests that there is either a mechanistic difference in the 
enzymic hydrolys is of inos itol monophosphates and adenos ine 2 '- 
monophosphate (i.e. adenosine is not the true product of enzymic hydrolysis), 
or that adenosine is such a weak substrate that exchange between inorganic 
phosphate and the solvent is too slow to be observed. Slow exchange could 
result from the alcohol (adenosine) not being recognised by the enzyme in the 
absence of the phosphate group.
In separate studies, adenosine was tested as an inhibitor for inositol 
monophosphatase. The nucleoside showed no inhibitory properties at almost 
saturating concentrations (up to 30 mM) with regard to the hydrolysis of (+/-) 
inositol 1-phosphate or adenosine 2’-monophosphate. (Inhibition studies were 
performed at a substrate concentration of 0.1 mM for inositol 1-phosphate and a 
substrate concentration of 5 mM for adenosine 2’-monophosphate.)
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Figure 2.3.1. Expanded mass spectrum of derivatised inorganic phosphate 
isolated from  enzymic incubations containing inositol and fl^OJ-ioater;
Also see Figure 2.3.3.
Figure 2.3.2. Expanded mass spectrum of derivatised inorganic phosphate 
isolated from  enzymic incubations containing adenosine and fl^O]-zvater;
Also see Figure 2.3.4.
51
freCTrw o r c»# sa is rio o  •  # n 3S*w^i UC.C.SS^ CCONOSw M - 20 *3 0 0  TEM#* 142 DEC. C
Lllll I.. 3€ "r .  ,fi
M*I i
Figure 2.3.3. Expanded mass spectrum of derivatised inorganic phosphate 
isolated from  control incubations containing inositol and [^^0]-zoater.
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Figure 2.3.4. Expanded mass spectrum of derivatised inorganic phosphate 
isolated from  control incubations containing adenosine and [  0]-water.
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In addition to the isotope exchange experiments, adenosine 2’,3’-cyclic 
monophosphate (c40, Figure 2.3.5) was tested as a possibie substrate. 
Although the formation of nucieoside cyclic phosphates is a phenomenon 
normally associated with nucleotidases (Scheme 1.5.2, type c), the possibie 
involvement of the 3'-0H was considered. If the hydrolysis did occur through 
such a cyclic intermediate, the enzyme should be capable of processing 2',3'-
cAMP (c40). Incubation (in a 50 mM Tris HCI, 150 mM KOI, 2 mM MgClg buffer 
system) at 37 °C with concentrations of cAMP up to 100 mM showed no 
formation of inorganic phosphate, even with extended incubation periods.
NH,
HO
(C40)
Figure  2 .3 .5 .  Adenosine 2',3'-cyclic monophosphate.
2.4 Synthesis of adenosine 2’-phosphorothloate.
As in the case of the inositol phosphate synthesis, specific protection of 
the parent alcohol is required to ensure the production of the desired isomer of 
the thiophosphate. Treatment of adenosine (98) with excess benzoyl chloride in 
pyridine followed by base hydrolysis (aqueous sodium hydroxide in pyridine) of 
the undesired benzoyl esters afforded N^-benzoyl adenosine (99). The desired 
product (9 9) was separated from the unwanted benzoic acid by acidic 
prec ipitation and was recrystaliised from aqueous methanol. 3 ',5 '- f-  
Butyldimethylsilyl bis-etherification^167 wag carried out in low yield to give 
the fully protected alcohol for phosphltylation (100). Due to the lack of 
selectivity of secondary alcohol siiyiation, an isomeric resolution step is 
required to remove the unrequired 2’5’-biS“Oprotected adenosine derivative. 
Initial attempts to obtain a protected alcohol suitable for phosphltylation with
trimethylsilyl chloride proved unsuccessful. Treatment of N^-benzoyl adenosine 
(99) with 2 .2  equivalents of trimethylsilyl chloride gave an isomeric mixture of
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the 3’,5’- and 2’,5’-bis-Oprotected adenosine derivatives (as observed by TLC). 
After separation of the components of the mixture by siiica chromatography, the 
desired product was found to be unstabie, readiiy isomerising in soiution (most 
rapidiy in methanoi and DMSO). The f-butyidimethyisiiyi ethers proved to be 
stabie, and showed only slow isomérisation in poiar soivents such as methanoi. 
(TLC 2’,3’ ,5’-triS"OTBDMS N^-benzoyl adenosine, = 0.93, 2’,5’ b is-O 
TBDMS N®-benzoyi adenosine, Rf = 0.67, 3’,5’ bis-OTBDMS N®-benzoyi 
adenosine, Rf = 0.58 (50% ethyi acetate/ petroieum ether)). The aicohoi (3’,5’ 
bis-0-TBDMS-N®-benzoyi adenosine (100)) was phosphitylated with N,N'- 
diisopropyl-(2 -cyanoethyl)chlorophosphoramidite in its racemic form (Scheme
2.4.1), which resulted in the formation of a pair of diastereomers which were 
separated by siiica gei chromatography (0-30% ethyi acetate/ petroleum ether) 
on triethyiamine basified siiica. (High Rf diastereomer, 4.86 (1H, dt, 2'H), Low 
R| diastereomer 6^ 4.70 (1H, dt, 2'H)).
NHBzNH;
HO
HO OH
HO
HO OH
(9 8) (99)
TBDMSO
TBDMSO OH 
(100)
R = N® Benzoyl adenine
TBDMSO-
Mi)
TBDMSO-
TBDMSO O.
....
TBDMSO O,
V ..... .. V
> - f  h  > - (  hA  CN A  CN
(101a) (101b)
Reagents: I) a) Benzoyl chloride, pyridine, b) NaOH, pyridine, 71%;
ii) a) TBDMSCI, imidazole, DMF, b) separate isomers, 39%,
Hi) a) N'N-dilsopropyl(2-oyanoethyl)chlorophosphoramldite, 
DMAP,/-Pr2 NEt, THF, b) separate diastereomers, 76%.
Scheme 2.4.1. Synthesis of N 'N-diisopropyl cyanoethyl adenosine
diastereomers.
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Initially transestérification was performed on the racemic phosphoramidite using 
cyanoethyl alcohol and 1-H tetrazole in dry acetonitrile. Analysis of the
phosphite intermediate by H-NMR spectroscopy showed that the reaction had 
proceeded to at least 70% with respect to the desired product (based on the 
integration of the 1 ’-H doublets In the crude reaction mixture). Re-dissoiution of 
the residue in pyridine and treatment with an excess of elemental sulfur (re­
sublimed) gave the fully protected phosphoramidite, proceeding quantitatively 
as Judged by '^H-NMR spectroscopy, isolation of the desired product by siiica 
column chromatography on triethyiamine basified silica gave the desired 
compound in disappointing yieid (48%). Decomposition of the bis-cyanoethyl 
phosphoramidite was considered as a possibie cause of the low yieid (given 
that the desired product accounted for approximately 70% of the total
nucieoside content in the reaction mixture as determined by ‘^ H-NMR 
spectroscopy). The transestérification and oxidation were repeated using each 
of the separated diastereomers and shown to give the same compound (as
shown by TLC ^H- and '•^G-NMR spectroscopy), again in disappointing yieid. 
Purification of the reaction mixture at the phosphite stage did not result in an 
improved overall yieid for the reaction. Production of the protected 
phosphorothioate without isolation of the phosphoramidite diastereomers gave
(102) in 39% yield from (100). Deprotection of compound (102) was 
undertaken, initially with alcoholic ammonia/ concentrated ammonia using a 
modification of the method of Usman et a/."*®® to remove the cyanoethyl groups
and cleave the N®-amide. The reaction was conducted at 60 °C in a pressurised 
vessel to prevent evaporation of the d issolved ammonia gas. 
Decyanoethylation appeared to be rapid, whereas debenzoyiation was slow, 
isolation of the siiyi protected nucieoside phosphorothioate was achieved by 
simple evaporation of the solvent followed by treatment of the residue with 
diethyl ether. The desired product formed a white precipitate which was 
desilyiated without further purification. Tetra-n-butyi ammonium fluoride was 
employed as the desiiyiating agent, and on completion, the solvent was 
removed in vacuo and the product dissolved in water and applied to an ion
exchange column of Amberilte IRA 118 (H)+ (pretreated with cyclohexylamine 
and washed to neutral pH with water), initial attempts to isolate the product as
the free acid (by ion exchange on Amberilte IRA 118 (H)'*’) proved unsuccessful,
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possibly due to the insolubility of adenosine phosphorothioate in the form of the 
free acid in a neutral aqueous medium. (Adenosine 2’-monophosphate free 
acid has an extremely low solubility product in water.) Isolation of the compound 
as the bis-cyclohexylammonium salt gave adenosine 2 ' monophosphorothioate
(103) in 53% yield from (102) (Scheme 2.4.2).
In order to make the substrate analogue chiral at the phosphorus centre, 
the possible manipulation of the separated phosphoramidite diastereomers 
(101a & 101b) was investigated. If the transestérification step was 
stereospecific, transestérification of a single diastereomer using '’^O-labelied 
cyanoethyl alcohol would allow the introduction of a single chirality at the 
phosphorus centre. The production of cyanoethyl aicohoi was therefore 
required in a manner that would allow isotopic incorporation in good yieid.
TBDMSO AdBz
TBDMSO O
CN
(1 01#
J il
TBDMSO AdBz
TBDMSO O^ ^
CN
CN
(1 0 ?
(1 0 ?
Reagents: Î) a) 3-hydroxyproplonitrile, 1-H tetrazole, CHgCN, b) Sg,
pyridine,39%, II) a) NH4OH/ EtOH (3:1 ), b) TBAF, THF, 
c) Amberlite 118 (cyciohexyiammonium)+, 53%.
Scheme 2 .4 .2 .  Synthesis of adenosine 2 '-monophosphorothioate.
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Hence, M ichael c o n d e n s a t io n ,'*o f acrylonitrile with [i^O]-water was 
investigated as a method of producing [^0o]-3-hydroxy propionitriie. Reaction 
of acrylonitriie with water in the presence of triethyiamine gave none of the 
desired material. In addition, extensive acryionitrile polymerisation was 
observed when the reaction was conducted in the iight. The eventual use of a 
catalytic quantity (< 5%) of sodium metal with a 1:1 ratio of acrylonitrile to water 
in acetonitrile in the dark gave the desired product in 81% yieid after distillation. 
The use of an excess acrylonitrile resulted in the formation of unwanted bis- 
cyanoethyl ether (as determined by the change in boiling point and the 
reduction in intensity of the acidic proton in the  ^H-NMR spectrum).
To determine the stereoselectivity of transestérification, a single 
phosphoramidite diastereomer (1 0 1 a o r 1 0 1 b) was reacted with benzyi 
aicohoi in the presence of 1-H tetrazoie. This resuited in the formation of a pair 
of phosphite diastereomers (105a &105b) identical to those obtained from 
reaction of a mixture of the phosphoramidite diastereomers (1 0 1 a & b) with 
benzyl alcohol in the presence of 1-H tetrazoie. Synthesis of the nucleoside 
thiophosphate in a chirai form would therefore require transestérification of the 
unpurified phosphoramidite diastereomers with, for example ['*®0 ]-benzyl 
alcohol,®® followed by diastereomeric resolution (Scheme 2.4.3). Simple 
oxidation of the separate phosphite diastereomers, foiiowed by deprotection 
would give access to Rp- and Sp-adenosine 2 ’-phosphorothioate.
4  .a
'  - r " H ON ^OBn
R.— OH  R'— o— °— %
C*04) jjj BnOH, 1-Htetrazole I
(105a) L -C N  (105b)
Scheme 2.4.3 Alcohol phosphitylation and phosphoramidite
transestérification.
For the purpose of stereochemical analysis of chiral thiophosphate, (S)- 
2-iodophenylethanol (28) was synthesised from (S)-mandelic acid (31) by the
method of Betheii and Lowe (Scheme 2.4.4).'*®® Lithium aiuminium hydride
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reduction of mandelic acid (31) foiiowed by regioseiective pyridine catalysed 
tosylation of the primary alcohol yields 1 -(S)-phenylethanol 2-tosylate (107) in 
71% from (31). 8^2 tosyl displacement by iodide (in the form of tetra-n-butyl 
ammonium iodide) gives (S)-2 -iodophenylethanol (28), to which the inorganic 
thiophosphate hydrolysis product can be coupled (See section 1 .6 ).1^3 in 
add ition, inorganic thiophosphate was synthesised by the method of
Akerfeldt’’^® (8 p 32.3 ppm) to couple to compound (28). 8^2 Displacement of 
iodide by the sulfur atom of inorganic thiophosphate (See page 2 2 ) allows the 
production of TLC and NMR standards for the alkylated thiophosphate.
OH
COOH
(31 )
i l l
OH
Hi) OH
(2 8 )
Reagents: I) UAIH4, THF, 83%, II) TsOi, pyridine, 86%; 
lll)tetra-n-butyi ammonium iodide, PhH, 76%.
Scheme 2.4.4 Synthesis of (S)-iodophenylethanol.
2.5 Adenosine 2’~phosphorothloate as a substrate for inositol 
monophosphatase.
Incubation of the adenosine 2'-phosphoroth ioate w ith inos itol 
monophosphatase under optimum hydrolysis conditions in the presence of
Mg2+ did not lead to a reaction as judged by  ^H-NMR spectroscopy in 
comparison to controls containing no enzyme. Extended incubation times led to 
minimal hydrolysis {ca. 10%) as determined by the appearance of a signal at 8^ 
5.95 ppm assigned as T-H of adenosine.
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Knowles et al. have reported the use of alternative metal ions In the 
enzymic processing of phosphorothioate substrates by magnesium dependent
phosphatase e n z y m e s T h u s  utility of the thiophilic metal ion 0 0 %+ in the 
hydrolysis of adenosine 2 '-phosphorothioate by Inositol monophosphatase 
resulted in an increase in the rate of reaction in comparison to similar 
incubations containing magnesium. The initial rate of hydrolysis of adenosine
2'-phosphorothioate in the presence of Co2+ was approximately 50 fold slower 
than the hydrolysis of 2’-AMP in the presence of Mg^t In addition to increased 
rates of hydrolysis, the formation of a black precipitate was also observed. 
Separate experiments involving the solvation of differing amounts of inorganic 
thiophosphate (in the form of its tri-iithium salt) in the cobalt containing buffer 
gave an identical black precipitate. This suggests that a cobalt-thiophosphate 
complex forms between the hydrolysis product (inorganic thiophosphate) and 
the cobalt cofactor. In accord with this, it was noted that as the precipitate 
became more dense, the rate of hydrolysis slowed dramatically, even in the 
presence of excess substrate.
Additional metal ion systems used with adenosine 2’-phosphorothioate 
and inositol monophosphatase included Zn^+, a Zn^+ and Mg^+ cocktail (1 :1) 
and Mn^ -f-. The Zn^+ and the Zn^+Z Mg^+assays showed minimal hydrolysis of 
the substrate analogue. Monitoring the incubation containing Mn^+ by NMR 
spectroscopy was difficult due to manganese possessing a nuclear quadrupoiar 
moment. This resulted in extensive broadening of all the signals in the ^H-NMR 
spectrum, and meant that identification of the T-H doublets of the substrate 
analogue and the hydrolysis product (adenosine) could not be achieved. The 
formation of a pale cream precipitate was however evident in the adenosine 2  - 
phosphorothioateZ Mn^+ enzymic reaction mixture. The dissolution of inorganic 
thiophosphate in the manganese containing buffer gave an identical pale 
cream precipitate, again indicating that precipitation results from the formation 
of a metal ion-thiophosphate complex. Subsequent examination of the ‘‘H-NMR 
spectrum revealed that all of the starting material had been processed to 
adenosine, with no line broadening present. The ^H-NMR spectrum of the 
control reaction, which contained no enzyme could not be accurately
interpreted due to the Mn^+-dependent line broadening. However, analysis of
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the control reaction by TLC showed the absence of hydrolysis product. Although 
complete hydrolysis had been achieved, it was evident that levels of Inorganic 
thiophosphate had been depleted through complexation with the metal ion co­
factor. The deduction of the stereochemical course of the phosphate ester 
hydrolysis would require the isolation of the inorganic thiophosphate hydrolysis 
product, and as a result of these studies, the synthesis of the chiral 
phosphorothioate substrate analogue was not investigated further.
Other adenosine phosphates that were tested with the enzyme were 
adenos ine 5 ’-monophosphoro th ioate^^^ (produced in a crude form 
contaminated by adenosine), 5 ’-AMP and 2’,3’-cyciic AMP, none of which 
showed any change in comparison with controls containing no enzyme,
2.6 Hydrogen bonded water molecule in the hydrolys is of inos itol
1-phosphate.
Exam ination of the results from the Merck Sharpe and Dohme 
laboratories''"*^"’*'*  ^which highlight the roles of the a-hydroxyl groups of inositol 
1-phosphate (33) (see section 1.9) shows an analogy between adenosine 2'- 
monophosphate and inositol 1 -phosphate. There is good overlap between C-2  
OH and C-4 OH of D-inositol 1-phosphate with C-3’ OH and C-5’ OH of 2 '-AMP 
respectively as determined by molecular modelling. This suggests that these 
groups on nucleoside 2 ’-phosphates are involved in binding to the enzyme 
(Figure 2.6.1). The absence of a catalytic hydroxyl group on 2’AMP (40) and 
also the apparent inability of the enzyme to catalyse phosphate-oxygen ligand 
exchange in the presence of adenosine (see section 2.3) appears to suggest a 
difference in the mechanism of hydrolysis of the two substrates by inositol 
monophosphatase. The presence of C-6  OH in D-lns 1-P is known to be an 
absolute requirement for catalysis.^*® Comparison of (33) and (40) (Figure
2 .6 .1) with regard to the three dimensional arrangement of the functional groups 
presents two possibilities. Either the ribose ether oxygen is acting as a 
surrogate for the catalytic hydroxyl group of inositol 1-phosphate, and has a 
similar ‘mechanistic’ role, or the nucleoside base (adenine) is in some way 
involved in the hydrolysis reaction.
6 0
HO
O'
O '
HO
(4Q
Figure 2,6.1. Proposed binding groups of D~inositol 1-phosphate 
and adenosine 2 '-monophosphate.
Due to the fact that C-6 OH is required for catalytic activity in the 
hydrolysis of D-lns 1-P, it seems reasonable that its function is to hydrogen bond 
a water molecule, which is actually the attacking species in phosphate ester 
hydrolysis. This would result in the formation of a seven membered ring, with 
nucleophiiic attack by water being essentially intramolecular. Also, molecular 
modelling has shown that the adenine N^-nitrogen of 2'-AMP (40) occupies the 
same three dimensional space as the proposed attacking water molecule, 
resulting in a similar seven membered ring being formed (Figure 2 .6 .2 ).
OH
o-HQ, p  p;
O-
HO'
OH
HO'
%
(39 (4Q Nhb
Figure 2.6.2. Possible mechanism of hydrolysis of inositol 1-phosphate and
adenosine 2 '-monophosphate.
To probe the mechanism of the enzyme further, a number of analogues of 
inositol and glycerol phosphates have been synthesised. In addition, to 
determine whether a C-6  OH hydrogen bonded water molecule is present and 
involved in the hydrolysis, analogues of glycerol 2 -phosphate (108) replacing 
the catalytic hydroxyl group by a hydroxyethylene group (Figure 2.6.3) were
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synthesised (109) (See section 2.8). If there is a hydrogen bonded water 
molecule involved as hypothesised, enzyme catalysed phosphoryl transfer
between 2-OH and 5-OH should be detectable in compound (109) by ‘‘ H-NMR 
spectroscopy.
OH
o
o
. I L - O'
OH
OH
O'
(108) (109)
Figure  2 .6 .3 .  Phosphoryl transfer through replacement of one of the possible 
catalytic hydroxyl group of glycerol 2-phosphate.
2.7 Synthesis and incubation of ethane 1,2-diol monophosphate.
The simplest example of a monophosphate that should be hydrolysed by 
the enzyme is that of ethane 1,2-diol monophosphate (113). The presence of a 
single a-hydroxyl group should allow hydrolysis to occur, however, the absence 
of further hydroxyl groups to fulfil the structural binding requirements means the 
substrate should be weak. The important feature is that ethane 1 ,2-diol 
monophosphate (113) will be processed by the enzyme, which will show that 
the presence of essentially no binding hydroxyl groups (comparable to 2-OH 
and 4-0H of D-inositol 1-phosphate) will not cause complete inactivation.
(110)
i) ^  T B D IV iS (\^ ^ X \
(111) OH
T B D M S Q ^ ^ ^
T ° ^ c n
(112)
O'—
(113)
Reagents: I) TBDMSCI, imidazole, DMF; ii) a) N’N-diisopropyi biscyanoethyl
phosphoramidite, 1-H tetrazoie, CH3CN; b) m-CPBA, CHgClg, 54%; 
III) a) NaOMe, MeOH; b)TBAF, THF, c) cyclohexylamine, H2O60%
Scheme 2.7.1. Synthesis of ethane 1,2-diol monophosphate.
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Initial protection as the mono f-butyldimethyl silyl ether (111) conducted 
w ith a five fold excess of ethylene glycol (1 1 0 ) to ensure that the 
monoprotected glycol was the sole product was followed by immediate 
phosphitylation using N’N-diisopropyl bis-cyanoethyl phosphoramidite (116) 
(Scheme 2.7.2) The resulting phosphite was oxidised to the phosphate with m- 
CPBA (Scheme 2.7.1). The bis-cyanoethyl phosphate (112) was purified by 
silica column chromatography, and deprotected firstly with sodium methoxide 
and secondly w ith tetra-n-butyl ammonium fluoride. Ion exchange 
chromatography (Amberlite 118 (H)+) allowed isolation of the compound as the 
free acid, and the removal of the tetra-n-butyl ammonium counter-ion. 
Conversion to the biscyclohexylammonium salt and recrystallisation from water 
and acetone yielded the desired compound in 33%yield from ethylene glycol as 
the di-hydrate. Incubation of the glycerol 2-phosphate analogue (113), 
showed, as expected slow substrate activity as determined by both NMR 
spectroscopy and by the colormetric assay.^
Cl- /\
01
I) -JB- N"
01
/\
01
(114)
ii)
01
(115)
(116)
Reagents: I) /-PrgNH, EtgO, 68%; II) HO(OH2)2CN, EtgN, OH2OI2 , 87%.
Scheme 2.7.2. Synthesis of N,N'-diisopropyl biscyanoethyl phosphoramidite
phosphitylating agent.
The substrate analogue (113) was processed by the enzyme at a rate 
(Vfnax) of between 10-12% that of (+/-) inositol 1-phosphate (33), and a K^ p 
value of approximately 0.7 mM (Figure 2.7.4) (compared with around 0.1 mM for 
(+/-) Ins 1-P, Figure 2.7.3). When following the reaction course by f H-NMR
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spectroscopy, the initial rate can be thought of as comparable to since the 
substrate is present at a concentration of 50 mM (several tens of times K^ )^. The 
rate of hydrolysis becomes increasingly slower with time due to product 
inhibition caused by inorganic phosphate (Kj = 0.5 mM), which is present in an 
equimolar amount with respect to substrate after hydrolysis has proceeded to 
50%. As expected ethane 1,2-diol monophosphate (113) was also a weak 
competitive inhibitor for the enzyme (Kj = 1.0 mM) (Figure 2.7.5).
2.0
1.4
1Î 0.8
^  0.6 
^  0.4
0.2
0.0
- 1 2 1 0  8 - 6 - 4 - 2 0  2 4 6  8 1 0 1 2 1 4 1 6 1 8 2 0 2 2 2 4 2 6 2 8 3 0
1/[S] m M -1
Figure 2.7.3 Lineweaver-Burk double reciprocal plot fo r (+ /-) inositol 1-
phosphate,
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Figure 2.7.4 Lineweaver-Burk double reciprocal plot fo r ethane 1,2-diol
monophosphate.
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H 1/v (0.5 Ins P)
•  1/v (1.0 InsP)
□l 4.0
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Figure 2.7.5 Dixon plot for (+/-) inositol 1-phosphate inhibited by ethane 1,2-
diol monophosphate.
2.8 Synthesis and incubation of pentane 1,2,5-trioi 2-phosphate
To determine whether a C-6  OH hydrogen bonded water molecule was 
present and involved in the hydrolysis of D-inositol 1-phosphate (Section 2 .6 ), 
analogues of glycerol 2 -phosphate ((SR)-, (S)- and (R)-pentane 1 ,2,5-triol 2 - 
phosphate) were synthesised. The replacement of 0-1 OH of glycerol 2 - 
phosphate by a hydroxyethylene group should result in the substrate analogue 
occupying the same three-dimensional space as glycerol 2 -phosphate 
possessing a water molecule hydrogen bonded to the 0-1 OH. (See figure 
2.6.3, page 62). If there is a hydrogen bonded water molecule involved as 
hypothesised, enzyme catalysed phosphoryl transfer between 2-OH and 5-OH 
should be detectable in compound (109) by ^H-, ^^0- and ^"*P-NMR 
spectroscopy. Phosphate transfer would be evident from the upfield shift and 
loss of P,H coupling of the 0-2H and 0-2 signals in the ‘•H- and '•^0-NMR 
spectra respectively.
Initial attempts to synthesise the racemic material started from allyl acetic 
(1 2 2 ) acid. Reduction with lithium aluminium hydride yielded pent-4-ene-1-ol in 
64% yield after distillation (b.pt. 130 °0). Protection of the alcohol as the benzyl 
ether followed by treatment with metachloroperbenzoic acid gave 1 -0 - 
benzylpentane-4,5-epoxide (m/z(Found; [M+ H]+193.1229. requires
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193.1228)). Opening of the epoxide at C-5 with benzyl alcohol and sodium 
hydride (benzoxide) would have given the required protected pentane trio I for 
phosphorylation. Extended reaction times and the application of heat to the 
reaction mixture gave none of the desired product, so the use of alternative
starting materials was investigated. a-Keto glutaric acid (117) was identified as 
a suitable starting material with respect to the arrangement of the oxygen 
functionality. Complete reduction with lithium aluminium hydride gave the 
parent alcohol, pentane 1,2,5-triol (118) in moderate yield (45%). Soxhlet 
extraction of the inorganic precipitate with acetone did not give a substantial 
increase in the overall yield of the reaction. Protection of the two secondary 
alcohols with TBDMSCI and imidazole afforded the fully protected alcohol 
(119) (Scheme 2.8.1). Phosphitylation as in the synthesis of ethane 1,2-diol 
monophosphate (113) with N,N’-diisopropyl bis-cyanoethyl phosphoramidite
(116) followed by oxidation gave the crude fully protected phosphate (120), (ô|_j 
1.65, (4H, t, 3 -H2 and 4 -H2) 2.75 (4H, t, cyanoethyl CH2CN), 3.65 (4H, m, I-H2 
and 5 -H2), 4.30 (5H, m, POCH2 and 2-H)). Attempted purification of the bis­
cyanoethyl phosphate by silica column chromatography on triethylamlne 
basified silica gave a very poor recovery of material (< 5%). Deprotection of the 
crude bis-cyanoethyl phosphate (120) with sodium methoxide in methanol 
followed by tetra-n-butyl ammonium fluoride desilylation resulted in the 
production of the crude phosphate (121). Ion exchange chromatography on
Amberlite IRA 118 (Na)"  ^ gave the product as the bis- sodium salt (121) 
(Scheme 2,8.1), which proved difficult to crystallise from aqueous acetone. 
Although a crystalline material was obtained, it was evident that inorganic 
phosphate arising from the phosphitylation step was present as an impurity 
(determined by the addition of acidic malachite green solution which detects the 
total phosphate present in a system).
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y - Yo o(117)
îi)
TBDMSO
(120)
(118)
TBDMSO^ ^OTBDMS
(119)
iii)
CN
CN Iv) 
OTBDMS HO,
OH^O+Na 
O'" ""Q - +Na
(121)
Reagents: i) LIAIH4, THF, ii) TBDMSCI, Imidazole, DMF, iii) a) ^ Pr2NP(OCH2CH20N)2
tetrazole, OH3CN, b) m-CPBA, CH2CI2 Iv) a) MeONa/ MeOH, b) TBAF,
THF, c) Amberlite 118 (Na)+
Scheme 2.8.1. Synthesis of (+/-) pentane 1,2,5-triol 2-phosphate,
Enzymic assay of the crude material with inositol monophosphatase, 
following the reaction course by NMR spectroscopy showed no detectable 
transfer of the phosphate functionality to the terminal hydroxyl group or any 
appreciable hydrolysis. Due to the contamination by phosphate, and the 
apparent instability the bis-cyanoethyl phosphate (1 2 0 ) on silica, an alternative 
phosphitylating agent was used, namely N,N’-d ilsopropyl b is-benzyl 
phosphoramidite (116a) (which was prepared from diisopropyl dlchloro- 
phosphoramidite (115) and benzyl alcohol). The resulting 1,5-bis-0-TBDMS-2-
O-dibenzyl phosphate was stable to silica gel chromatography, and the product 
was isolated in good yield (78%). Deprotection firstly under an atmosphere of 
hydrogen gas in the presence of 10% palladium on activated charcoal catalyst, 
in methanol afforded complete débenzylation. Desilylation was again achieved 
with TBAF in THF, and the product isolated as the free acid (by ion exchange 
chromatography). Conversion to the bis-cyclohexylammonium salt followed by 
recrystallisation from water and acetone yielded the desired compound as the
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dihydrate in the form of white needles (m.pt. 165-167 °C)
Assaying of this phosphate against the enzyme showed no detectable 
substrate properties as judged by colormetric a s s a y and ‘'H-NMR 
spectroscopy. In addition, transestérification was not detected. For TLC and 
NMR comparison, racemic pentane 1,2,5-triol 5-phosphate (125) was 
synthesised in three steps from allyl acetic acid (122). Reduction to pent-4-ene-
l-o l (123) as described previously was followed by phosphitylation using N,N'- 
diisopropyibiscyanoethyl phosphoramidite (116). Oxidation of the phosphite to 
the phosphate was accompanied by epoxidation of the olefin (Scheme 2 .8 .2 ). 
The phosphate epoxide was purified by column chromatography on neutral 
alumina, and deprotected under basic conditions. Due to the fact that epoxides 
are relatively stable to nucleophiiic attack under basic conditions, the removal of 
the cyanoethyl groups was achieved with sodium hydroxide in aqueous 
acetone, leaving the epoxide intact. On complete decyanoethylation, the solvent 
was removed in vacuo to prevent the formation of cyanoethyl alcohol through 
Michael attack by hydroxide on acrylonitrile. Epoxide opening was achieved 
using excess sodium hydroxide to give pentane 1,2,5-triol 5-phosphate (125).
o(122) (123)
(124)
iii) OH O
- + Na
(125)
Reagents: I) LIAIH4, THF, 86%, ii) a) ^ Pr2NP(OCH2CH2CN)2 tetrazole, CH3CN,
b) m-CPBA, CH2CI2, 63%; Iii) a) H2O/ NaOH/ acetone, b) Amberlite 118 
(Na)+, 68%.
Scheme 2.8.2 Synthesis of pentane 1,2,5-triol 5-phosphate.
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Initial purification firstly by ion exchange chromatography followed by 
conversion to the bis-cyclohexylammonium salt gave the product as a gum 
which resisted crystallisation. NMR spectroscopic and TLC analysis showed no 
terminal 5-phosphate was formed in the pentane 1,2,5-triol 2-phosphate 
enzyme incubation mixture. To determine whether the proposed 
transphosphorylation between the 2-OH and 5-OH was an equilibrium 
balanced In favour of the initial starting material (121), pentane 1,2,5-triol 5- 
phosphate was incubated with the enzyme and the course of the reaction 
followed. No changes were detected.
The inhibitory properties of racemic pentane 1,2,5-triol 2-phosphate 
(1 2 1  ) were assessed by a radiochemical assay using a known concentration of 
unlabelled inositol 1-phosphate and a small amount of [U^^G]-L-inositol 1- 
phosphate (with respect to concentration) (see experimental section) of known 
activity. The racemic material was shown to be a weak inhibitor of the enzyme in 
comparison to controls containing no inhibitor. To study the inhibitory properties 
in more detail, the syntheses of the (R)- and (S)-enantiomers were undertaken. 
Two methods of synthesis of the enantiomerically pure pentane 1,2,5 trio! 2 - 
phosphates were considered. Firstly, the formation of the camphanate ester of 
1,5-bis-O-TBDMS pentane 1,2,5-triol (119) with camphanoyl chloride, followed 
by chromatographic diastereomeric resolution and chiral ester hydrolysis would 
allow the production of the chiral phosphate precursors (119a & b). Simple 
phosphorylation of the enantiomeric components, followed by deprotection, as 
in the case of the racemic material, would give the required compounds. 
Alternatively, (8 )- and (R)-glutamic acid (126) could be used as chiral starting 
materials to provide the stereocontrol. Diazotisation of (8 )- or (R)-giutamic acid 
using sodium nitrite in aqueous acid, would results in a two step double
Invertlve process giving the lactone (129) resulting from attack by the y-
acid."*^®»^ ^® (Scheme 2.8.3). Complete reduction of the lactone (129) affords 
the parent alcohol, pentane 1,2,5-triol in a chiral form.
Hence, lactonisation by a modification of the method of Ravid et al., 
followed by complete reduction with lithium aluminium hydride yields (R)- and 
(8 )- pentane 1,2,5-triol, from which the desired phosphates were synthesised in 
an identical manner to that described for the racemic material
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OHHO
(126a)
NaNOg
 .......   HO
HCI (aq)
(128a)
o
(127a)
o
H
"^COOH
(129a)
Scheme 2.83 Mechanism of lactonisation of glutamic acid.
Incubation of the individual enantiomers of pentane 1,2,5-triol 2- 
phosphate with inositol monophosphatase revealed that as with the racemic 
material, neither compound underwent transphosphorylation from C-2 to 0-5. In 
addition, neither (S)- or (R)-pentane 1,2,5 triol 2-phosphate exhibited any 
significant substrate activity. Extremely slow enzymic hydrolysis of the pentane 
triol phosphates was observed in comparison to control reactions containing no 
enzyme, however, the rates of reaction were slow enough for the compounds to 
be classed as non-substrates. Examination of the inhibitory properties of the 
individual enantiomers revealed that the (2S)-enantiomer (1 2 1 a ) was a good 
competitive inhibitor (Kj = 0.12 mM, Figure 2.8.4), whereas the (2R)-enantiomer 
(121b) was a weak competitive inhibitor (Kj = 3.8 mM, Figure 2.8.5). These 
results are in total agreement with the inhibition data for the deoxyinositol 
phosphate a n a l o g u e s ’* ^^-117 (section 1.9) and show that although the potency 
of the inhibitors is reduced, non cyclic phosphate monoesters with the correct 
stereochemical arrangement of hydroxyl groups can bind effectively to the 
enzyme.
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Figure 2.8A  Dixon plot fo r (+/-) inositol 1-phosphate inhibited by (S)-pentane
1,2,5-triol 2-phosphate.
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Figure 2.8.5. D ixon plot fo r (+/-) inositol 1-phosphate inhibited by (R)- 
pentane 1,2,5-triol 2-phosphate.
2.9 Alternative transphosphorylation substrates
Pyridoxol S’-phosphate (130, figure 2.9.1) was assessed as a possible 
1,7-transphosphorylation substrate for inositol monophosphatase. Reduction of 
pyridoxal 5’-phosphate with sodium borohydride in water yielded pyridoxol 5’-
phosphate (130) (5h (^HgO) 4.80 (2H, s, 4  H2), 5p (^HgO) 3.98), with
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contamination arising from boric acid (approximately 20%, as judged by  ^H- 
NMR spectroscopy using a known quantity of N’N-dimethyl formamide as an 
integration standard).
HO.
HO. OHP-— o
HO
CH.
(130)
Figure 2.9,1 Pyridoxol phosphate.
On incubation of pyridoxol 5 ’-phosphate (130) w ith inositol 
monophosphatase, transphosphorylation was not detected. Analysis of the 
mixture as an inhibitor of the enzyme (by the radiochemical assay) in parallel 
with Incubations containing known concentrations of boric acid revealed that 
pyridoxol phosphate showed no appreciable inhibitory properties and that boric 
acid acted as a weak inhibitor (probably inhibiting in the same manner as 
inorganic phosphate).
2.10 New nucleoside substrates of inositol monophosphatase.
To investigate the possible involvement of the hP-ntrogen of the adenine 
ring in the hydrolysis of adenosine 2’-monophosphate (40), uridine 2'- 
monophosphate (131 , figure 2.10.1) was tested w ith inositol 
monophosphatase.
NH
Figure 2.10.1 Uridine 2 '-monophosphate.
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Nucleophiiic attack at the phosphorus centre by N^- of adenine in the case of 2'- 
AMP (40), is analogous to attack by the urea carbonyl oxygen of uracil in the 
case of uridine 2’-monophosphate (131). Both systems involve the possible 
formation of similar seven membered ring Intermediates (Figure 2.10.2).
< I I
HO
HO
NH
(131)
2^
( 4 0 )
Figure 2.10.2 Comparison of structures of 2 '-AM P and 2 '-U M P.
The proposed phosphorylated uracil ring system (132) was predicted to be 
longer lived than the analogous pyridinium type phosphate species in the case 
of 2’-AMP. As uridine 2’-monophosphate is only commercially available as the 
di-lithium salt, cation exchange chromatography was performed prior to 
incubation as lithium is known to be an inhibitor of the enzyme (see section 1.3) 
when 2’-AMP and inositol 1-phosphate are substrates. Incubations ran in 
parallel contained the following:
1) uridine 2'-monophosphate di-sodium salt with enzyme;
2) uridine 2’-monophosphate di-lithium salt with enzyme;
3) uridine 2’-monophosphate di-sodium salt without enzyme;
4) uridine 2'-monophosphate di-lithium salt without enzyme;
Assignment of the ‘^ H-NMR spectra recorded at regular time intervals, revealed 
that hydrolysis of 2’-UMP by inositol monophosphatase was rapid, as shown by 
the reduction in intensity of the 2'-H multiplet of 2’-UMP at 4.65 ppm, and the 
appearance of an additional signal at 4.20 ppm, assigned as 2’H of uridine 
(Figure 2.10.3). In addition, the phosphate monoester and the parent alcohol 
(uridine) were the only species detected (Figure 2.10.3). Assay 2 was slow, 
showing that 2’-UMP hydrolysis is inhibited by lithium, whereas assays 3 and 4
showed no change by ‘‘ H- or ^'•P-NMR spectroscopy. Intramolecular 
nucleophiiic displacement of phosphate was not observed.
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2 -H (2'-UMP)
PPM
2 -H (2*-UMP)
t s 30 minutes
Ajmiili iwiiiii'iiirT
P B i
S - S  a . 2 7 . S  7 . 2  S . S  B. 2  s ! s  s i  0 ç ! s  4 . 2
PPM
2'-H (2’-UMP) 2'H (uridine)
t = 1 hour 
45 minutes
2’H (uridine)
t s 3 hours 
30 minutes
MAI#
Figure 2.10.3, Uridine 2'-monophosphate as a substrate for inositol
monophosphatase.
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If formed, the uracil phosphate Intermediate (132) may have been 
sufficiently unstable In aqueous solution to undergo Immediate non-enzymic 
hydrolysis to uridine and Inorganic phosphate. The possible mechanism of 
breakdown of the proposed intermediate (132) Wa attack at C-2 (analogously to 
phosphoenol pyruvate hydrolysis) was Investigated, by conducting the 
hydrolysis reaction In an [^®0]-enriched aqueous medium. The assay was 
Incubated at 37 °C for 24 hours to ensure complete hydrolysis, and the products 
analysed by high field and p.NMR spectroscopy and by mass 
spectrometry. If hydrolysis via attack at 0-2 had occurred, an Isotope shift'* 
would be evident in the ‘*^0- NMR spectrum. A single peak was present for 0-2 
of uridine at 150 MHz. ^^P-NMR spectroscopic analysis at 242 MHz did 
however show an upfield Isotope shift of 0.018 ppm (of the expected Intensity
with respect to the atom % of [“*®0]-H20 used In the Incubation). In addition, 
mass spectroscopic analysis of the nucleoside hydrolysis product showed no 
Incorporation of ['•®0]-label, with the enzyme derived sample showing Identical 
mass Ions and fragments to authentic uridine (135).
HO
HO OH 
(132)
HO
HO OH
HO OH
HO OH
(133)
Uridine(135)
(134)
Scheme 2.10.4, Possible mechanism of uridine phosphate breakdown,
75
5,6“Dihydrourldine 2’-monophosphate (136, figure 2.10.6) was also 
tested as a substrate for inositol monophosphatase, in the hope that the 
breakdown of the proposed phosphouracil type intermediate would be more 
informative. Hydrogenation of the uridyl double bond of 2’-LIMP with rhodium on 
alumina as the catalyst, under mildly acidic conditions'*^® gave (136) in good 
yield. Similarly, a sample of uridine was reduced to dihydro uridine (137) to 
serve as an NMR and TLC standard for analysis of the incubation mixture.
NH
HO
HO OPO; 
(136)
Figure 2.10.5 5,6~dihydrouridine 2'-monophosphate
5,6-Dihydrouridine 2'-monophosphate (136) was found to be a substrate 
for the enzyme (as determined by NMR spectroscopy) however at a greatly 
reduced rate in comparison to that of uridine 2’-monophosphate (131). No 
material other than the starting material, the parent alcohol (dihydrouridine) and 
inorganic phosphate was detected.
The kinetic parameters of the nucleoside phosphates are shown in table 
2.10.6 and figures 2.10.7 - 2.10.9.
Table 2.5.6 Kinetic parameters of 2'-UMP and 5,6-(2H)-2'-UMP.
^max K|yi (mM)
Uridine 2’-monophosphate 230% that of2'-AMP 4.0
5,6-(2H)-U ridine 2'-monophosphate 70% that cf2’-AMP 1.4 1
Adenosine 2' -mpnophsophate 2'-AMP 0.5
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In the case of adenosine 2 - and uridine 2’-monophosphate, the 
nucleoside base is essentially planar. All carbon and nitrogen atoms are sp^ 
hybridised. Upon hydrogenation of the C-C double bond of uridine, the 
introduction of two sp® centres makes the base more bulky In its out of plane 
dimension. This may account for the difference in rates of reaction for the two 
substrates.
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Figure 2.10.7 Lineweaver-Burk double reciprocal plot for Adenosine 2'-
monophosphate.
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Figure 2.10.8 Lineweaver-Burk double reciprocal plot for uridine T -
monophosphate.
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Figure 2.10.9 Lineweaver- Burk double reciprocal plot for dihydro uridine T -
monophosphate.
2.11 Role of the nucleoside base in the hydrolysis of nucleoside
2 -monophosphates by Inositol monophosphatase.
Very recent results from the Merck Sharp and Dohme laboratories have 
shown that deletion of the nucleoside base of 2’-AMP in compound (138), 
(figure 2.11.1) does not reduce the rate of hydrolys is by inositol 
m o n o p h o s p h a t a s e . ‘•^9 Furthermore, additional deletion of the ribofuranosyl 
oxygen gave a non-hydrolysable phosphate monoester (139), indicating that 
the ribofuranosyl oxygen may be involved in the mechanism of nucleoside 2'- 
monophosphate hydrolysis by inositol monophosphatase. Also, deletion of the 
5'-hydroxymethylene group (140) gave a weaker substrate, providing further 
evidence that the 5’-0H group of 2’-AMP has a binding function (binding in the 
same position at the active site as the 4-OH group of inositol 1-phosphate). 
Thus, these results indicate that ribofuran 2'-phosphate hydrolysis is facile in 
the absence of the nucleoside base, and that there is a specific requirement for 
the ribofuranosyl oxygen atom. Comparison of the structures of 2’-AMP (40) 
and Ins 1-P (33) reveals that the 1,4-phosphorus-catalytic oxygen relationship 
in Ins 1-P is repeated in 2’-AMP, with the ribofuranosyl oxygen acting as a 
surrogate catalytic hydroxyl group.
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HO—
(40) R = Adenine, X = O
(138)R = H,X = 0
(139)R = H,X = CH2
HO OH
(140)R = H,X = O
(141) R = H,X = CH2
Figure 2.11.1 Adenosine 2 '-monophosphate substrate analogues.
Examination of the structure of adenosine 2’-monophosphate shows that 
the catalytic ribofuranosyl oxygen atom^^® is relatively distant from the 
phosphate moiety of the substrate. Molecular modelling studies in this 
laboratory have revealed that in order to obtain congruence between the 
catalytic and the binding groups of D-lns 1-P (33a) and 2 -AMP (40), 2'-AMP 
must exist in a very unfavourable conformation with a 1,3-interaction between 
the adenine and the 4-hydroxymethylene groups and a 1,2-interaction between 
the 2 -0  and 3 -0 atoms (Figure 2.11.2).
5':
Figure 2.11.2 Proposed active conformation of adenosine 2 '-monophosphate.
By analogy with the Ins 1-P system, which this strained conformation now 
accurately mimics, the adenosine 2 -0 atom and the ribofuranosyl-O atom are 
key binding and catalytic functionalities, and must, therefore, interact with other
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species on the enzyme. Neither of the 0-atoms possess a hydrogen atom so, H- 
bonding cannot stabilise the system. However, the chelation of a second Mg^+ 
ion to produce a five membered metallocycle would substantially stabilise the 
system (Figure 2.11.3), and also provide a possible site on the Mg2+ ion for 
water or hydroxide ion suitably disposed for attacking the phosphorus atom.
Figure 2.11.3 Proposed active conformation of adenosine 2 '-monophosphate 
incorporating stabilisation by Mg^'^ coordination to the 2 '-0  and
ribofuranosyl-O atoms.
2.12 Requirement for two magnesium ions in enzymic hydrolyses 
by inositol monophosphatase.
In 1990, Ganzhorn and Chanal proposed a mechanism for the inhibition 
of inositol monophosphatase by lithium involving acid-base catalysis and 
alignment of two metal ions in the active site of the enzyme (Figure 2.12.1).53 
The requirement for two metal ions per subunit with regard to substrate 
hydrolysis is now considered. The role of the second metal ion can be many 
fold. It can orientate the phosphate and catalytic hydroxyl groups, and also the 
hydrolysis nucleophile itself (water or hydroxide) making the hydrolysis 
effectively intramolecular. Additional binding of an active site amino acid
residue to the second Mg2+ ion is also possible (see page 82).
80
Mg (Li+)
Figure 2.12.1. Ganzhorn and Chanal double metal ion mechanism for the 
inhibition of inositol monophosphatase by magnesium and lithium.
The assessment of adenosine as an Inhib itor for inositol 
monophosphatase at almost saturating concentration (30 mM) showed that the 
nucleoside was not active. Calculations predict that adenosine in the proposed 
enzyme bound conformation is 100-105 kJ/ mol less stable than the 
unconstrained form which would certainly explain why adenosine is not 
recognised by the enzyme. To determine whether this conformation could be 
achieved in free solution with the assistance of Mg^+, 2’-AMP was dissolved in 
2 H2O and its ^H-NMR spectrum recorded. Magnesium chloride in ^HgO was 
introduced and the Mg^+ concentration gradually increased to a maximum of 
250 mM. After each addition the ^H-NMR spectrum was recorded. The binding 
of magnesium in the ‘active’ conformation would have resulted in a significant 
change in coupling constants for the ribose sugar protons. No change in 
frequency or coupling constant was observed in the presence of a vast excess 
of Mg2+, suggesting that 2'-AMP requires additional interaction with the active 
site to achieve the ‘active’ conformation.
The introduction of substantial bulk in the nucleoside base was 
undertaken as a possible way of increasing the energy of the proposed 
conformation through add itional steric interaction between the 4 '- 
hydroxymethylene group and the nucleoside base. 8 -Bromoadenosine 2’- 
monophosphate (142, figure 2.12.2) was considered a suitable target, being 
synthesised from 2'-AMP (40) and bromine.^so 5 .1 5  (1H, m, 2’-H), 6.15 (1H, 
d, Ji* 2 ’ 6 .8  Hz, T-H), 8.10 (1 H, s, adenine-H); 5p 3.26).
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HO OPO32- 
(142 )
Figure 2.12.2 8-Bromoadenosine 2'-monophosphate.
Incubation of 8 -Bromoadenosine 2’-monophosphate with inositol 
monophosphatase, in parallel with similar incubations containing 2’AMP (40), 
showed no noticable changes in rates of hydrolysis. Closer examination of the 
nucleoside substrates by molecular modelling compared the relative energies 
of minimised 2’-AMP (40) and minimised (8-Br)-2’-AMP (142) in the gas phase 
with and without stabilisation from a metal ion via coordination to the 
riblfuranosyl and 2’-0  atoms. Molecular modelling has shown that the 
introduction of a bromine atom on the adenine ring does not increase the 
energy of the already high energy conformation for 2'-AMP. With metal ion 
coordination, (8-Br)-2’-AMP (142) is in fact slightly lower in energy than 2’-AMP 
(40) in the minimised gas phase structures. Also, experimentation has shown 
that the introduction of a bromine atom on the adenine ring does not decrease 
the rate of hydrolysis of 2-AMP.
Figure 2.12.3 shows the proposed model for2'-AMP binding incorporating 
two Mg^ -*- ions. The role of the first (buried) Mg^+ ion is that of coordination to 
the phosphate moiety of the substrate at the active site. The role of the second 
(catalytic) Mg^+ ion in stabilising the conformation of the active form of 2 ’-AMP 
(and other nucleoside 2 ’-monophosphates), through chelation to the 2  - 0  and 
ribofuranosyl 0-atoms is also represented. Other ligands for the second Mg^+ 
are possibly the nucleophiiic water (hydroxide) and Asp-220.
8 2
First (Buried)
Ligand Provided 
by Enzyme
Catalytic
Enzyme
Binding
Figure 2.12.3. stabilised active conformation of 2 '-AM P.
Molecular modelling studies incorporating two Mg^+ metal ions at the 
active site have shown the following in the non solvated minimised structure of 
the enzyme-inositol 1-phosphate complex. The binding group 0-4 OH of inositol 
1-phosphate is within good coordination distance of Glu 513 (3.11 and 2 .9 3  A 
from each oxygen of Glu 513 and 0-4 OH). In addition, the second binding 
group on the inositol ring (0-2 OH of D-lns 1-P) is positioned 2.82 A from Asp 
393. With regard to coordination of the Mg^+ ions to the active site residues, the 
first (buried) metal ion is positioned 2 .0 2  and 3.14 A from two of the phosphate 
oxygens and also appears to coordinate to Asp 390 (2.08 A separation) in 
addition to further residues deeper within the protein. The same aspartate 
residue (Asp 390) is also positioned 2.03 A from the second (catalytic) metal 
ion. Asp 520 appears to interact with the catalytic hydroxyl group (C-6  OH of D- 
Ins 1-P) with a separation of 2.48 A and also to the second (catalytic) metal ion, 
with a separation of 2 .0  A. Water 683 (2.09 A from the second metal ion) 
appears to be the catalytic species causing hydrolysis (Figures 2.12.4 & 2.12.5)
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B370
B520 92
B893
1497
THR \B395
GL’
M  B496
GLU B613
HR B396
LY B494
lRG A191
Figure 2.12.4. Minimised active site residue interactions with inositol 1
phosphate.
8 4
Asp 393
'O
,o
I> Asp 390
;:Mg2^........... -O h^638
..HO O
Asp 520 
Glu 513
Figure 2.12.5 Active site interactions of D-inositol 1-phosphate.
2-OH
5-OH
4-OH
Figure 2.12.6 Active conformation of D-inositol 1-phosphate showing 
stabilisation through coordination of a second Mg^~^ metal ion.
Comparison of figure 2.12.3 with figure 2.12.6 which depicts the 
conformation of D-inositol 1-phosphate and the important catalytic and binding 
interactions with the two Mg2+ ions, shows good overlap between the catalytic 
and binding functionality of the nucleoside and inositol substrates.
Closer examination of the three dimensional structure of inositol 
monophosphatase shows that further stabilisation of the developing negative
charge may arise from the positive dipole of the Thr-195-Thr-205 a-helix (Figure 
2.12.7) and also from the Thr-95-His-100 a-helix (Figure 2.12.8) in modelled 
enzyme-substrate complexes.
85
Figure 2.12.7. Inositol monophosphatase showing possible stabilisation of the 
phosphate group from the Thr 195-Thr 205 a-helix (highlighted in green).
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Figure 2.12.8. Inositol monophosphatase showing possible stabilisation of the 
alkoxide leaving group from the Thr 95-His 100 a-helix (highlighted in green).
8 7
The Thr-195-Thr-205 a-helix (highlighted in green in figure 2.12.7, viewing 
down the helix to reveal the substrate) points directly at the sulfate anion In the 
published crystal structure."*In modelled enzyme-substrate complexes, the 
helix points directly towards the phosphate group of Ins 1-P, leading to 
additional stabilisation of the phosphate monoester dianion. Also the Thr-95-
His-100 a-helix (highlighted in green in figure 2.12.8, viewing down the helix to 
reveal the substrate), points directly towards the leaving 1 - 0  atom of the inositol 
moiety in the same modelled enzyme-substrate complex. This allows 
stabilisation of the developing negative of the inositol alkoxide leaving group.
To determine the validity of the proposed active structure of inositol 
monophosphatase, a number of mechanism designed inhib itors were 
produced. The free hydroxyl group of ethane 1,2-diol monophosphate (113) 
was further elaborated to provide molecules that might displace the nucleophilic 
water molecule (or hydroxide ion) from its site on the second Mg^+ ion. 
Accordingly, diethylene glycol phosphate (149) and diethylene glycol cyclic 
phosphate diester (157) were produced. The free hydroxyl group of diethylene 
glycol phosphate (149) should be capable of displacing the hydrolysis 
nucleophile via coordination to the catalytic Mg^+ ion. If the hydrolysis 
nucleophile was displaced, 1,5-phosphoryl group transfer, but not phosphate 
monoester hydrolysis, would be possible. The cyclic phosphate diester (157) 
should also displace the hydrolysis nucleophile and thus cause inhibition. For 
comparison, pentane 1,5-diol 1-phosphate (150) and pentane 1,5-diol cyclic 
phosphate diester (158) were also prepared, and their inhibition properties 
studied.
Diethylene glycol phosphate (149) and pentane 1,5-diol 1-phosphate 
(150) were synthesised from diethylene glycol (143) and pentane 1,5-diol 
(144) respectively. A five fold excess of the parent alcohols, (143) and (144) 
was treated with benzyl bromide and sodium hydride in DMF, and on 
completion (as judged by TLC) the reaction mixture quenched with water. The 
monobenzylated diols were extracted into diethyl ether and washed with water 
to remove the excess alcohol. Phosphitylation with N,N’-diisopropyl bis-benzyl 
phosphoramidite was performed without further purification, followed by 
phosphite oxidation w ith m-CPBA and purification by s ilica column 
chromatography to yield the fully benzylated alkyl phosphates. (Benzyl
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diethylene glycol phosphate dibenzyl ester (147) m/z (Found: [M + H]+ 
457.1780. C2 5 H3 OO0 P requires 457.1780); benzyl pentane 1,5-diol 1 - 
phosphate dibenzyl ester (148) (Found: [M + H]+ 455.1990. C2 0 H32O5 P 
requires 455.1987)). Palladium on activated charcoal catalysed deprotection 
under an atmosphere of hydrogen gas followed by conversion to the bis- 
cyclohexylammonium salts and recrystallisation from water/ acetone afforded 
diethylene glycol monophosphate (149) and pentane 1,5-diol monophosphate 
(150) as white solids (Scheme 2.12.9). (Diethylene glycol phosphate 
(derivatised as the dimethyl ester) m/z (Found: [M + H]+ 216.0685. CgHigOgP 
requires 215.0685); pentane 1,5-diol 1-phosphate (derivatised as the dimethyl 
ester) (Found: [M+ H]+213.0890. CyHigOgP requires 213.0892)).
i)
X = 0(143) 
XzzCHg (144)
il)
o
II OBn
X = 0(145)
X = CH2 (146)
ill)
X = 0(147)
X = CH2 (148)
=» NHa —
X = 0(149)
X = CH2 (150)
Reagents: l)BnBr, NaH, DMF; II) a) N,N’-dlisopropyl bisbenzyl 
phosphoramidite, 1*H tetrazole, CH3CN, b) m^GPBA, CH2Ci2: 
ill) a) Hg, Pd/ C, b) cyclohexyiamine, H2O.
Scheme 2,12.9. Synthesis of phosphate monoester inhibitors of inositol
monophosphatase.
The cyclic d iester substrate analogues (157) and (1 58) were
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synthesised in three steps, again from the parent alcohois. Treatment of the 
diols with N,N’“diisopropyl dichloro phosphoramidite and triethylamine in 
dichloromethane gave the cyciic phosphoramidites (153) and (154) from which 
the corresponding benzyl phosphites were produced via the phosphityiation of 
benzyl alcohol. Oxidation with m-CPBA and rapid debenzyiation (by 
hydrogenation) and conversion to the mono-cyclohexylammonium salts yielded
(157) (m/z (Found: [M (free acid) -f H]*^  169.0266. G^H^QOgP requires 
169.0266)) and (158) (m/z (Found: [A/f (free acid) + H]+ 167.0470. C5 H12O4P 
requires 167.0473)) as white crystailine solids (Scheme 2.12.10).
X = 0(143)
X = C H 2 ( 1 4 4 )
I) P— N
X = 0(153)
X = C H 2 ( 1 5 4 )
I) X o
X = 0(155)
X = C H 2 ( 1 5 6 )
i)
X = 0(157)
X = C H 2 ( 1 5 8 )
Reagents: I) a) N,N’-dilsopropyl dichlorophosphoramidite, EtgN, CH2CI2;
II) a) 1-H tetrazole, BnOH, CH3CN, b) m-CPBA, CH2CI2;
III) a) H2, Pd/ C, b) cyclohexyiamine, H2O.
Scheme 2.12,10 Synthesis of cyclic phosphate diester inhibitors of inositol
monophosphatase.
For comparison, 2-methoxyethanoi 1-phosphate (160) and propyl 
phosphate (162) were also prepared (Figure 2.12.11).
H,c HqC
(160) (16 ?
Figure 2.12.11 Methoxyethanol phosphate and propyl phosphate.
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Each of the compounds were tested as potential substrates and inhibitors 
for the enzyme, and none acted as a substrate, as expected (with the exception 
of diethylene glycol monophosphate (149) which showed extremely slow 
hydrolysis in comparison to controls containing no enzyme. The rate of enzymic 
hydrolysis was approximately 1 0 -foid slower than that of ethane 1 ,2 -diol 
monophosphate (113)).
Their competitive modes of inhibition and the values of the inhibition 
constants are informative and are consistent with the proposed mechanism of 
hydrolysis. For example, the replacement of the 2-OH group in ethane 1,2-dioi 
monophosphate (113) by OMe, to give (160), led to a 25 fold reduction in 
binding affinity (Kj > 25 mM) (Propyl phosphate (162) was devoid of inhibitory 
activity). Replacement of the methyl group by a 2 -hydroxyethyl group, 
compound (149), led to an 8 -fold increase in binding affinity (Kj = 3.5 mM). This 
increase in affinity is ascribed to the ability of the inhibitor to provide extra 
ligands for the second Mg^+, by displacing the nucleophilic hydroxide ligand. 
The replacement of the ether 0-atom to give compound (150) did not affect the 
Kj value (Kj = 3.8 mM) as would be expected if the co-hydroxyl group binds to the 
Mg2+ ion. The fact that neither compound served as a substrate (to any 
significant extent) excludes the possibility that the co-hydroxyl group binds in the 
site for the 5-OH of 2 -AMP.
The cyclic diester (157) was a weak inhibitor (K j = 8  mM). Nevertheless, 
this latter result is remarkable given that the compound is a monoanion and that
Kj for sulfate is 20 mM.®^ As predicted on the basis of the properties of 
diethyiene glycol phosphate (149) and pentane 1,5-diol phosphate (150), 
removal of the ether 0-atom in the monoanion (157) to give (158) had little 
effect on Kj (Kj = 7.5 mM). As mentioned above, none of the compounds showed
any appreciable activity as substrates, as determined by ^H-, and ^^P- 
NMR spectroscopy, and notably the cyclic diesters were not cleaved to give 
monoesters. These results give clues to the location of the active site 
nucleophile. Since each of the compounds contains a phosphate ester group 
and at least the two requisite oxygen functionalities for binding to the second 
Mg2+ ion on the enzyme (of which one interactions stabilises the leaving 
group), the compounds which serve as competitive inhibitors should also serve
as substrates, if the first Mg^+ ion chelates and activates the nucleophilic water
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molecule. Conversely, if the second Mg^+ ion provides the site for the 
nucleophile (water or hydroxide) neither of the compounds which can provide a 
iigand to displace the nucleophile would be hydrolysed. Thus, the results of the 
study are in accord with a mechanism involving two Mg2+ ions, and also 
indicate that the second Mg2+ ion chelates and activates the nucleophile, 
hydroxide ion. Given that two Mg^+ ions are required and that Li+ and Mg2+ (at
high Mg2+concentration) serve as mutually exclusive uncompetitive inhibitors^® 
and bind to the E.Pj product complex, it appears that the proposal that Kj for 
inhibition by Li+ is different for different substrates because the steady-state 
concentration of E.Pj varies for different substrates,®^ is correct. However, with 
the emergence of the new catalytic Mg^+ ion site it is necessary to point out that 
Li+ must occupy the second site for Mg^+ in the E.Pj product complex. At higher 
concentration Li+ is able to bind into the first Mg2+ (buried) site (occupied by 
Gd®+ in an X-ray crystal structure) as is demonstrated by the almost unique 
change in the mode of inhibition by Li+ from uncompetitive to noncompetitive 
(with respect to substrate) with increasing Li+ concentration.
Conclusion:
As a result of this research, a mechanism for phosphate monoester 
hydrolysis by inositol monophosphatase has been proposed that is In accord 
with ail published kinetic data. Hydrolysis occurs via the direct displacement of 
phosphate by water, rather than the more common substituted enzyme
mechanism, and two Mg^+ ions per subunit are required for hydrolysis. The 
inability of inositol monophosphatase to catalyse phosphate-oxygen ligand 
exchange in the presence of adenosine, and the lack of inhibitory activity of 
adenosine suggests that the active form of adenosine in 2’-AMP hydrolysis 
cannot be achieved in the absence of the phosphate moiety. Given that inositol 
is recognised as a product, the enzyme-bound form must exist in a low energy 
conformation, and can thus serve as a template for deducing the high energy 
conformation of adenosine. The discovery of new nucleoside 2  - 
monophosphate substrates and the use of molecular modelling has identified 
the conformation of the active form of adenosine, which exhibits an adverse 1 ,3 - 
interaction between the adenine and the hydroxymethyl groups and also a 1 ,2 -
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interaction between the 2-0 and 3-0 atoms. Calculations predict that the active 
structure of adenosine is 100-105 kJ/ moi less stable than the unconstrained 
form (K ~ 10"^^). This high energy conformation explains the lack of phosphate- 
oxygen ligand exchange in the presence of adenosine and also the lack of 
inhibitory activity of adenosine. The proposed mechanism demonstrates distinct 
roles for the catalytic hydroxyl group‘d and the 1 - 0  atom of inositol 1 - 
phosphate in coordinating to the second (catalytic) Mg^+ ion, and orientating 
the hydrolysis nucleophile (water or hydroxide), with analogous 
coordination to the ribofuranosyi- and the 2  - 0  atoms in the hydrolysis of 2 ’- 
AMP. Synthetic mechanism based inhibitors (diethyiene glycol monophosphate 
and diethyiene glycol cyclic monophosphate), which have no binding 
interactions comparable to C-2  OH and C-4 OH of D-inositol 1-phosphate, have 
been shown to bind to the enzyme. Notably, cyclic phosphate diester substrate 
analogues have been shown to bind to the enzyme despite suffering from 
reduced coordination to the first (buried) Mg^+ ion. The proposed mechanism is 
in accord with earlier results from this laboratory demonstrating cooperativity
effects observed for Mg^+ with inositol 1 -phosphate and adenosine 2 '- 
monophosphate as substrates.®® in the E.P; product complex, Li+ inhibition 
occurs by Li+ occupying the catalytic Mg2+ site. At higher concentration Li+ is 
able to bind into the first Mg^+ (buried) site as is demonstrated by the almost 
unique change in the mode of inhibition by Li+ from uncompetitive to 
noncompetitive (with respect to substrate) with increasing Li+ concentration.
The understanding of the mode of action of inositol monophosphatase 
now allows the design and synthesis of more potent inhibitors incorporating 
functional groups capable of chelating to the Mg2+ ions in addition to binding 
groups comparable to C-2 OH and 0-4 OH of D-inositol 1-phosphate.
93
CHAPTER THREE 
EXPERIMENTAL
3. EXPERIMENTAL
NMR Spectra were recorded on a Bruker AM-300 f.t. spectrometer (‘•H, 
300 MHz; 75 MHz; 121.5 MHz) and a Varian Gemini f.t. spectrometer
C*H, 200 MHz; 50 MHz). High field NMR spectra were obtained on an 
S.E.R.C. service basis at the University of Warwick (^H, 400 MHz) and the 
University of Edinburgh (^®C, 150 MHz; ®^P, 242 MHz) ^H NMR spectra were 
referenced on chloroform, IMS, methanol or DMSO, NMR spectra were 
referenced on chloroform, IMS, methanol or DMSO and ®^P spectra on 
external H3 PO4 . NMR spectra are described In parts per million downfield shift
from TMS and are reported consecutively as position (5^ or §q), relative 
integral, multiplicity (s-singlet, d-doublet, t-triplet, q-quartet, m-muitipiet, dd- 
doublet of doublets and b-broad), coupling constant (J x,Y Hz if applicable) and 
assignment. Infrared spectra were recorded using a Perkin Elmer 1420 ratio 
recording spectrometer and a Perkin Elmer 1710 f.t. i.r. spectrometer. The 
samples were prepared as nujol mulls or thin films between sodium chloride 
discs. Absorption maxima are given in wavenumbers (cm"'') relative to a 
polystyrene standard. Melting points were measured using electrothermal 
melting point apparatus and are uncorrected. Optical rotations were measured 
on an Optical Activity Ltd. AA-100 polarimeter using 10 cm path length ceils at 
room temperature. Mass spectra were recorded on a Kratos MS50, and 
obtained on an S.E.R.C. service basis at the University of Swansea using a VG 
ZAB E. Major fragments are given as percentages of the base peak intensity. 
GC/ MS spectra were recorded on a Hewlett Packard 5890A 6 C. U.V./ vis. 
optical densities were measured on a Cam Spec M302 spectrophotometer. 
Solvents and common reagents were purified according to the method of Perrin 
and Armarego.^®^ Flash chromatography was performed according to the 
procedure of StilM®  ^ using Sorbisil C60 (40-60 pm) silica gel. Analytical thin 
layer chromatography was carried out on 0.25 mm precoated silica gel plates 
(MN SIL G/UV254) or on 0.1 mm precoated cellulose plates (CEL MN 300-10 
/UV254), and compounds were visualised by UV fluorescence, iodine vapour, 
ethanoiic phosphomolybdic acid, aqueous potassium permanganate, acidic 
palladium chloride or ninhydrin. Radiochemical data of ^^C-compounds was
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obtained using a Packard Tri-Carb 4000 scintillation counter.
Ha
OH
3'
(+/.)-cis-1,2«Cyclohexylidene-/nyo-inositol myo-lnositol (7)
(10 g, 55.5 mmol) was added to a mixture of cyclohexanone (100 ml), 
toluene (50 ml) and DMF (10 ml) with stirring, and the mixture refluxed 
(Dean-Stark apparatus, 155 °C) under a nitrogen atmosphere for 2  hours to 
dry the reagents. p-Toluene sulphonic acid (90 mg) was added and the 
mixture refluxed for a further 24 hours, until no further water was produced. 
On cooling to 35 °C, toluene (50 ml), petroleum ether (50 ml) and ethanol 
(25 ml) were added to the resulting clear solution. p-Toluene sulphonic acid 
(0 .6  g) was added and the solution stirred at 4 °C for 2  hours. Triethylamine 
(0.6 ml) was added, and the solution allowed to stand at -2 0  °C for a further 
24 hours. On filtering, the resultant paste was heated in a mixture of ethanol 
(180 ml) and triethylamine (1 ml) for 1 hour (100 °C), hot filtered, and on 
cooling the white crystalline product collected by filtration (9.39 g, 65%);
m.pt. 181-183 °C (dec) (Iit.,l32 184-186 °C (dec)); m/z (Found: [M + H]+ 
261.1338. C ,2H2 ,Og requires 261.1338); (nujol)/ cm'^ 3000-3600 sb 
(OH), 1240 m, 1120 s, 1040 s (C-0) and 1005 s; 8^ (300 MHz; 2H2O) 1.15-
1.85 (10H, m. CgHio). 3.25 (1H, t, J4 5 9.0 Hz, Jg g 10.6 Hz, 5-H), 3.60 (1H, 
dd, Jg g 10.6 Hz, J, g 8.0 Hz, 6 -H), 3.65 (1H, t, J4 5 9.0 Hz, J3 4 9.6 Hz, 4-H),
3.85 (1H, dd, J3 4 9.6 Hz, ^2,3 4.1 Hz, 3-H), 4.05 (1H, dd, 2 5-0 Hz, g
8.0Hz, 1-H) and 4.50 (1H, t, J  ^2 5 0 Hz, ^2,3 4.1 Hz, 2 -H); (75.5 MHz;
2 H2O) 26.1, 26.4, 27.1, (3 -C, 4’-C and 5 -C), 37.4, 40.2 (2 ’-C and 6  -C), 72.4,
75.1, 75.5, 77.9, 78.5, 80.1 (Ins-CH) and 114.3 ( I ’-C); m/z (Cl) 261 ([M + 
H]+,100%) and 217 (5).
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OBn
(+/-)-c/s-1,2“Cyclohexylidene-3,4,5,6-tetra-0-benzyl-myO"inositol 
(8 2 ): 132 Potassium hydroxide (55.5 g) was added to a mixture of (+/-) cis-
1.2-cyciohexylidene-myo-inositol (81) (9.11 g, 35 mmol) and benzyl 
chloride (90 mi), and the resulting mixture heated (140°C) under a nitrogen 
atmosphere for 24 hours. Toluene (50 ml) and water (150 ml) were added 
with stirring, and the phases separated. The aqueous phase was extracted 
with toluene (50 ml) and the combined organic extracts washed with water 
(3 X 50 mi, until neutral), saturated brine (50 mi) and dried (MgSO^). The 
solvent was removed in vacuo, and the product purified by silica column 
chromatography (0-10% ethyl acetate/ petroleum ether, in 5% steps) and 
recrystaiiised from ethanol to give white crystals (18.25 g, 84%); m.pt. 82-85
"C, (lit.,132 84-86 °C); m/z (Found: [M + NH4]+ 638.3480. C^oH^gOeN 
requires 638.3481); Umax (nujoi)/ cm 1 1490 w, 1360 m, 1100 m, 1070 s, 930 
m and 700 s; 5h (300 MHz; C2HCig) 3.40 (1H. t, J4 5  8.5 Hz, Jg g 9.8 Hz, 5-H), 
3.70 (1H, dd, Jg 4 8.4 Hz, Jg.s 3.8 Hz, 3-H), 3.83 (1H, dd, Jg g 9.8 Hz, J, g 6.9 
Hz, 6 -H), 3.94 (1H, t, J3 4 8.4 Hz, ^4  5 8.5 Hz, 4-H), 4.10 (1H, t, J, g 5-6 Hz, 
J, g 6.9 Hz, 1-H), 4.30 (1H, dd, g 5-6 Hz, Jg g 3.8 Hz, 2-H), 4.70-5.00 (8 H,
m. Benzyl CHg) and 7.20 (20H, m, Ar-H); 5c(75.5 MHz; C2HCig) 26.4, 26.7, 
27.8 (3 -C, 4 -C and 5 -C), 37.8, 40.2 (2 -C and 6 '-C), 75.9, 76.7, 77.8, 78.0 
(Benzyl CHg), 76.8, 80.2, 81.5, 83.7, 84.9, 85.7 (Ins-CH), 113.2 (I'-C) and
130.2-131.1 (Ar-C); m/z (Cl) 638 ([iW+ NH4)+,100%), 621 ([/W+ H]+,5%), 351
(20), 108 (25, [OBn + H+]) and 91 (10, PhCHg+); TLC R, = 0.43 (20% ethyl 
acetate/ petroleum ether).
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OH
BnO. ,OH
BnO' 'OBn
OBn
(+ /- ) -3 ,4 ,5 ,6 "T e tra -0 -b e n z y l-m y o - ln o s ito i (83):^^^ (+/-)-c/s-1,2 - 
Cyclohexylidene-3,4,5,6-tetra-0-benzyl-myo-inositol (82) (12.4 g, 20 mmol) 
was refluxed in acetic acid (160 ml) and water (40 ml) for 2  hours. The solvents 
were removed in vacuo and the resulting oil dried azeotropically using toiuene. 
The crude product was recrystaiiised from methanoi to give a white solid. (9.62
g, 8 8 %); m.pt. 113-115 °C. (lit.,1^2 113-115 °C); m/z (Found: [M + NH4 ]+
558.2855. Gg^H^oOgN requires 558.2855); (nujol)/ cm"  ^ 3390 sb (OH),
3300 sb (OH), 1495 w, 1460 s, 1320 m, 1300 w, 1130 m, 1060 s and 930 s; 6^
(400 MHz; C^HCy 2.44 (1H, s, OH), 2.53 (1H, s, OH), 3.48 (3H, m, Ins-CH),
3.85 (1H, t, Ins-CH), 3.97 (1H, t, Ins-CH), 4.20 (1H, t, Ins-CH), 4.68-4.98 (8 H, m.
Benzyl CHg) and 7.28 (2 0 H, m, Ar-H); 6^ (75.5 MHz; C^HCy 70.1, 72.6 (Ins- 
CH), 73.6, 76.5, 76.7 (Benzyl CHg), 80.8, 82.2, 82.5, 84.1 (Ins-CH), 128.5, 
128.6, 128.8, 129.3, 129.4, 138.7, 139.4 and 139.5 (Ar-C); m/z (Cl) 558 ([M +
NH4 ]+, 100%), 541 (20, [M+ H]+), 449 (30, [M + H- BnH]+), 359 (45, [A4 + H -
2Bn]+) and 108 (60, [OBn + H]+); TLC Rf = 0.13 (20% ethyl acetate/ petroleum 
ether).
OH
BnO,
BnO' 'OBn
OBn
(•f>/-)-1-0 -A lly l-3 ,4 ,5 ,6 -te tra -0-benzyl-m yoH nosito l (84):^32 3^4 5 6^ - 
Tetra-0 -benzyl-/T7yo-inositol (83) (9.19 g, 17 mmol), in dry benzene (250 mi) 
was treated with dibutyi tin oxide (4.22 g, 1.0 mmol) and the mixture refiuxed
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under a nitrogen atmosphere (Dean Stark apparatus) for 24 hours until 
formation of the stannyiidene complex was complete as judged by infra-red 
spectroscopy. The volume of the solvent was reduced to one half of its original 
volume by distillation, and the reaction mixture cooled to 60 °C. Tetrabutyl 
ammonium bromide (5.48 g, 17 mmol) and allyl bromide (4.43 mi, 51 mmol) 
were added and the reaction was stirred for a further 48 hours until no starting 
material remained. Water (3.5 ml) was added and the reaction mixture stirred for 
a further 1 h. On removal of the solvents in vacuo, the product was purified by 
silica column chromatography (0-30% ethyl acetate/ petroleum ether, in 5% 
steps) and recrystaiiised from ethyl acetate and heptane to give a white solid.
(9.32 g, 94%); m.pt. 61-63 °C, (lit.Jl'* 63-66 °C): m/z (Found: [M+ H]+ 581.2900.
CayH^^Og requires 581.2903); (nujol)/ cm \  3600-3300 mb, (O-H), 2760
w, 1760 w, 1640 w, 1340 w, 1220 w, 1080 m, 1040 m, 740 s and 710 s; 8^ (300
MHz; C^HCIg) 2.47 (1H. s, OH), 3.30 (IN, dd, J2.7 Hz, J 9.6 Hz, Ins-H), 3.41 
(1H, dd, J2.7 Hz, J9.7 Hz, Ins-H), 3.42-3.77 (1H, dd, J9.5 Hz, J2.7Hz, Ins-H), 
3.95 (1H, t, J9.6HZ, Ins-H), 3.99 (1H, t, J9.6Hz, Ins-H), 4.18 (2H, dd, Jy z- 5.7 
Hz, Jr,3’c\s 1-3 Hz, Cl'Hg), 4.23 (1H, t, J 2.7 Hz, lns-2H), 4.70-4.91 (8 H, m. 
Benzyl CHg), 5.17-5.20 (1H, dd, 10.4 Hz, Jg-cis.S’trans 1-3 Hz, 3’Hcls), 5.28
(1H, dd, /^2‘,Straps Hz, ^s'cts.Strans  ^ 3 Hz, 3 H trans), 5.94 (1H, m, »/2’,3 trans
17.2 Hz, J2’,3’cIs 10 4 Hz, Jy z’ S.7 Hz, 2’-H) and 7.32 (20H, m, Ar-H); Sg (75.5
MHz; C^HCIg) 67.7 (2-C), 71.9, 72.8, 75.9 (Benzyl-CHg and I ’-C), 79.7, 79.9,
81.2, 83.2 (Ins-C), 117.4 (3’-C), 127.6, 127.8, 127.9, 128.0, 128.1, 128.3 (Ar-C),
134.7 (2  -C); m/z (Cl) 598 [ [M+ NH4]+,1 0 0%), 581 (60, [M + H]+), 498 (25, [M +
H - BnH]+), 399 (25, [ M+H-  2 Bn]+), 108 (25, [OBn + H]+) and 91 (10, Bn+); TLC 
R(= 0.16 (2 0 % ethyl acetate/ petroleum ether).
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OBn
Bna
'OBnB na
OBn
(4-/-)-1 “ 0 -Allyl»2 ,3 ,4 ,5 ,6 -penta-0 -benzyl-#nyO“inos lto l ( 8 5 ) : (4-/-)-1 - 
OAIIyl-3 ,4 ,6 ,6 -tetra-0 -Benzyl-/77yo-inositol (84) (8.71 g, 15 mmol) in dry DMF 
(360 ml) was added dropwise to a suspension of sodium hydride (1.44 g, 30 
mmol (50% dispersion in oil)) and benzyl bromide (3.3 ml, 30.6 mmol) under a 
nitrogen atmosphere. The reaction was stirred at room temperature for 24 
hours, water (90 ml) added with extreme caution and the solvents removed in 
vacuo. The residual oil was partitioned between water (90 mi) and ethyl acetate 
(250 ml) and the organic phases coilected. The aqueous phase was extracted 
with ethyi acetate (3 x 50 ml) and the combined organic extracts washed with 
saturated brine (250 mi) and dried (MgSO^). The solvent was removed in  
vacuo, the product purified by silica column chromatography (0 -2 0 % ethyl 
acetate/ petroleum ether, in 5% steps) and recrystaiiised from ethanol to give 
white crystals. (9.31 g, 93%); m.pt. 60-62 °C, (lit.,57 60-62 °C); (Found: C. 78.65; 
H, 6.9. Calc, for C^^H^gOg: C, 78.8; H, 6.9%); m/z (Found: [M + H]+ 671.3370. 
C^^H^yOg requires 671.3372); (nujol)/ cm*  ^ 3010 m, 2880 m, 1500 m, 
1460 m, 1370 s, 1080 s and 700 s; 8^(300 MHz; C^HCIg) 3.26 (IN, dd, J9.8 
Hz, J2.3 Hz, InsH), 3.36 (1H, dd, J9.8 Hz, J2.3 Hz, InsH), 3.47 (1H, t, V9.3 Hz, 
InsH), 4.10 (5H, m, 3 X InsH and T-Hg), 4.60-4.95 (ION, m, Benzyl CHg), 5.15-
5.20 (1H, dd, Jgds 2 ' 10.4 Hz, Js'cis.S'trans 1-5 Hz, 3'-H cis), 5.30 (1H, dd, 
‘^2’,3’trans 1^*^ '^ 3’cis,3’trans 1 Hz, 3 -H trans), 5.92 (1H, m, « '^ 3 * trans 1T.3 Hz, 
^2  ,3" cis 10 4 Hz, Jg'.i' 5.7 Hz, 2 '-H) and 7.32 (25H, m, Ar-H); 6q (50.3 MHz; 
C^HCIg) 72.2 (2-C) 73.3, 74.5, 74.7, 76.2, 76.4 (Benzyl-CHg & I ’-G), 81.2, 81.4,
82.2, 84.1 (Ins-C), 117.2 (3'-C), 127.9 ,128.0, 128.1, 128.3, 128.5, 128.6, 128.9 
(Ar-C), 135.4 (2 -C); m/z (Cl) 6 8 8  {[M ■¥ NH4I+, 35%), 671 (65, [M + H]+), 108 
(100, [OBn + H]+) and 91 (50, Bn"^ ); TLC Rf = 0.57 (20% ethyl acetate/ petroleum 
ether).
99
OBn
BnOi ,OH
BnO' OBn
OBn
(*i*/-)-2,3,4,5,6-Penta-0-benzyl-m yo-inosito l (8 6 ) :^ ^ 2  jq (+/-)-i-OAllyl- 
2,3,4,5,6-'penta-0-benzyl-m/o-inositol (85) (5.0 g, 7.5 mmol) in ethanol/ water 
(9:1 v/v, 90 ml) was added Wilkinson’s complex (0.7 g, 0 .8  mmol) and DABCO 
(0.27 g, 2.4 mmol) and the mixture refluxed under a nitrogen atmosphere for 4 
hours. The suspension was hot filtered and the precipitate washed with ethanol. 
The solvents were removed in vacuo to give an oil which was refluxed in a 
mixture of acetic acid (120 ml), water (40 ml) and THF (80 ml) for 4 hours. The 
solvents were removed in vacuo and the product purified by silica column 
chromatography (0-40% ethyl acetate/ petroleum ether, in 5% steps) and 
recrystaiiised from ethanol to give white crystals. (4.29 g, 91%); m.pt. 90-92 °C,
(lit.,132 9 1 -9 3  °c); m/z (Found: [M + H]+ 631.3060. C^iH^gOg requires
631.3059); u^ax (nujol)/ cnr’ 3600 sb (O-H), 3010 m, 2880 m, 1500 m, 1460 s,
1370 s, 1040 s, 1070 s and 700 s; 8^ (300 MHz; C^HCIg) 2.20 (1H, bs. OH), 
3.30-3.56 (3H, m, Ins-H), 3.64-3.98 (1H, t, J 9 .6  Hz, Ins-H), 3.90-4.15 (2H, m. Ins 
-H), 4.55-5.05 (10H, m. Benzyl CHg) and 7.30 (25H, m, Ar-H); 8^ (75.5 MHz;
C^HCIg) 72.5 (2 -C), 73.0, 74.8, 75.5, 75.7, 75.9 (Benzyl-CHg), 77.2, 81.2, 81.9,
82.2, 83.6 (Ins-C), 127.5, 127.6, 127.7, 127.8, 128.0, 128.1, 128.3, 128.4 and
128.5 (Ar-C); m/z (Cl) 648 ([W+ NH4]+, 30%), 631 (15, [M+ H]+), 108 (100, [OBn 
+ H]+) and 91 (40, Bn'*’); TLC R(= 0.16 (20% ethyl acetate/ petroleum ether).
100
OBn
BnO,
Bna OBn
OBn
(+ /- ) -2 ,3 ,4 ,5 ,6 -P e n ta k is -0 -b e n zy [“/nyo-lnositol»blscyanoethy[ 
phosphorothioate ( 9 5 ) To 2,3,4,5,6-penta-O-benzyl-myo-inositol (86) 
(2.5 g, 4 mmol) and N’N-diisopropylethylamlne (1.0 ml, 6  mmol) in anhydrous 
acetonitrile (15 ml) was added N’N-d iisopropyl(2-cyanoethyl)chloro- 
phosphoramidite (1.57 g, 1.4 ml, 6 mmol) at 0 °C under an argon atmosphere 
and the reaction mixture stirred for 4 hours. 3-Hydroxyproplonltrile (1.3 ml, 18 
mmol) and 1-H tetrazole (0.4 g, 6 mmol) in dry acetonitrile (15 ml) were added 
and the reaction mixture stirred for 16 hours at room temperature. The solvent 
was removed in vacuo, and the residue partitioned between ethyl acetate (1 0 0  
ml) and 100 mM phosphate buffer (50 ml, pH 7, 100 mM). The aqueous fraction 
was extracted with ethyl acetate (2 x 50 ml) and the combined organic extracts 
washed with saturated brine (100 ml) and dried (MgSO,^). The solvent was 
removed in vacuo, the residual oil redissolved in pyridine (1 0 0  ml), and sulphur 
(1.9 g, 60 mmol) added. The reaction mixture was stirred at room temperature 
for 15 minutes. The solvent was removed in vacuo and the residue extracted in 
toluene. Excess sulphur was removed by filtration. On removal of the solvents 
the residual oil was redissolved In toluene (5 ml), purified by silica column 
chromatography on triethylamine basified silica (0-50% ethyl acetate/ petroleum 
ether, in 5% steps) and recrystaiiised from methanol to give white crystals. (2.16 
g, 65%); m.pt. 96-97 °C, (lit.J32 97.93 °C); (Found, C, 67.8; H, 5.95; N, 3.35. 
Calc, for C4 7H4 9N2O8 PS, 0, 68.1 ; H, 6.1; N, 3.35 %); (nujol)/ cm'^ 3050 w, 
2900 w, 2270 w (ON), 1500 m, 1460 m, 1370 m, 1070 vs, 1030 vs, 950 m, 800 
m (P=S) and 700 s; 8h (C^HCIg; 300 MHz) 2.15-2.58 (4H, m, 2 ”H2), 3.48 (IN, 
dd, ^2,3 2.3 Hz, 4 9.6 Hz, 3-H), 3.55 (1H, t, ^4 5 9.2 Hz, Jg g 9.2 Hz, 5-H), 4.00 
(6 H, m, 1’’H2 and 4-H and 6 -H), 4.36 (1H, Id, 2 2-5 Hz, ^2,3 2.3 Hz, 2 -H), 4.70-
5.05 (1 0 H, m. Benzyl GH2) and 7.33 (25H, m, Ar-H); Sq (75.5 MHz; C^HCIg),
19.8, 19.9, 20.1, 2 0 .2  (2"0), 63.1, 63.2, 63.3 (1"G), 73.9 (2-G), 75.8, 76.3, 76.7,
76.9 (Benzyl GH2), 80.3, 80.4, 80.6, 80.7, 81.3, 82.2, 84.1 (Ins-G), 117.3 (GN),
128.3, 128.4, 128.6, 128.7, 128.1, 128.7, 128.8 and 129.2 (Ar-G); 8 p (G^HGIg,
101
121.5 MHz) 66.5; m/z (Cl), 850 ([M+ NH^]+, 10%), 833 (10, [M+ H]+), 201 (10), 
181 (20), 105 (30) and 91 (100, Bn+); TLC Rf = 0.09 (20% ethyl acetate/ 
petroleum ether).
OH
HO, O '
'OH
OH
(°t>/-)-/nyo-lnositol 1 -phosphorothioate b is-cyclohexy iammonium salt 
(95a);'*32 ^  freshly prepared solution of sodium methoxide (4 mmoi) in dry 
methanoi (10 mi) was added to (+/-)-2,3,4,5,6-pentakis-Obenzyl-myo-inositoi- 
bis-cyanoethyl phosphorothioate (95) (0.83 g, 1 mmoi) in dry methanol (10 ml) 
at 4 °C under an argon atmosphere, and stirred for 4 hours. The soivent was 
removed in vacuo to give disodium sait, which showed the expected NMR 
parameters. The crude 2,3,4,5,6-penta-O-benzyl-myo-inositol 1-phosphoro­
thioate disodium salt was dissolved in THF (50 ml), and this solution added 
dropwise with stirring to a soiution of sodium (50 mg) in iiquid ammonia (100 
mi), at -78 °C, under an argon atmosphere. When the biue coiouration of the 
ammonia solution became faint, further smaii pieces of sodium were added to 
the ammonia soiution folio wed by further amounts of the disodium salt solution. 
After the finai addition of this solution the reaction mixture was stirred for a 
further 30 minutes and dry methanol (10 ml) added. The ammonia was allowed 
to evaporate and the solvents removed in vacuo. The residue was then 
partitioned between water (100 ml) and diethyl ether (50 ml). The aqueous layer 
was removed, reduced to a volume of approximately 10 ml and subjected to
chromatography on Amberlite IR-118 (H+) ion exchange resin, eiuting with 
water. The acid fractions containing the product were collected and freshly 
distilled cyclohexyiamine (3 mi) added. The mixture stirred at room temperature 
for 4 hours, and the aqueous solution extracted with diethyl ether (3 x 50 ml) to 
remove the excess cyclohexyiamine. The solution was lyophilised overnight 
and the residue recrystaiiised from water/ acetone to give a white soiid (2.16 g.
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65%); m.p. 165-170 °C (dec.), (lit.,1^2 165-170 °C (dec.)); D^ax (nujol)/ cm'l 
3500-2500 bs (O-H and N-H), 1608 m, 1523 m, 1114 s, 1040 s, 979 s, 811 s and 
722 s; 8h (20 0  MHz; 2 H2O) 1.00-2.00 (2 0 H, m, cyclohexylamlne-CHg), 3.08 (2 H, 
m, cyclohexylamine-CH), 3.28 (1H, t, J^ qB.2 Hz, J4  5  9.0 Hz, 5-H), 3.52 (1H, dd, 
^2,3 2 .8  Hz, J3 4 9.7 Hz, 3-H), 3.62 (1H, t, J3 4 9.7 Hz, J4 5 9.0 Hz, 4-H), 3.73 (1H, 
t, 6 9.7 Hz, Jq q 9.2 Hz, 6 -H), 4.08 (1H, td, p 11.0 Hz, J^^q9.7 Hz, 2 2 7
Hz, 1-H) and 4.20 (1H, t, 2 2 7 Hz, J2.3 2.8 Hz, 2-H); Ôq (75.5 MHz; 2 H2O)
26.74, 27.24, 33.61, (cyclohexyl-GHg), 53.12, (cyclohexyl-CH) 73.68, 74.01, 
74.92, 75.16, 77.29 and 77.63 (Ins-CH); 6p (121.5 MHz; 2H2O) 44.4; m/z (FAB) 
475 ([/W+ H]+, 2%), 376 (6 , [M - C0 H13N + H]+) and 100 (100, cyclohexyl- 
ammonium+).
OBn
BnO II ^OPh
B nO ^'^Y '^^'^O B n  
OBn
(+ /“) 2,3,4,5,6-Penta-O-benzy! myo inositol bis-phenyi phosphate
(96):^®s (+/-) 2,3,4,5,6-Penta-Obenzyl myo-lnositol (8 6 ) (4.5 g, 7.2 mmol), 
dimethyl amino pyridine (90 mg, 0.72 mmoi) and dry triethyiamine (3.0 ml, 21.4 
mmol) were dissolved in dry dichioromethane (25 ml) under an argon 
atmosphere. Diphenylphosphorochloridate (2.28 ml, 11.1 mmol) was added 
and the reaction mixture stirred at room temperature for 24 hours. The soivent 
was removed in vacuo, redissoived in diethyl ether (10 0  ml) and washed with 
water (50 ml). The aqueous phase was washed with diethyi ether (3 x 50 ml), 
the combined organic fractions washed with saturated brine (40 mi) and dried 
(MgS0 4 ). The soivent was removed in vacuo to give a pale brown oil that was 
purified by siiica column chromatography (25% ethyl acetate/ petroleum ether) 
and recrystaiiised from hexane to give white crystais (4.23 g, 6 8 %); m.pt. 96-99
°C, (iit.,165 9 7 -9 9  oQ). (Found: [M + H]+ 863.3350. C5 3H52O9 NP requires 
863.3349); o^ax (nujol)/ cm'^ 3000 s, 2850 s (CH), 1600 s, 1200 m, 1050 s (C-
103
O) and 970 s; 5h (300 MHz; C^HCIg) 3.45 (2H, m, Ins-H), 4.00 ( 1H, t, J9.3 Hz. 
Ins-H), 4.05 (1H, t, J9.3 Hz, Ins-H), 4.25 (1H, t, J2.1 Hz Ins-H), 4.45 (1H, m, 1- 
H), 4.75 (1 0 H, m. Benzyl CHg) and 7.20 (35H, m, Ar-H); 8c (75.5 MHz; C^HCIg)
72.8, 74.9, 75.4, 75.8, 75.9, 76.6 (Benzyl GHg), 79.7, 79.8, 80.4, 81.1, 83.0 (Ins- 
C), 119.8, 120.0, 125.1,127.3, 127.4, 127.9, 128.2,128.3,129.6 (Ar-CH), 137.9,
138.1, 138.3, 138.4, 150.3 and 150.4 (Ar-C quaternary); ôp (121.5 MHz;
C^HCIg) -1 2 .0 ; m/z (Cl) 863 {[M + H]+, 10%), 108 (35, BnOH+) and 91 (100,
Bn+).
OBn
OBnBnO, OBn
BnO" OBn
OBn
(+/-) 2,3,4,3,6»Pentâ-0-benzyl myo inos ito l b is benzy i phosphate
(97):''®® Benzyl alcohol (0.51 ml, 4.8 mmol) in dry THF (2 0  ml) was added 
dropwise to a solution of {+/-) 2,3,4,5,6-penta-Obenzyl myo-inositol bis phenyl 
phosphate (96) (2.15 g, 2.45 mmol) and sodium hydride (0.27 g, 45% 
dispersion in oil, 5.04 mmol) in dry THF (20 ml). The reaction mixture was stirred 
at room temperature for 18 hours and on compietion saturated ammonium 
chloride solution (10 ml) added with extreme caution. The solvent was removed 
in vacuo, the residue redissolved in dichloromethane (1 0 0  ml) and washed with 
water (3 x 50 ml). The aqueous phase was washed with dichloromethane (3 x 
30 ml) and the combined organic fractions dried (IVIgSO )^. The solvent was 
removed In vacuo and the resulting paie brown oil purified by silica column 
chromatography (15-45% ethyl acetate/ petroleum ether, in 10% steps) to give a 
pale yellow oil (1.35 g, 63%); (nujol)/ cm'^ 3030 s, 3000 s, 2800 s (C-H),
1500 m, 1450 s, 1370 s, 1180 s, 1030 s (C-0) and 700 s;8h (200 MHz; C^HCIg) 
3.50 (2H, m, Ins-H), 4.10 (2H, m, Ins-H), 4.30 (2H, m, Ins-H), 4.90 (14H, m, 
Benzyl CHg) and 7.30 (35H, m, Ar-H); 8^ (50.5 MHz; C^HCy 69.7, 69.8, 69.9,
73.2, 75.4, 76.0, 76.8 (Benzyl CHg), 78.2, 79.1, 79.2, 7806, 80.7, 81.0, 81.8,
104
83.6 (Ins-C), 127.9, 128.0, 128.2, 128.3, 128.5, 128.6, 128.8, 129.0, 129.1 (Ar- 
0), 136.2, 136.3,139.0 and 139.2 (Ar-C quaternary): ôp (121.5 MHz; C^HCIg) -
1 .1 ; m/z (Cl), 892 {[M + H]+, 2 0 %), 784 (5, [M + H  -BnO]+), 678 (5, [M + H -
2BnO]+), 255 (7, [M+H - 7Bn]+), 108 (20, BnOH+) and 91 (40, Bn+).
OH
HO, O '
OHHO
OH
( + / - )  m y o - ln o s i to l  1-phosphate bis  oyclohexylatnmonium s a l t
(3 3 ): 128 2,3,4,5,6-Penta-O-benzyl-myo-lnositol bis benzyl phosphate (97) 
(1.20 g, 1.35 mmol) was dissolved in THF (30 ml), and this soiution added 
dropwise to a solution of sodium (50 mg) in iiquid ammonia (100 mi) at -78 
under an argon atmosphere, with stirring. When the blue coiouration of the 
ammonia solution became faint, further smaii pieces of sodium were added to 
the ammonia soiution followed by further amounts of protected phosphate 
solution. After the final addition of this soiution the reaction mixture was stirred 
for a further 30 minutes and dry methanol (10 ml) added. The ammonia was 
allowed to evaporate and the solvents removed in vacuo. The residue was 
dissolved in water (10  mi) and subjected to chromatography on Amberlite IR- 
118 (H+) ion-exchange resin, eiuting with water. The acid fractions containing 
the product were collected, and freshly distilled cyclohexyiamine (5 mi) added 
and the reaction mixture stirred at room temperature for 4 hours. The aqueous 
solution was extracted with diethyl ether (3 x 50 mi) to remove the excess 
cyclohexyiamine and the sample lyophilised. The residue was recrystaiiised 
from water/ acetone to give a white solid. (0.43 g, 69%); m.p. 185-195 °C (dec.), 
(lit.,165 185-190 °C (dec.)); (Found; C, 45.55; H, 8.7; N, 5.7. Calc, for 
CiaHggNgOgPHgO: C, 45.4; H, 8.7; N, 5.9%); (nujol)/ cm i 3500-2000 bvs 
(O-H and N-H ), 1640 s, 1560 s, 1260-950 bs, 840 s and 740 s; 6^ (200 MHz; 
^HgO) 1 .0 -2.1 (2 0 H, m, cyclohexyl-CHg), 3.13 (2 H, m, cyclohexyl-CH), 3.33 (1H,
105
t, J4  5  9.2 Hz, Js,e 9.2 Hz, 5-H), 3.56 (1 H, dd, J3  4  9.9 Hz, Jg.s 2.8 Hz, 3-H), 3.63 
(1H, t, Jg^4 9.5 Hz, J 4  5  9.5 Hz, 4-H), 3.74 (1H, t, g 9.6 Hz, Jg g 9.6 Hz, 6-H), 
3.89 (1H, td, Jyp and 1,6 9 1 Hz, g 2 8 Hz, 1-H) and 4.21 (1H, t, J, g and 2,3 2 8 
Hz, 2-H): 5c (50.5 MHz; ^HgO) 21.8, 22.3, 28.4 (cyclohexyl-CHg), 48.4 
(cyclohexyl-CH), 69.0, 69.2, 69.7, 69.8, 70.2, 70.4, 72.3 and 72.5 (Ins-C); Sp 
(121.5 MHz; ^HgO) 4.3; m/z (FAB) 459 ([M+ H]+, 24%), 360 (2, [M - CgHigN + 
H]+) and 100 (100, [cyclohexyiamine + H]+).
O
HN
HO
HO OH
N®"Benzoyl adenosine Benzoyl chloride (18.5 g, 15 ml, 131 mmoi)
was added to a suspension of adenosine (98) (6.30 g, 25.0 mmol) in dry 
pyridine (40 ml) at 0 °C, and the reaction mixture stirred under a nitrogen 
atmosphere for 4 hours. The resulting pink solution was poured into iced water 
(ca. 60 ml) and the adenosine derivative extracted into dichloromethane (3 x 
100 ml). The combined organic extracts were washed with water (100 ml) and 
saturated sodium bicarbonate solution (100 ml) and the solvent removed in  
vacuo. The resulting yellow oil was redissolved in ethanol (150 ml) and pyridine 
(100 ml) and this solution treated with a mixture of sodium hydroxide (200 ml, 2 
M) and ethanol (100 ml), and stirred at room temperature for 5 minutes. The 
solvent was removed in vacuo, and the resulting solid redissolved in water (100 
ml). Hydrochloric acid (150 ml, 2 M) was added to form a white precipitate, 
which was filtered and washed with diethyl ether to remove any benzoic acid 
present. Recrystallisation from methanol afforded white crystals (6.60 g, 71%); 
m.pt. 152 °C (dec); (Found: C, 52.45; H, 4.95; N, 18.0. Calc, for
1 0 6
C17H17N5O5 H2O: C, 52.45; H, 4.65; N, 17.8%.) m/z(Found: [M+ H f  372.1308. 
C17H18N5O5 requires 372.1308); [a]p-49.5° (c 0.052 In CH3OH); (nujol)/ 
cnr^ 3500 w, 3420 w, 3340 w, 3100 w (OH and NH), 1700 s, (amide C=0), 1300 
m, 1220 m, 1050 m and 700 m; ôn(200 MHz; DMSG) 3.70 (2H, ABX,  ^^
Hz, ^ Hz, (^ 4' g'g 3 Hz, 5 -Hg), 4.05 (1H, q, L^ « 3» 4 Hz, 4 Hz, 4 -H),
4.24 (1H, t, J3. 4.4 Hz, ^2 3 ' 4 Hz, 3'-H), 4.65 (1H, t, 4 Hz, 5 Hz, 2'-H), 
6.13 (1H, d, Jj. g. 5 Hz, 1"’Hi, 7.60 (3H, m, Ar-H meta and para), 8.08-8.12 (2H, 
m, Ar-H ortho), 8.87 (1H, s, adenine CH)) and 9.11 (1H, a, adenine CH); 6q (200 
MHz; DMSG) 61.6 (C-5'), 70.7 (C-3'), 74.0 (C-2 ), 86.0 (C-4 ), 87.9 (C-1’), 126.1 
(5-0), 128.8 (Ar-0 meta and para), 132.7 (Ar-0 ortho), 133.7 (Ar-G quaternary),
143.4 (2-0), 150.8, 151.9, 152.6 (8-0, 4-0 and 6-0) and 166.1 (amide 0=G);
m/z(E\) 371 (A/f**, 5%), 238 (8 , benzoyl adenine), 135 (100, [adenine-H]+), 105 
(95, PhOG) and 77 (85, Ph+); TLO R, = 0.62 (50% ethyl acetate/ methanol).
NHBz
S i-0  OH
N®-Benzoyl 3*,5’ -0 -^bu ty l d im e th y ls ily ! adenosine (1 0 0 );^^? ^ 6 . 
Benzoyl adenosine (99) (4.0 g, 10.8 mmol) was dried azeotropicaily by the 
addition and evaporation of aliquots of dry DMF (3 x 20 ml). The resulting 
residue and imidazole (4.40 g, 64 mmol) were dissolved in dry DMF (15 mi) 
under an argon atmosphere, and f-butyldimethylsilyl chloride (4.54 g, 32.3 
mmol) added. The reaction mixture was stirred at room temperature for 2 hours 
and quenched by the addition to ammonia solution (40 ml, 5%). The silylated 
adenosine derivatives were extracted into ethyl acetate (3 x 50 ml) and the 
extracts dried (MgSG4). The solvents were removed in vacuo to give a mixture 
of four compounds as a yellow oil. The products were separated by short silica
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column chromatography, (0-35% ethyl acetate/ petroleum ether, in 5% steps) to 
give the desired product as a white foam (3.89 g, 36%); (Found: C, 57.6; H, 
7.95; N, 11.4: Calc, for CggH^sNsOgSig: C, 58.05; H, 7.55; N, 11.65%); m/z
(Found: [M +H]^ 600.3040. CggH^gN 5O5 Slg requires 600.3037); [a]p-2 1 ° (c
0.33 in EtgO); (nujol)/ cm“  ^ 3300 m (0-H), 2900 s (C-H), 1710 s (amide
0=0), 1450 s, 1240 m, 1050 m and 850 m; 6^(200 MHz; O^HOIg) 0.03 (3H, s), 
0.05 (3 H, s), 0.13 (3H, s) and 0.14 (3H, s) (SiOHg), 0.87 (9H, s) and 0.93 (9H, s)
(S i^u Hg s), 3.85 (2H, ABX, Hz, g A^ ‘ 4^ ’ 5 ’b ^  Hz, 5 Hg), 4.11
(1H, q, J4. 3 , 4 Hz, J4. 5 . 3 Hz 4'H), 4.57 (2H, m, 2’H and 3'H), 6.07-6.09 (1H, d, 
Jy 2' 4 Hz, 1'H), 7.53 (3H, m, Ar-H meta and para), 8.02 (2H, m, Ar-H ortho), 
8.21 (1H, s, adenine H), 8.76 (1H, s, adenine H) and 9.24 (1 H, bs, amide NH);
6c (75 MHz; O^HOIg) -1 0 .2  - -10.3 (SiOHg's), 18.6, 18.9 (Sif-Bu, quaternary 0),
26.4, 26.9 (Si^Bu OHg's), 64.7 (5'-0), 72.1, 75.6, 86.0, 89.4 (ribose ring 0),
123.8 (5-0), 128.4,129.3 (Ar-0 mata and para), 133.2 (Ar-0 ortho), 134.2 (Ar-0 
quaternary), 142.1 (8-0), 150.1, 152.1, 153.1 (2-0, 4-0 and 6-0), and 165.3
(amide 0=0); m/z (Oi) 600 ([M+ H f , 70 %), 343 (5, [TBDMSOg ribose + H]+),
240 (100, [AdBz + H]+) and 121 (10, BzNHg+); TLO: 2’,3’,5’-tris-0-TBDMS-
N^BzAd, Rf = 0.93; 2',5'-bis-OTBDMS-N6Bz Ad, Rf = 0.67; 3’,5*-bis-0-TBDMS-
N®Bz Ad, Rf = 0.58 and 5 -aTBDMS-N^Bz Ad, Rf = 0.48 (50% ethyi acetate/ 
diethyl ether).
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NHBz
TBDMSO
TBDMSO Q
NC
N^-Benzoyl 3*,5 '-0-^Butyl €limethy!silyl-aci@nosine-2’-0 - (N ,N * -  
diisopropyl eyanoethy I) phosphoramidite (101):1^8,183 Diisopropyl 
ethyl amine (2.97 ml, 16.9 mmol), DMAP (106 mg, 1.69 mmol) and N’N- 
diisopropyl(cyanoethyl)chlorophosphoroamidite (1.31 g, 0.97 ml, 5.5 mmol) 
were dissolved in THF (40 ml) under an argon atmosphere, and the mixture
stirred at room temperature for 10 minutes. A solution of N®-Benzoyl 3',5'-0- 
^utyl dimethyisilyl adenosine (100) (2.5 g, 4.24 mmol) in THF (30 ml) was 
added dropwise, and the reaction mixture was stirred at room temperature for 3 
hours. The solvents were removed in vacuo, and the resulting oil partitioned 
between ethyl acetate (50 ml) and saturated sodium bicarbonate solution (50 
ml). The organic layer was washed with saturated sodium bicarbonate solution 
(3 X 30 ml) and dried (MgSO^) The solvents were removed in vacuo, and the 
residue applied to a triethylamine basified silica column (35% ethyl acetate/ 
petroleum ether) giving the desired product as two separate diastereomers
(2.11 g, 62%); Lower Rf diastereomer; m/z (Found, [A4 +Na]"^ 822.3935.
^ 3 8 *^ 6 2N7 0 eSi2Na requires 822.3935); [aj^ -62.2° (c 0.8 in CH3OH);
(nujol)/ cm-1 3200 bs, 1700 s (amide C=0), 1611 s, 1460 s, 1250 s and 1073 s;
ÔH (200 MHz; C^HCIg), 0.09 (3H, s, SiCHg), 0.11 (3H, s, SiCHg), 0.13 (3H, s,
SiCHg) and 0.14 (3H, s, SiCHg), 0.92 (9H, s, Si^BuCHg’s) and 0.94 (9H, s,
Si^uCHg's), 1.13 (12H, dd, J\prCH3,P 1^ 6 Hz, »/iPrCH3,iPrH 6 G Hz, ^PrCHg's), 
3.58 (4H, m, CHgCN), 3.90 (2H, ABX, g g 11.4 Hz, */4,*^5 ’j \ 3 .6  Hz, t/4 'g 'g 3 .4
Hz, 5'-Hg), 4.15 (1H, q, J4.3 ,3.6 Hz, 4 Hz C4’-H), 4.55 (1H. t, J4. 3 ' 4 Hz,
L/2 ,3 ' 4.4 Hz C3’-H), 4.70 (1H, dt, Jg'.s' 4.5 Hz, Jy g' 5.2Hz, Jg. p 10 Hz, 2'-H),
6.35 (1H, d, Jy 2 ' 4.9 Hz, T-H), 7.58 (3H, m, Ar-H meta and para), 8.05 (2 H, m,
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Ar-H ortho), 8.39 (1H, s, adenine-H) and 8.80 (1H, s, adenine-H) and 9.14 (1 H, 
s, amide NJÜ): Sq (75 MHz; C^HCIg) -4.9 - -3.9 (SiCHg's), 18.6 (Sl'Bu, 
quaternary C), 18.9 (Sl'Bu, quaternary C), 23.1 ('PrCHg), 23.2 (frCHg) 24.9 
(Sl'Bu CHg's), 43.5 ('PrC-H), 43.9 (PrC-H), 58.4 (Jp Q 18 Hz, POCHg), 62.8 (5’- 
C), 70.8 (4’-C), 77.0, 77.2 (2’-C Jp,c 15 Hz), 86.0, 87.9 (I'-C and 4-C), 116.9 
(CN), 123.7 (5-C), 128.4,129.3 (Ar-C meta and para), 133.2 (Ar-C ortho), 134.3 
(Ar-C quaternary), 142.6 (8 -C), 149.9, 152.3, 152.9 (2-C, 4-C and 6-0) and
165.3 (amide 0=0 ); Sp (121.5 MHz; O^HOig) 150.4; m/z (FAB) 823 ([M+ Na]+, 
45%), 801 (1 0 , [M+ H]+), 699 (25, [M - iPrjNH]+), 343 (45, [(TBDMS0 ) 2  ribose + 
H]+), 262 (15, [AdBz + Na]+) and 240 (45, [AdBz + Na]+); R, = 0.32 (50 % ethyl 
acetate/ petroleum ether).
Higher R, diastereomer; m/z (Found: [M + Na]+ 822.3935. CggHggNyOgSigNa
requires 822.3935); [a]p -54.4° (o 0.8 in OHgOH); (nujol)/ cm 1 3200 bs,
1700 s (amide 0=0), 1611 s, 1456 s, 1255 s, 1073 s and 839 s; 8^ (200 MHz ;
O^HOig), 0 .1 0  (3H, s, SiOHg), 0.11 (3 H, s, SiOHg), 0.15 (3 H, s, SiOHg) and 0.20
(3 H, s, SiOHg), 0.92 (9H, s, Si‘Bu OHg), 0.95 (9H, s, Si'Bu OHg), 1.15 (12H, dd,
4 prCH3,P ^4.6 Hz, >/iPrCH3,iPrH 5 6 Hz, 'PrOHg's), 3.60 (4H, m, OHgON), 4.00 (3H, 
m, 5 '-H2 and 4'-H), 4.55 (1H, t, J4. 3 . 4 Hz, ^2 ,3 ' 4.4Hz 3’-H),4.86 (1 H, dt, Jg'.s'
4.5 Hz, 2 ' 5.2 Hz, J2 ',p 10 Hz, 2 '-H), 6.25 (1H, d, 4.9 Hz, I ’-H), 7.58 (3H, 
m, Ar-H meta and para), 8.05 (2H, m, Ar-H ortho), 8.39 (1H, s, adenine OH),
8.80 (1H, s adenine OH) and 9.12 (1H, bs, amide NH); 5c(75 MHz; O^HOig) -
4.9 - -3.9 (SiOHg's), 17.0, 17.3 (Sl'Bu, quaternary 0), 23.1, 23.2 ('PrOHg) 24.7,
25.0 (Si'BuOHg's), 41.9, 42.1 ('PrO-H), 57.1, 57.3 (Jp ^ lO  Hz, POOH2), 61.0 (5’ 
-H2), 69.9 (4’-0), 74.9, 75.1 (2’-0 Jp c15 Hz), 84.3, 86.4 (I'-O and 4’-0), 115.6 
(ON), 122.1 (5-0), 126.6,127.7 (Ar-0 meta and para), 131.6 (Ar-0 ortho), 132.7 
(Ar-0 quaternary), 140.8 (8-0), 148.3, 150.4, 151.5 (2-0, 4-0 and 6-0) and
165.4 (amide 0=0 ); 8p (121.5 MHz; O^HOig) 150.6; m/z (FAB) 823 {[M + Na+, 
90%), 801 (5, [M + H]+), 700 (40, [M + H - 'Pr2 NH]+), 343 (1 0 0 , [(TBDMSO); 
ribose + H]+), 262 (45, [AdBz + Na]+) and 240 (55, [AdBz -r Na]+); R,= 0.39 (50% 
ethyl acetate/ petroleum ether).
110
NHBz
TBDMSO
TBDMSO O,
NO
NO
N^-Benzoyl 3*,5*-b ls-0-f-B utyld lm ethyls ily i ad en o s in e -(2 -b is - 
cyanoethyl) phosphorothloate (1 0 2 ):^^^ jq  tetrazole (0.3 g, 4.2 
mmol) in dry acetonitriie (10 ml) under an argon atmosphere was added 3- 
hydroxy propionltrlle (0.41 ml, 6.0 mmol). The protected phosphoramidite 
nucleoside (101 ) (1.58 g, 2.0 mmol) in dry acetonitriie (10 ml) was added, and 
the reaction mixture stirred at room temperature for 3 hours. The solvent was 
removed in vacuo and the resulting oil redissolved in dry pyridine (2 0  ml). 
Sulfur (0.64 g, 20 mmol) was added and the reaction mixture stirred at room 
temperature for 15 minutes. Excess sulfur was removed by filtration, using ethyl 
acetate as a solvent for the phosphorothloate. The product was further purified 
by silica column chromatography on triethylamine basified silica gel (65% ethyl 
acetate/ petroleum ether) to give the product as a white foam. (0.75 g, 48%);
m/z (Found: [M+ 802.3003. CggHggNyOyPSSig requires 802.3003); [a]p
“50.6° (c 0 .6  in CH3OH); u^ax (nujol)/ cm'"* 2520 w, 1700 s, 1580 s, 1550 s, 
1300 s, 1150 s, 1000 s, 950 w, 930 w, 890 w, 830 m, 790 m and 725 s; (200 
MHz; C^HCIa) 0.12 (3H, s, Si-CHg), 0.13 (3H, s, Si-CHg), 0.17 (3H, s, Si-CHg),
0.19 (3H, s, Si-CHg), 0.93 (9H, s, Si-^uCHg), 0.96 (9H, s, Si-^uCHg), 2.62 
(2H, t, CHgCN), 2.69 (2H, t, CHgCN), 3.90 (2H, ABX, 3  11,6 Hz, 2 9 Hz, 
Jq x ^.3 Hz, 5'-H), 4.20 (5H, m, 4’-H and POCHg), 4.60 (1H, t. J4. 3. 3.1 Hz, Jg-.a*
4.3 Hz, 3'-H), 5.40 (1H, dq, 6.2 Hz, Jg',3 ' 4.7 Hz, Jg. p 10.6 Hz, 2'-H), 6.40 
(1H, d. Jp g’ 6.2 Hz T-H), 7.55 (3H, m, Ar-H meta and para), 8.05 (2H, d, J 6 .8  
Hz, Ar-H ortho), 8.81 (1H, s, adenine-H) and 8.82 (1H, s, adenine-H); 0q(75.5 
MHz; C^HCIg) -4.8, -4.4, -4.0 (Si-CH3 's), 18.9, 19.3 (Sl'Bu quaternary C), 20.0,
20.1, 20.2 (CHgCN), 26.5, 26.7, 26.8 (Si'BuCHg), 60.3, 62.2, 62.4, 62.8 (5’-C
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and POCH2), 72.0. 80.4, 86.3, 87.2 (ribose C-H), 117.0,117.1 (CN), 123.9 (5-C),
128.7,129.6 (Ar-C meta and para), 133.6 (Ar-C ortho), 134.3 (Ar-C quaternary),
142.5 (8 -C), 150.4, 152.7, 153.3 (2-C, 4-C and 6 -C) and 165.6 (amideC=0); 5p
(121.5 MHz; C^HCIg) 66.5; m/z (FAB) 824 {[M+ Na]+, 100%), 802 (55, [M-f- H]+)
and 600 (5, [ M+H-  PS(OR)2D .
NH.
HO
-O -O
Adenosine 2’-phosphorothioate b is-cyclohexylam ine sa il (103):^^^ 
N®-Benzoyl 3 ’,5’-bis-0-f-Buty!dimethylsilyl adenosine-(2’-biS“Cyanoethyl) 
phosphorothloate (102) (300 mg, 0.375 mmol) was dissolved in an ethanollc 
ammonia/ concentrated ammonia solution (1:3 v/v; 5 ml) in a sealed glass vial, 
and stirred at 60 °C for 20 h. The solvent was removed in vacuo and the residue 
partitioned between 5% ammonia solution (5 ml) and diethyl ether (10 ml). The 
organic phase was washed with water ( 3 x 5  ml) and the combined aqueous 
phases concentrated under reduced pressure. The resulting oil was dissolved 
in dry THF (2.0 ml) and tetra-n-butyl ammonium fluoride (1.0 M solution in THF, 
0.8 ml) added. The reaction mixture was stirred for 10 hours and the solvents 
removed in vacuo. The residue was redissolved in water (2 ml) and the product 
subjected to ion exchange chromatography on Amberlite IR 118
(cyclohexylammonium)t The uv active fractions were combined and lyophilised 
to give a white solid (35 mg, 53%); m.pt. >250°C; (Found: C, 47.65; H, 7.25; N,
17.1. Calc, for C22H40N7O6 PS: 0, 47.1; H, 7.2; N, 17.45%); [a]D-41.2° (c 1.4 in
CH3OH); (nujol)/ cm"  ^ 3400 bs, 2200 w, 1700 s, 1300 s, 1150 s and 700 s;
Ôh (200 MHz; ^H2 0 ), 0.9-2.1 (cyclohexyl CH2), 3.10 (cyclohexyl CH), 3.85 (2H,
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m, 5’-H), 4.28 (1H, m, 4'-H), 4.38 (1H, m, 3 -H), 5.20 (1H, m, 2'-H), 6.00 (1H, d, 
Jy 2' 6.0 r-H), 8 .2  (1H, s, adenine-H) and 8.4 (1H, s, adenine-H); (75.5 MHz;
2 H2O) 26.7, 27.3, 33.3 (cyclohexyl CH2), 53.2 (cyclohexyl CH), 64.7 (5 -C), 73.6 
(4'-C), 79,1 (3'-C), 88.5 (l'-C), 90.5 (2 -C) 12 1 .8  (5-C), 144.0 (8 -C), 151.5, 155.2
and 158.2 (2-C, 4-C and 6 -C); ôp (121.5 MHz; 2H2O) 45.2; m/z (FAB) 463 ([M- 
CgH^^N + H]+, 2%), 430 (4, [M (bis sodium sait) + Na]+), 408 (10, [M (mono 
sodium sait) + Na]+), 386 (15, [M (mono sodium sait) + H]+), 364 (15, [M (free 
acid) + H]+) and 272 (25, [M- thiophosphate + Na]+).
3-Hydroxy propionitrile:'*®® To water (1.0 g, 1.0 ml, 55.6 mmol) in dry 
acetonitriie (5 ml) was added dry acrylonitrile (3.7 ml, 56 mmol) and the reaction 
mixture stirred at room temperature under an argon atmosphere. Freshly cut 
sodium metal (50 mg) was added with extreme caution, and the reaction 
mixture stirred at room temperature for 6 days. Hydrochloric acid (0.36 ml, 6 M) 
was then added and the solvents removed in vacuo. The residue was 
resuspended in acetone (30 ml) and the salts removed by filtration. The solvent 
was once again removed in vacuo to give a pale yellow liquid (crude yield 
94%), which was purified by distillation at reduced pressure (3.20 g, 81%); b.pt.
105 °C, 10 mm/ Hg. (lil.J^G 2 2 8  °C); D^ax (nujol)/ cm'^ 3470 bs (OH). 2250 s,
1680 8,1410 s. 1350 s, 1200 s and 1070 s; By (200 MHz; C^HCIg), 1.70 (1 H, bs,
OH), 2.60 (2 H, t, CHgCN) and 3.70 (2 H, t, OCHg); Bq (50.5 MHz; C^HCIg), 19.3
(ÛHgCN), 66.3 (OCHg) and 112.8 (CN); nVz (El), 71 {M*-, 55%), 54 (70, [M -
0H]+) and 45 (58, [M- CN]+).
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,0H
OH
(+)-(S)-Phenyl ethane-1,2-d io l (106):^®^ (+)"(S)-Mandelic acid (31) (7.5 
g, 50 mmol) in dry THF (100 ml) was added over a period of 2 hours to a stirred 
suspension of lithium aluminium hydride (2.0 g, 55 mmol) in dry THF (100 ml) 
under a nitrogen atmosphere. The reaction mixture was stirred under reflux for 4 
hours, and then stirred overnight at room temperature. Water (5 ml) was added 
with extreme caution, and the resulting suspension filtered through celite. The 
precipitate was washed with diethyl ether (50 ml) and the solvent removed in  
vacuo to yield a solid residue that was recrystallised from toluene and hexane
to give white crystals (5.68 g, 83%); m.pt. 65-66°C, lit.,^ G4 qj o q . /n/z(Found: 
138.0681. CgHioOg requires 138.0681); [a jp +58.2° (c 0.97 in EtgO) (lit.,184 
+60.7° (c 0.97 in EtgO)); o)max (nujo!)/ cm"1 3350 bs, 3210 bs (0-H), 1530 
m, 1200 w, 1305 w, 820 m, 680 w and 650 w; 6^ (200 MHz; C^HCIg), 3.65 (2H, 
m, 1-OH and 2 -OH), 3.65 ( 2H, ABX, g 11.6 Hz, 3 6 Hz, 8.1 Hz, 2- 
Hg), 4.75 (1H, q, Ja.X 3-6 Hz, Hz, 1-H) and 7.30 (5H, m, Ar-H); (50.5
MHz; C^HCIg), 68.3 (2-C), 75.1 (1-0), 126.6, 128.4, 129.0 (Ar-C) and 141.0 (Ar- 
C quaternary); m/z (El) 138 (M +, 20%), 107 (1 0 0 , [M-CHgOHf) and 77 (90, 
Ph+).
OH
OT@
1“(S )-P henyle thano l"2 -tosyla îe  (lOT):'’ ®^  (+)-s-Phenyl ethane-1,2-diol 
(106) (4.80 g, 35 mmol) was dissolved in pyridine (10 ml) under an argon
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atmosphere, and cooled to 0 °C. p-Toluene sulphonyl chloride (7.15 g, 37.5 
mmol) was added, and the reaction mixture stirred at 4°C for 3 days. The 
solution was poured into ice water (70 ml), and extracted with diethyl ether (3 x 
70 ml). The combined organic fractions were washed with hydrochloric acid (2 x 
70 ml, 1 M) and water (70 ml) and dried (NagSO^). The solvent was removed 
in vacuo to give an off white solid that was recrystallised from toluene and 
hexane to give white needles (8.76g, 8 6 %); m.pt. 71-72°C, (lit.,^®^ 72 °C); 
(Found, C, 61.9; H, 5.5: Calc, for 0, 61.65; H, 5.65%); m/z (Found:
[M+NH4I+ 310.1110. C15H20O4SN requires 310.1113); [a]p+31.2° (c 4.22 in
GH3OH), (lit.,103 [a]o+30.3° (c 3.35 in CH3OH)); D^ax (nujol)/ cm"1 3540 s (O- 
H), 1730 w, 1370 s, 1180 S (OSOg), 1000 s, 925 s, 850 s, 816 s, 760 s, 685 s 
and 651 s; 8^(200 MHz; C^HOy, 2.45 (3H, s, Ar-GH3 ), 2.60 (IN, bs, OH), 4.10 
(2H, ABX, Ja.b 10 3 Hz, Jp^  x 3*5 Hz, Jb,x3*4 Hz, 2-Hg), 4.95 (1H, q, 3.5 Hz, 
Jg X 3 4 Hz, 1-H), 7.35 (7H, m, Ar-H) and 7.75 (2 H, d, J8.4 Hz, tosyl Ar-H ortho
to sulfur); ÔQ (50.5 MHz; G^HCy, 21.5 (Ph-GH3), 71.8 (2-G), 74.2 (1-G), 126.0,
127.8, 128.4, 128.5, 129.8 (Ar-G), 132.4 (Ph-Me quaternary G)138.1 (Ar-G 
quaternary) and 144.9 (Ph-S0 2  quaternary G); m/z(GI) 310 {[M+ NH4]+, 100%), 
292 (5, M+), 275 (50, [M + H - H2 0 ]+), 156 (60, MePhSOg"^) 120 (60, [M+ H- 
GH2 0 Tsr), 91 (70, PhGH3+) and 78 (15, [Ph + H]+).
.OH
(S )-2-lod lophenytethanol (28):133 1 -(S)-Phenylethanol-2-tosylate (107) 
(4.0 g, 14 mmol) and tetra-n-butyl ammonium iodide (10.0 g, 28 mmol) were 
dissolved in dry benzene (60 ml) and heated under reflux, under an argon 
atmosphere for 5 hours. On cooling, the solution was washed with water (100 
ml), 5% sodium bisulphite solution (2 x 100 ml), saturated sodium bicarbonate 
solution (100 ml) and water (100 ml). The organic phase was dried (MgS0 4 )
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and the solvent removed in vacuo to give a brown oil, which was recrystaiilsed 
from petroleum ether to give pale yellow needles (2.56g, 76%); m.pt. 28-29 °C, 
(lit.,103 30 °C); (Found: C, 38.7; H, 3.65. Calc, for CgHgOI; 0, 38.75 H, 3.65%); 
m/z (Found: [M + NH4 - HgOf 247.9940. CgHnON requires 247.9938); (a]o + 
47.8“ (c 0.62 In CHGIg). (lit.,103 [a]g+ 43.6“ (c 1.58 In CHCI3)); (oujol)/ cm" 
1, 3800 bs (0-H), 1560 m, 1505 s, 1250 m and 570 s (0-1); 5h (200 MHz; 
C^HCIg), 2.50 (1H, bs, OH), 3.45 (2 H, ABX, 10.3 Hz, Ja,x3.7 Hz,
Hz, 2 -H2), 4.82 (1H, q, Ja,x 3 7 Hz, Jb,x8-6  Hz, 1-H) and 7.40 (5H, m, Ar-H); Sq 
(50.5 MHz, C^HCIg), 15.9 (2-0), 74.5 (1-0), 126.2, 128.9, 129.2, (Ar-0) and
141.6 (Ar-0 quaternary); m/z(01) 248 {[M+ NH4 - HgOji-, 15%), 231 (10, [M +H 
- HaOji-), 138 (30, [/W+ NH4 - 1]+), 122 (40, [M+ H - l]+) and 108 (25, [W + H - 
0H2l]+).
y - C
N ,N ’ -d i is o p ro p y ld ic h lo ro p h o s p h o ra m id i te  (115);130 Dry 
diisopropylamine (31.8g, 44.3 ml, 0.155 mol) in dry diethyl ether (75 ml) was 
added dropwise to a vigorously stirred solution of phosphorus trichloride (114) 
(21.3 g, 0.155 mol) in dry diethyl ether (75 ml), at -20 °G under a nitrogen 
atmosphere. After 2 hours the reaction was allowed to warm to room 
temperature and stirred for a further 1 hour. The salts were removed by filtration 
and solvent removed in vacuo. The residue was fractionally distilled at reduced 
pressure to yield the product as a colourless liquid which solidified on cooling.
(18.8 g, 60 %), b.pt. 80-81 “0, 8 mm Hg, (lit.,57 72-74“0, 7 mm Hg); m/z (Found: 
[/W1+201.0241. 0 gH i4NP0 l2 requires 201.0241 ); (nujol)/ cm'i 2800 s (0-
H), 1500 m, 1450 m, 1200 s and 1050 s; 8 ,^ (200 MHz; O^HOIg) 1.25 (12H, d, 
Jwe.H 6.3 Hz, 'Pr-OHg) and 3.90 (2H, dsept, Jp Hl2.5 Hz, Jwe.H 6 3 Hz, 'Pr-H);
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5c(50 MHz; C^HCIg) 23.7 (d, Jp g 8  Hz. Me-C) and 48.4 (d, Jp_c14.8 Hz, 'Pr-C); 
5p (121.5 MHz; C^HCIg) 169; m/z (El) 203 (/M* 35c|37CI, 6 %), 201 (15, 
35c|35ci), 186 (65, [Cl2 PN'Pr2-Me]+), 166 (46, CIPNlPr2+), 144 (48, Cl2 P'Pr+). 
124 (18, CIPNH'Pr+), 101 (8 , CI2 P+), 88  (32, PN'Pr^) and 43 (95. 'Pr+).
ON
ON
N,N-D lisopropyl-b is-cyanoethyl phosphoram id ite (116):5^'^30 jq  N,N- 
d iisopropyl d ichlorophosphoramid ite (115) (5.05 g, 25 mmol) in dry 
dichloromethane (2 0  ml), at -10 °C under a nitrogen atmosphere was added a 
soiution of 3-hydroxypropionitrile (4.6 g, 65 mmol) and anhydrous triethylamine 
(6 .6  g, 65 mmol) in dry dichioromethane (20 ml). The reaction mixture was 
stirred for 30 minutes, warmed to room temperature and stirred for a further 5 
hours. The reaction was diiuted with dichloromethane (50 ml), washed with 
sodium bicarbonate solution (50 ml, 5%), saturated brine (50 ml), dried 
(IVIgSO^) and the solvent removed in vacuo to yield a colourless oil (3.9 g,
61%); m/z (Found: [A4 ]+ 271.1452. C12H22N3O2 P requires 271.1450);
(nujol)/ cm-1 3000 s, 2280 w (CN), 1030 vs and 730 s; 6^ (200 MHz; G^HCIg)
1.20 (12H, d, JMe-H 7 Hz, /Pr-CHg), 2.62 (4H, t, 2 6  4 Hz, CHg ON) and 3.38
(7H, m, 'Pr-H and GHgOP); (50 MHz; G^HGIg) 20.5 (d Jp g 6.7 Hz, GH2 GN),
24.6 (d, Jpjpr-Me6-1 Hz, 'Pr-GHg), 43.5 (d, Jpjpr-CH  ^ Hz, 'Pr-G), 58.6 (d, Jp 2
18.8 Hz, GHgOP) and 118.0 (GN); ôp (121.5 MHz; GDGI3) 159; m/z (El) 271 
(A4+, 7%), 256 (35, [A4 -GH3I+), 201(25, [A4 - 0(GH2)2CNM, 171 (95, 
P(0 (GH2)2CN)2+), 70 (15, 0 (GH2)2CN+) and 54 (100, (GH2)2CN+).
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T D B M S a
1-0 -T B D M S -2 -b iscyanoe thane  1 ,2 -d io l phospha te  (112): f-Butyi 
dimethyisilyl chloride (1.5 g, 10 mmol) was added to a solution of ethylene 
glycol (110) (2.5 g, 50 mmol) and imidazole (1.85 g, 20 mmol) in dry DMF (30 
ml) under an nitrogen atmosphere, and the solution stirred at room temperature 
for 3 hours. The reaction was quenched by the addition of sodium bicarbonate 
solution (30 ml, 5%), and extracted into diethyl ether (3 x 30 ml). The pooled 
organic fractions were washed with water (20 ml) and saturated brine (30 ml), 
dried (Na2S0 4 ) and the solvent removed in vacuo to yield a colourless liquid 
which showed the expected NMR parameters. The silyl protected glycol was 
redissolved in dry acetonitriie (30 ml), and 1-H tetrazole (0.7 g, 10 mmol) added. 
A solution of N,N’-di iso propyl bis-cyanoethylphosphoramidite (116) (3.50 g,13 
mmol) was added and the reaction mixture stirred at room temperature under a 
nitrogen atmosphere for 1 hour. The reaction mixture was cooled to -10 °C and 
a solution of m-CPBA (50-60%, 5.3 g, 15 mmol) in dry dichloromethane (50 ml) 
added, and stirred for a further 1 hour. The reaction mixture was diluted with 
dichloromethane (30 ml), washed with sodium sulfite solution (3 x 50 ml, 10%) 
and saturated brine (30 ml) and dried (NagSO^). The solvent was removed in  
vacuo to yield a pale yellow oil which was purified by chromatography on 
triethylamine treated silica (ethyl acetate) to yield a colourless liquid (1.94 g, 
54%); nVz (Found, [A4 + H]+ 363.1505, G i4H2gN2 0 5 PSi requires 363.1505); 
Dmax (nujol)/ cm-1 3000 s (C-H), 1285 s (P=0), 1050 s and 820 s; Sh (200 MHz;
C^HCIg) 0.08 (6 H, S, SICHg), 0.90 (9H, s, 'BuGHg), 2.85 (4H, t, J  6.2Hz, 
CHgCN), 3.82 (2H, t, J 4.7Hz, l-Hg), 4.20 (2H, m, 2-Hg ) and 4.28, (4H, m, 
cyanoethyl POCHg): Sq (50.5 MHz; CDCIg) -4.9 (SICHg), 10.6 (*Bu quaternary),
2 0 . 1  (GHgCN), 26.3 (*BuCHg), 62.4 (1 -C), 62.6 (J 5.5Hz, cyanoethyl POCHg),
70.2 (J 6 . 2  Hz, 2-C) and 116.8 (CN);8 p (121.5 MHz; C^HCIg) -1.95; m/z(CI) 380 
{[M+ NH41+, 45%), 363 (100, [A4+ H]+), 310 (10, [M+ NH4  - cyanoethyl]+), 266 
(10, [M+ NH4 - TBDMS]+) and 249 (15, [M+ H-TBDMS]+).
1 8
o '
Ethane 1,2-diol monophosphate bis-cyclohexylammonlum salt 
(113): 1-0-TBDMS 2-biscyanoethylphosphate (112) (0.5 g, 1.38 mmol) was 
dissolved in dry methanol (5 ml), and sodium methoxide in methanol (5.0 ml, 
1.0 M) added. The reaction mixture was stirred at room temperature for 4 hours 
and the solvent removed in vacuo. The residue was redissolved in dry THF (1 
ml) and a solution of tetra-n-butyl ammonium fluoride (1.4 ml, 1.0 M in THF) 
added. The solution was stirred overnight at room temperature and the solvent 
removed In vacuo. The residue was redissolved in water (5 ml) and subjected to
chromatography on Amberlite IRA 118 (H)*** ion exchange resin, eluting with 
water. The acidic fractions were combined, concentrated to a volume of ca. 10 
ml, and excess cyclohexylamine (4 ml) added. The mixture was stirred at room 
temperature for 4 hours, and extracted with diethyl ether (3 x 30 ml) to remove 
excess cyclohexylam ine. The aqueous phase was lyophilised and 
recrystallised from aqueous acetone to yield white needles (0.31 mg, 60%); 
(Found: C, 44.95; H, 9.95; N, 7.55. Calc, for Ci^Hg^NgOsP- aHgO, 0, 44.7; H, 
9.9; N, 7.45 %); m.pt. 134-136 °G; (nujol)/ cm"i 3400-2400 bs (O-H and N-
H), 1270 (P=0), 1100 s, 970 s and 750 s ;6 |_, (200 MHz; ^HgO) 1.00-2.00 (20H, 
m, cyclohexyl CHg), 3.05 (2H, m, cyclohexyl CH), 3.65 (2H, t, J 4.5Hz, 2-Hg),
3.80 (2H, m, l-Hg); Ôq (50.5 MHz; ^HgO) 26.6, 27.1, 33.1 (cyclohexyl CHg), 53.0 
(cyclohexyl CH), 64.7 (2-C) and 67.8 (J 5.8 Hz, 1-C); ôp (121.5 MHz; ^H^O) 
3.98; /77/z (F A B ) 341 ([M+ H]+, 3%), 242 (100, [ M - CgHi^N + H]+), 165 (45, [M- 
2 (CgHi^N) + Na]+), 143 (7, [M -2 (CgHi^N) + H]+) and 101 (20, [CHA + H]+).
119
4-Penteri“1-ol (123): Allyl acetic acid (122) (5.0 g, 50 mmol) in dry THF (50 
ml) was added over a period of 30 minutes to a stirred suspension of lithium 
aluminium hydride (2.1 g, 55 mmol) in dry THF (50 ml) under a nitrogen 
atmosphere. The reaction mixture was stirred for a further 30 minutes, water (5 
ml) in THF (20 ml) added with extreme caution, and the resulting suspension 
filtered. The precipitate was washed with diethyl ether (100 ml) and the solvent 
removed in vacuo to give a pale yellow liquid that was kugelrohr distilled to give
a colourless liquid (3.7 g, 43.1 mmol, 86 %); b.pt. 130-132 °C (lit.,^^^ 134-137 
°C); Umax (nujol)/ cm'l 3150 bs (0-H), 3490 s (C-H), 3080 m (vinyl C-H), 1641 s 
(C=C) and 1050 s (C-0); Ôh (200 MHz; C^HCy 1.65 (2 H, m, 2-Hg), 1.95 (1H, 
bs, OH), 2.10, (2H, m, 3 -H2) 3.60 (2H, t, 2 0.6 Hz, l-Hg), 4.95 (2H, m, 5-Hg) 
and 5.80, (1H, m, 4-H); 0c(50.5 MHz; C^HCIg) 30.5, 32.0 (2-C and 3-C), 62.8 (1- 
C), 115.4 (4-C) and 138.6 (1-C); m/z (Ei) 86 (M+, 1%), 68 ([M- HgOj^, 70%) and 
67 (100, [M - H2O - H]+); Rf = 0.25 (20% ethyl acetate/ petroleum ether)..
OH
Pentane-1,2,5-trio l (118):^04 2-Ketoglutaric acid (117) (2.5 g, 17.1 mmol) 
in dry THF (50 mi) was added over a period of 30 minutes to a stirred 
suspension of lithium aluminium hydride (1.63 g, 42.9 mmol) in dry THF (75 ml) 
under a nitrogen atmosphere. The reaction mixture was stirred for a further 1 
hour. Water (2.5 ml) in THF (10 ml) was added with extreme caution, and the 
resulting suspension filtered. The precipitate was washed with acetone (100 ml) 
and the solvent removed in vacuo. The residue was redissolved in acetone, and 
dried (MgSO^). The solvent was removed in vacuo to give a colourless liquid 
(0.93 g, 45%); m/z (Found: [M + NH^j^ 138.1130. CgH^gOgN requires 
138.1130); Dmax (nujol)/ cnr' 3350 bs (0-H), 2900 s (C-H) and 1075 s (0-0); Ôh 
(200 MHz; 2HgO),1.45 (4H, m, O-Hg and 4 -H2). 3.50 (4H, m, and 5-Hg) and 
3.60 (1H, m, 2-H); ôc (50.5 MHz; ^HgO) 30.3, 31.6 (3-0 and 4-0), 64.4 (5-0),
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6 8 .2  (1-C) and 74.4 (2-C); m/z (Cl) 138 ([M+ NH4]+, 100%), 121 (100, [M^  H]+), 
103 (5, [M+H -H2 0 ]+) and 85 (10, [M +H - 2 H2 0 ]+).
H O
"SI" •S I*
1.5-Bis-O-f-butyldimethylsilyl pentane-1,4,5-triol (119): To pentane-
1.4.5-triol (118) (0.72 g, 6.0 mmol) and Imidazole (0.9 g, 13.4 mmol) in dry DMF 
(2 0  ml) was added r-butyl dimethyl silyl chloride (2.0 g, 13.4 mmol). The reaction 
mixture was stirred at room temperature under a nitrogen atmosphere for 24 
hours. The solution was added to sodium bicarbonate solution (30 ml, 5%), and 
extracted into diethyl ether (3 x 50 ml). The organic phase was washed with 
saturated brine (30 ml) and dried (Na2S0 4 ). The solvent was removed in 
vacuo to yield a pale yellow liquid that was purified by silica column 
chromatography (1 0 % ethyl acetate/ petroleum ether) to give a colourless 
viscous liquid (1.43 g, 6 8 %); (Found: C, 58.7; H, 11.7. Calc, for C-j7144003812:
C, 58.6; H, 11.6%); m/z (Found: [M + H]+ 349.2594. C^7 H4 f 0 3 8 1 2  requires 
349.2594); u^ax (nujol)/ cm"1 3400 bs (0-H), 2950 s (C-H), 1100 bs (81-0), 840 
s and 790 s; 0^ (2 00  MHz; C2HCI3) 0.05 and 0.06 (12H, 2 x s, 8 ICH3 ), 0.89 and 
0.90 (18H, 2 X s, ^uCH3), 1.30-1.75 (4H, m, 3-Hg and 4 -H2), 2.70 (1H, bs, OH), 
3.45 (1H, dt, 2-H) and 3.60 (4H, m, I-H2 and 5 -H2); 6c (50.5 MHz; C^HCIg) -4.9 
(8 ICH3 ), 18.8 (^ Bu quaternary), 26.4 (^ Bu CH3) 28.4 (4-C), 30.2, (3-C), 63.7 (5- 
C), 67.7 (1-C) and 77.2 (2-C); m/z (Cl) 349 ([M+ H]+, 100  %), 331 (10, [M+ H- 
H2OM, 235 (5, [M+ NH4 - TBDMSO]-*-), 217 (15, [M-f H - TBDM80H]-*-), 132 
(15, TBDM80H-*-) and 58 (3, B^u + H"*").
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OBn
OBn
N,N’-d iisop ropy ! b isbenzylphosphoram id ite  (116a):^30,i85 This was 
prepared In an identical manner to compound (116) from N,N’-diisopropyl 
dichloro phosphoramidite (116) and benzyl alcohol to produce a pale yellow oil
(5.2 g, 72%); m/z (Found: [M+ H]+ 346.1936. C20H29NO2P requires 346.1936); 
Umax (nujol)/ cm''* 3000 s (C-H), 1010 s (P-0), 750 and 700 s (C-H Ar out of 
plane); 6^ (200 MHz; C^HCIg), 1.30 (12H, d, J^e-H 6 8  Hz, fr-CHg), 3.75 (2H, 
dsept, Jmg-H 6 .8  Hz, Jp.^ 6.4 Hz 'Pr-H), 4.80 (2H, m, CH2OP) and 7.35 (10H, m, 
Ar-H); Ôq (50 MHz; C^HCig) 25.0 (/Pr-CHg), 43.6 (d, Jp c12.2 Hz, Pr-CH), 65.9 
(d, Jp c 18.1 Hz, BnCH2 ), 127.5, 127.7, 128.8 (Ar-C) and 140.1 (Ar-C 
quaternary); 5p (121.5 MHz; C^HCIg) 148.1; m/z (Cl) 346 ([M+ H]+, 100%), 238 
(5, [M- BnO]+) and 91 (10, Bn+).
OBn
TBDMS
OBn
OTBDMS
( 4. / - ) - 1 ,6 -B is -O - f -b u ty l d im e th y is i ly l p e n ta n e -1 ,2 ,6 - t r io l-  
d ibenzylphosphate  (1 2 Oa) :^ 6 0  (+/_)_1 ,5-bis-O-TBDMS pentane-1,2,5-trlol 
(119) (0.80 g, 2.29 mmol) and 1 -H-tetrazole (0.32 g, 4.59 mmol) were dissolved 
in dry acetonitriie (10 ml) under an argon atmosphere and a solution of N,N’- 
diisopropyl bisbenzylphosphoramidite (116a) (1.03 g, 2.98 mmol) in dry 
acetonitriie (5 ml) added. The reaction mixture was stirred at room temperature 
for 2 hours and cooled to -10 °C. A solution of m-CPBA (55-60% purity, 1.08 g, 
3.44 mmol) in dichioromethane (10 ml) was added dropwise, and the resulting
122
solution stirred at 0 °C for 1 hour. The reaction mixture was diluted with 
dichloromethane (60 ml), washed with 10% sodium sulfite soiution (3 x 30 ml), 
sodium bicarbonate solution (2 x 20 ml, 5%), saturated brine (30 mi) and dried 
over (Na2S0 4 ). The solvent was removed in vacuo to give a pale yellow oil 
which was purified by silica column chromatography on triethylamine basified 
silica (30% ethyi acetate/ petroleum ether) to give a colourless liquid (1.09 g, 
78%); (Found: C, 61.0; H, 9.2: Calc, for OayHseOgPSig: 0, 61.15; H, 8 .8 %); m/z
(Found: [M + H]+ 609.3200. CgiHgyOgPSig requires 609.3196); (nujol)/
cm-1 2800 s (C-H), 1500 $, 1275 s (P=0), 1100 s and 1000 s; 5^ (200 MHz;
C^HCig) 0.08 (12H, s, SICHg), 0.88 (18H, s, feuCHg), 3.60 (2H, t, J5.9 Hz, 5- 
Hg), 3.70 (2 H, ABX, 10 6 Hz, Jax^ -6  Hz, 1-Hg), 4.40 (1 H, m, 2-H), 5.05 (4H, 
d, Jp H7.7 Hz, Benzyl CHg) and 7.35 (10H, m, Ar-H); §c (50 MHz; C^HCig) -4.9, 
-4.8 (SICHg), 18.8 (teu quaternary), 26.3, 26.4 (%uCHg), 28.6, 29.0 (3-C and 4- 
C), 63.2 (5-C), 65.2 (1-C), 69.6 (Jp c5.7 Hz, Benzyl CHg), 80.1 (Jpg 6.4 Hz, 2 - 
C), 128.3, 128.8, 128.9 (Ar-C) and 136.5 (Ar-C quaternary); 6 p (121.5 MHz;
C^HCig) -1.1 ; m/z (Ci) 609 ([M+ H]+, 10%), 132 (5, [TBDMSO + H]+) and 58 (60, 
pBu + H]+).
NH;o-
o-
HO. OH
-J 2
(+/-)-Pentan@-1,2,5-triol-2-phosphate b is cyelohexylammonfum salt 
(121): (+/-)>1,5-bis-OTBDMS pentane-1,2,5-triol-dibenzyIphosphate (120a) 
(0.80 g, 1.31 mmol) was dissolved in methanol (10 ml) and palladium on 
activated charcoal (80 mg, 10 %) added with stirring. The reaction vessel was 
flushed with hydrogen gas (approx. 500 mi) and the reaction mixture stirred 
under a hydrogen atmosphere at room temperature for 16 hours. The mixture 
was filtered through ceiite and the solvent removed in vacuo. The residue was 
redissoived in THF (5 mi) and TBAF (1.0 M soiution in THF, 1.31 mi) added. The 
mixture was stirred for a further 4 hours, and the solvent removed in vacuo. The
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residue was redissoived in water (5 ml) and subjected to chromatography on 
Amberlite 118 (H)+ ion exchange resin eluting with water. The acidic fractions 
were combined, treated with freshiy distilled cyclohexylamine (3 mi, 26.6 mmol) 
and the reaction mixture stirred at room temperature for 4 hours. The aqueous 
soiution was extracted with diethyl ether (3 x 50 ml) to remove the excess 
cyxlohexylamine, and the sample lyophilised. The residue was recrystaiilsed 
from water/ acetone to give white crystals. (0.36 g, 69 %); m.pt. 165-167 °C;
(Found: C, 46.7; H, 9.8; N, 6.1. Calc. forCiyHggNgOg ^HgOiC, 47.0; H, 10.0; N, 
6.45%); (nujol)/ cm'l 3200-2400 bs (OH and H-bonding), 1280 m (P=Q),
1055 s, and 880 s; 5^ (300 MHz; ^HgO) 1.00-2.00 (24H, m, cyclohexyl CHg and 
3-Hg & 4-Hg), 3.15 (2H, m, cyclohexyl CH), 3.50-3.70 (4H, m, 1-Hg and 5 -H2) 
and 4.10 (1H, m, 2-H); Ôq (75 MHz; ^HgO) 26.5, 27.0 (cyclohexyl CHg), 30.0 (4- 
C), 30.8 (3-C), 35.0 (cyclohexyl CH), 64.4 (5-C), 67.5 (1-C) and 78.0 (Jp Q 5.4 
Hz, 2-C); ôp (121.5 MHz; C^HCIg) 2.6; m/z (FAB) 300 ([M- CgH^^N + H]+, 95%), 
223 (50, [/W- 2 (CgHi^N) + Na]+), 143 (5, [M- phosphate 4-  Na]+) and 121 (100, 
[M- phosphate + H]'**).
Pentane-1-b iscyanoethyl phosphate-4,5-epoxide (124): Penten-1-ol 
(123) (0.30 g, 3.48 mmol) was dissolved in dry acetonitriie (10 ml) under an 
argon atmosphere, and 1-H tetrazole (0.24 g, 3.48 mmol) added. A solution of 
N,N’-diisopropyi bis-cyanoethyl phosphoramidite (116) (1.18 g, 4.35 mmol) 
was added and the solution stirred at room temperature for 2 hours. The solvent 
was removed in vacuo and the residue redissoived in dichioromethane. The 
resulting solution was cooled to -10 °C and a soiution of m-CPBA (50-60% 
purity, 4.2 g, 12.0 mmol) in dichioromethane (50 mi) added dropwise, and the 
solution stirred for 1 hour. The reaction mixture was d iiuted w ith 
dichioromethane (60 ml), washed with sodium sulfite solution (3 x 30 ml, 10%), 
sodium bicarbonate solution (2 x 20 mi, 5%), saturated brine (30 ml) and dried
124
(NagSO^). The solvent was removed in vacuo to give a pale yellow oil which 
was purified by silica column chromatography on triethylamine basified silica
(ethyl acetate) to give a colourless liquid (0.63 g, 63 %); m/z (Found: [M + H]+ 
289.0953. C11H18N2O5 P requires 289.0953); (neat)/ cm’  ^ 3000 s (C-H), 
1260 s (P=0), 1050 s and 950 s; Ôh (200 MHz; C^HCig) 1.3-1.9 (4H, m, 2-Hg 
and 3-Hg), 2.45 (1H, q, 5-H), 2.75 (5H, m, 5-H and cyanoethyl CHgCN), 2.9 (1- 
H, m, C4H), and 4.2 (6 H, m, 1-Hg and cyanoethyl POCH2); 5q (50 MHz; C^HCIg)
2 0 .2  (HHgCN), 27.2 (2-C) 28.9 (3-C), 47.4 (5-C), 51.0 (4-C), 62.8 (Jp c5.3 Hz, 
cyanoethyl POCHg), 6 8 .8  (Jp Q 6.2 Hz, 1-C), and 117.2 (CN); ôp (121.5 MHz;
C^HCIg) -1.98; m/z (Cl) 306 ([M+ N H ^jt 70%), 289 (100, [M + H]+), 253 (15, 
[M - C3 H4 N + NH4M , 236 (17, [M - C3 H4 N + H f), 222 (25, [biscyanoethyl 
phosphate + NH4 ]"*") and 222 (10, [biscyanoethyl phosphate + H]'*').
O H
,0
HO. O
(+/“)“Pentane 1,2,5-trio l 5-phosphate b iscyc iohexylam m oniu iri sa lt 
(125); Pentane 1-biscyanoethyl phosphate 4,5-epoxide (124) (85 mg, 0.3 
mmol) was dissolved in acetone (0.5 ml) and sodium hydroxide solution (0.44 
ml, 0.88 mmol, 2 M) added. The solution was stirred at room temperature for 2 
hours, the solvent removed in vacuo. Excess sodium hydroxide solution (2.5 ml, 
2M) was added and the reaction mixture stirred for a further 3 hours.The solvent 
was once again removed in vacuo and the residue subjected to chromatograph 
on Amberlite 118 (H)^ ion exchange resin eluting with water. The acidic 
fractions were combined, treated with freshly distilled cyclohexylamine (1 ml,
8 .8  mmol) and stirred at room temperature for 4 hours. The aqueous solution 
was extracted with diethyl ether (3 x 50 ml) to remove the excess 
cyxlohexylamine, and the solution was lyophilised to yield a pale yellow gum 
which resisted crystallisation. (60 mg, 68  %); m/z (Found, [M (derivatised as the
dimethyl ester) + H]+ 229.0841. CyH^g OgP requires 229.0841); (nujol)/
125
cm-1 3200-2400 bs (OH and N-H), 1270 m (P=0), 955 s, and 900 s; 5h (200 
MHz; ^HgO) 1.00-2.00 (24H, m, cyclohexyl CH2 and S-NgS 4-Hg), 3.00 (2H, m, 
cyclohexyl OH), 3.40 (2H, m, 5-Hg) and 3.50-3.90 (3H, m, 1-Hg and 2 -H); 5c (75
MHz; 2HgO) 26.7, 27.2 (cyclohexyl CHg), 29.0 (4-0), 31.6 (3-0), 33.2 
(cyclohexyl OHg), 53.1 (cyclohexyl OH), 67,5 (J p c 5.0 Hz, 5-0), 68.2 (1-0) and
74.4 (2-0); 5p (121.5 MHz; O^HOIg) 2.66 ; m/z (01) (as the dimethyl ester) 243 
([M+ NH4)+, 40%), 229 (100, [M+ H]+), 214 (10, [M + H - Me]+), 114 ([dimethyl 
phosphate + NH^]*), 127 ([dimethyl phosphate + H]+).
.-Ck"COOH
(S)-2-Oxo 5-te trahyd ro fu rancarboxy lio  acid (129a):^^^ (S)-Glutamic 
acid (126a) (10.0 g, 70.0 mmol) was dissolved in hydrochloric acid (100 ml, 1 
M) and cooled to -10 °C. Sodium nitrite (6 .21  g, 90 mmol) was added 
portionwise over a period of 1 hour, and the reaction mixture stirred at room 
temperature for a further 16 hours. The solvent was removed in vacuo and the 
residue stirred in hot acetone (200 ml). The inorganic salts were removed by 
filtration and the solvent removed in vacuo. The residue was stirred in hot ethyl 
acetate (2 0 0  ml) for 1 hr, the solution decanted, and once again the solvent 
removed in vacuo to give the desired product which crystallised on cooling to 
give white crystals (7.78 g, 76 %); m.pt. 70-71 (lit.,^^^ 72-73°C); m/z (Found:
[M + 148.0610. requires 148.0610); (nujol)/ cm"  ^ 3000
bs (O-H), 1725 s, 1750 s (C=0 lactone and acid), 1470 s and 1490 s; [a]p+16° 
(c 6  in CH3OH), (lit.,174 [a]p +14^ (c 6  in CH3OH)); 0^ (200 MHz; ^HgO) 2.05-
2.35 (1H, m, 4-H), 2.40-2.65 (3H, m, 4-H & 3-Hg) and 4.90-5.05 (1 H, q,
Hz Jbx 7.0 Hz 5-H); 6^ (50 MHz; ^HgO) 26.5, 28.4 (3-C & 4-C), 78.0 (5-C),
175.1 (2-C) and 181.8 (COOH); m/z (Cl) 148 ([M+ NH^ J"*", 50%), 102  (20, [A4+ H 
- COgHgM and 85 (30, [M - COgHJ^).
26
.k3<:"^COOH
(R )"2 -O xo»5 -t© trahyd ro fu ranca rboxy lic  acid (129b):^^^ This was 
prepared in an identical manner to compound (129a) from (R)-glutamic acid 
(126b). M o -14° (c 6  in CHgOH), (lit.,1^4 [aJp-U^ (c 6 in CHgOH)); All other 
spectral data was identical to that obtained for the (S)-enantiomer (129a).
OH
(S )-1 ,2,5-Pentane tr io l (118a):^^^ (S)-2-Oxo-5-tetrahydrofurancarboxylic 
acid (118a) (2.0 g, 15.4 mmol) in dry THF (30 ml) was added dropwise with 
stirring under a nitrogen atmosphere to a suspension of lithium aluminium 
hydride (1.17 g, 30.8 mmol) over a period of 30 minutes. The reaction mixture 
was stirred for 1 hour, and water (3 ml) in THF (15 ml) added with extreme 
caution. The resulting suspension was filtered and the solvent removed in  
vacuo. The residue was redissoived in acetone (50 ml) and dried (Na2 S0 4 ). 
The solvent was removed in vacuo to yield a colourless viscous liquid (0.84 g,
45%); [a]Q“8.0° (c 1.7 in C H gO H ); All other spectral data was identical to that 
obtained for the racemic compound (118).
OH
(R)-Pentane-1,4,5-triol (118b): This was prepared in an identical manner 
to compound (118a) from (R)-2-oxo-5-tetrahydrofurancarboxylic acid (129b). 
[a]Q +7.5° (c 2.05 in C H g O H ); All other spectral data was identical to that 
obtained for the racemic compound (118).
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TBDMSO OTBDMS
(S )-1 ,5 -B is-0 -f-bu ty ld im e thy ls ily l pentan@1,4,5-trfol (119a): This was 
prepared in an identical manner to compound (119) from (S)-Pentane-1 ,4,5-
triol (118a). [a]p-7.9 ° (c 5 in EtgO); All other spectral data was identical to that 
obtained for the racemic compound (119).
OH
TBDMSO, ,OTBDMS
(R )-1 ,5 -B is -0-f-buty ld iine thyls ily! pentane1,4,5-triol (119b): This was 
prepared in an identical manner to compound (119) from (R)-Pentane-1,4,5-
triol (118b). [a]Q+8.5° (c 4.2 in EtgO); All other spectral data was identical to 
that obtained for the racemic compound (119).
TBDMSO OTBDMS
(S )-1 ,5 -B is -O -T B D M S  pen tane  1 ,2 ,5 - tr lo l-d  I b e n zy l p h o s p h a te  
(120a): This was prepared in an identical manner to compound (120a) from
(S)-1,5-bis-oWyldimethylsilyl pentane 1 ,4,5-triol (119a). [ajp -1 0 .2 ° (c 2 .5  in 
EtgO); All other spectral data was identical to that obtained for the racemic 
compound (1 2 0 a).
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OBn
TBDMSO, ,OTBDMS
(R )-1 ,5 -b is -O  -TBDMS pentane-1 ,2 ,S-trlo l-d ibenzylphosphata  
(120b): This was prepared in an identical manner to compound (120a) from 
(R)-1,5-bis-Of"butyldimethylsilyl pentane 1,4,5-triol (119 b). [ajp +10.3° (c 2.5 in 
EtgO); All other spectral data was identical to that obtained for the racemic 
compound (1 2 0 a).
- J 2
(S)-Pentane 1,2,5-triol-2-phosphate bis cycfohexylammonlunn salt 
(121a): This was prepared in an Identical manner to compound (121) from 
(S)-1,5-biS“0 -TBDMS pentane-1,2,5-triol 2-dibenzylphosphate (120a). [a]p - 
2.1° (c 1.4 in H2O); All other spectral data was identical to that obtained for the 
racemic compound (1 2 0 a).
O"
o
HO. OH
(R)-Pentane 1,2,5-triol 2-phosphate bis-cyciohexyiammonium salt
(121b): This was prepared in an identical manner to compound (121) from 
(R)-1,5-biS“0-TBDMS pentane 1,2,5-triol 2-dibenzylphosphate (120b). [a]p 
+1.7° (c 1.4 in H2O); All other spectral data was identical to that obtained for the
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racemic compound (1 2 1 ).
O
NH
HO
HO O ^ ^
Dihydrouridine 2’-phosphate bIs-sodium sa it (136);^^^ Uridine 2 -  
phosphate bis-lithium sait (200 mg, 0.59 mmoi) was dissolved in aqueous 
hydrochloric acid (20 mi, 1 mM) and 5% rhodium on alumina added. The 
reaction vessel was flushed with hydrogen gas (ca. 500 mi), and the mixture 
stirred under an atmosphere of hydrogen for 12 hours. On completion, the 
reaction mixture was filtered through celite and the solvent removed in vacuo. 
The residue was redissoived in water (5 ml) and subjected to ion exchange
chromatography on Amberlite 118 (Na)+, eluting with water. The eluant was 
lyophilised to give yield a white powder (170 mg, 88  %); m.pt. 145-155 °C (dec); 
M o -32.3° (c 1.0 in HgO) (nujol)/ cm'l 3400-2400 bs (O-H and N-H), 1650
and 1670 (C=0), 1270 (P=0), 1100 s, 970 s and 750 s; 8^ (200 MHz; ^HgO)
2.70 (2H, t, J6.5 Hz, CHgCO), 3.50 (2 H, t, J6.4 Hz, CHgNR), 3.65 (2H, m, S'-Hg), 
3.95 (1H, m, 4’-H), 4.15 (1 H, m, 3’-H), 4.45 (1H, m, 2’-H) and 5.80 (1H, d, J6.2
Hz, I'-H); 8c (50.5 MHz; ^HgO) 32.9 (GHgCO), 39.5 (CHgNRg), 64.1 (5’-C), 72.9 
(4-C), 75.5 (3'-C), 8 6 .0  (I'-C), 89.8 (Jpg 9.7 Hz, 2 '-C), 157.5 (NC(O)N) and 
176.8 (CH2£ (0 )N); 8 p (121.5 MHz; ZHgO) 3.90; m/z (FAB) 393 ([/W+ Na]+, 5%), 
371 (5, [M + H]"*"), 137 (15, [dihydrouracil + Na]^) and 115 (10, [dihydrouracil + 
H]+).
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oHO
HO OH
Dihydrouridine (137);''^® Uridine (135) (250 mg, 1.02 mmol) was 
hydrogenated in the presence of 5% rhodium on alumina catalyst as described 
for compound (131). On filtering through ceiite, the solvent was removed in 
vacuo to yield a white gum which resisted crystallisation (210 mg, 83%); m/z
(Found: [M+ H]+247.0930. CgH^gNgOe requires 247.0930); M o -25.3° (c 1.0 in
H20) 5h (200 MHz; ^HgO) 2.70 (2H, t, J 6 .8  Hz, CHgCC), 3.50 (2H, m, CHgNR),
3.70 (2H, m, 5 '-H2), 3.95 (1H, m, 4-H), 4.10 (1H, m, 2’-H), 4.25 (1H, m, 3'-H) and 
5.80 (1H, d, J6.4 Hz, I ’-H); Sq (50.5 MHz; ^HgO) 33.0 (CHgNR), 39.3 (IlHgCO), 
64.2 (5’-C), 72.9 and 73.2 (2 -C and 3 -C), 86.3 (4'-C), 90 3 (1’-C), 157.6
(NC(O)N) and 176.8 (CH2&(0 )N); m/z(Ci) 264 ([/W+ NH4]+, 5%), 247 (100, (M +
H]+), 132 (5, [Uracil + NH41+) and 115 (10, [Uracil + H]+).
OPhIIO
D iphenyl propy l phosphate (161);^®5 n-Propanol (0.5 g, 8.33 mmol), 
DMAP (50 mg) and triethylamine (2.1 ml, 1.55 g, 15.4 mmol) were dissolved in 
dry THF under an argon atmosphere and the reaction mixture cooled to -10 °C. 
Diphenyl chlorophosphate (1.88 g, 145 ml, 7.0 mmol) was added dropwise and 
the reaction mixture stirred at room temperature for 2  hours. The salts were 
removed by filtration and the solvent removed in vacuo. The product was 
purified by silica column chromatography (30% ethyl acetate/ petroleum ether)
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to yield a colourless liquid (1.68 g, 84 %), m/z (Found: A4+ 292.0864 
C15H17O4P requires 292.0864); 'ü^gx (nujol)/ cm"  ^ 2900 s (C-H), 1600 s (Ar), 
1490 s, 1300 s, 1200 s (P=0), 1100 s, 1050 s, 790 s and 595 s; 6^ (200 MHz; 
C^HCIa) 0.95 (3H, t, J2.3 7.4 Hz, CH3). 3.55 (2H, m, CjjgCHg), 4.25 (2H, m, 
CHgOP) and 7.20 (10H, m, Ar-H); Ôq (50.5 MHz; C^HCig) 9.9 (CH3 ), 23.5 
(C.H2CH3), 70.8 (Jp Q 6.5 Hz, CHgOP), 120.0, 125.3, 129.8 (Ar-C) and 136.4 
(Jp Q5.9 Hz, Ar-C quaternary); 6p (121.5 MHz; C^HCy -11.4;m/z(C!) 310 ([M + 
NH4I+, 76%), 293 (100, [M+ H]+) and 93 (20, PhO+); TLC R, = 0.47 (30% ethyl 
acetate/ petroleum ether)
NH;.0
O'
Propyl phosphate b is oyclohexylam m onlum  sa lt (162); This was 
prepared in an identical manner to compound (97) from diphenyl propyl 
phosphate (161 ) and benzyl alcohol, followed by hydrogenation over Pc/ 0 
catalyst and recrystaiiisation from water and acetone (0.42 g, 59 %); m.pt. 96-99
°C; m/z (Found: [M (derivatised as the dimethyl ester) + H]"  ^ 169.0630.
C5 H14O4 P requires 169.0630); (nujol)/ cm"  ^ 2850 s (N-H and C-H), 1210
m (P=0), 1050 s (C-O), 790 w and 700 w; 6^ (200 MHz; ^HgO) 0.95 (2H, t, ^2,3
7.5 Hz, CH3), 1.10-2.00 (22H, m, cyciohexyi CH2 and £H 2CH3 ), 3.10 (2H, m, 
cyclohexyl CH) and 3.70 (2H, m, CHgOP); §c (50.5 MHz; ^HgO) 12.5 (CH3) 
26.6, 27.1, 33.1 (cyclohexyl CH2 and C.H2CH3), 53.1 (cyclohexyl CH), 68.9 (Jp q 
4.4 Hz, CH2OP); 5p (121.5 MHz; 2H2O) 4.10; m/z (derivatised as the dimethyl 
ester) (Ci) 186 (M+ NH4]+, 40%) and 169 (100, [M+ H]+).
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CHgO'
&
M ethoxyethanol d ibenzyl phosphate (159); This was prepared in an 
identical manner to compound (1 2 0 a) from methoxyethanol, and purified by 
silica column chromatography (50% ethyl acetate/ petroleum ether) to give the
desired compound as a colourless oil (1.31 g, 78 %); m/z (Found: [M + H]"^
337.1205. GiyHggOgP requires 337.1205); (neat)/ cm"^ 2900 s (C-H),
1485 s, 1260 s (P=0), 1050 s (0-0), 760 s and 700 s; 8^ (200 MHz; C^HCIg) 
3.38 (3H, s, OOH3), 3.55 (2 H, m, GHgOMe), 4.15 (2 H, m, GHgOP), 5.05 (4H, d, 
J7.9  Hz, Benzyl GHg) and 7.35 (1 0H, m, Ar-H); Ôq (50.5 MHz; G^HGIg) 59.5 
(OGH3 ), 67.1 (GHgOMe), 69.8 (Jp Q 5.7 Hz, Benzyl CH2),71.7 (Jp ^ 7.2
Hz,GH2 0 P), 128.3, 128.5, 129.0, 129.1 (Ar-G) and 136.4 (Ar-G quaternary); 8 p 
(121.5 MHz; G2hGI3)-0.50; m/z (Cl) 354 ([M+ NH^ ]-*-, 3%), 337 (100, [M+ H]+).
CH3O'
NH.0
O
-J2
Methoxy ethanol 2-phosphate bls-cyclohexylamtnonium sa lt (160); 
This was prepared in an identical manner to compound (121) from methoxy 
ethanol dibenzyl phosphate (159) (0.72 g, 6 8 %); m.pt. 191-195 °G; m/z (Found:
[A4 (free acid) + H]*^  157.0266. G3 H^q0 5 P requires 157.0266); (nujol)/ cm'i 
2850 s (N-H and H-bonding), 1200 m (P=0), 1050 s (G-0), 770 w and 720 w; 8^
(200 MHz; G2 HGI3) 1.10-2.00 (20H, m, cyclohexyl GH2), 3.0 (2H, m, cyclohexyl 
GH), 3.27 (3H, s, OGH3), 3.50 (2H, t, J^h,2H 4.7 Hz, GHgOMe) and 3.50 (2 H, dt, 
JlH,2H 4.6 Hz, Jp o 4.9 Hz GHgOP); 8q (50.5 MHz; G2 HGI3) 26.6, 27.1, 33.1 
(cyclohexyl GH2), 53.1 (cyclohexyl GH), 60.8 (OGH3), 65.6 (GH2 0 Me) and 75.0
33
(Jp c8.1 Hz, Benzyl CHg); ôp (121.5 MHz; C^HCIg) 3.52; m/z (El) 157 ([M+ H]^ 
5%), 99 (5, [phosphate + H]+) and 45 (100, MeOCNg^).
BnOx.
5 -O -B e n zy ! d ie th y le n e  g ly c o l- 1 -b ls b e n z y i p h o s p h a te  (14 7 ); 
Diethylene glycol (143) (2.0 g, 18.9 mmol) and benzyl bromide (0.64 g, 3.78 
mmol) were dissolved in dry DMF (30 ml) under a nitrogen atmosphere, and 
sodium hydride (0.36 g, 7.5 mmol (50% dispersion in oil)) added potlionwise 
over a period of 30 minutes. The reaction mixture was stirred at room 
temperature for 2 hours and quenched by the addition of water (30 ml). The 
product was extracted into diethyl ether (3 x 50 ml), washed with sodium 
bicarbonate solution (3 x 30 ml, 5%) and saturated brine (30 ml), and dried 
(MgSO^). The solvent was removed in vacuo and the residue added to 1-H 
tetrazole (0.53 g, 7.5 mmol), and dissolved in dry acetonitrile (20 ml). A solution 
of N,N’-diisopropylbisbenzyl phosphoramidite (116a) (1.68 g, 4.9 mmol) in dry 
acetonitrile (1 0  ml) was added and the reaction mixture stirred at room 
temperature under a nitrogen atmosphere for 30 minutes. The reaction mixture 
was cooled to -10°C and a solution of m-CPBA (1.72 g, 4.9 mmol, 50%) in 
dichloromethane (30 ml) added dropwise over a period of 10 minutes at -10 °C. 
The reaction mixture was diluted with dichloromethane and washed with 10% 
sodium sulfite solution (3 x 30 ml), sodium bicarbonate solution (30 ml, 5%), 
saturated brine (30 ml), and dried (Na2S0 ^). The solvent was removed in  
vacuo and the residue purified by silica column chromatography on 
triethylamine basified silica (60% ethyl acetate/ petroleum ether) to yield a 
colourless oil. (0.76 g, 44% (from diethylene glycol)); m/z (Found: [M + H]+ 
457.1780. C25H30O6P requires 475.1780); (neat)/ cm'i 2900-3100 s (C-
H), 1280 s (P=0), 1050 s (C-O), 750 s and 700 s; Ôh (200 MHz; C^HCIg) 3.60 
(6 H, m, diethylene glycol CH2), 4.15 (2H, m, CH2OP), 4.50 (2H, s. Benzyl ether 
CH2), 5.05 (4H, d, J 8 Hz, Benzyl ester CHg) and 7.30 (15H, m, Ar-H); 6^ (50.5 
MHz, 2H2O) 67.2, 67.3, 69.7, 69.9, 70.3, 70.5, 71.2 (CH2), 128.1, 128.2, 128.5,
134
128.9, 129.0 (Ar-G) and 136.3, 138.8 (Ar-G quaternary); 6p (121.5 MHz; 
G^HGIg) -0.55; m/z (Gl) 457 ([M+ H]+, 100%), 277 (10, [M(free acid) + H]+), 259 
(5, [M + H - 2 BnOn, 108 (85, BnOH) and 91 (55, Bn+); TLG Rf = 0.32 (60% 
ethyl acetate/ petroleum ether).
NH
■J2
Diethylene glycol monophosphate bis cyclohexyiammonium sa lt
(149); This was prepared In an Identical manner to compound (121 ) from 1-0- 
benzyl diethylene glycol-1-bisbenzyl phosphate (147) (0.28 g, 78 %); m.pt. 
135-145 °G (phase transition); m/z ((derivatised as the dimethyl ester); Found:
[M + H]+ 215.0685. GgH j^gOgP requires 215.0685); (nujol)/ cm"  ^ 3300 bs 
(0-H), 2850 bs (N-H and G-H), 1210 s (P=0), 1070 s (G-O), 770 w and 700 w; 
5h (200 MHz; ^HgO) 1.00-2.00 (20H, m, cyclohexyl GHg), 3.00 (2H, m, 
cyclohexyl GHg), 3.65 (6H, m, diethylene glycol GHg), 4.15 (2H, m, GH2OP); 
(50.5 MHz, ZHgO) 26.6, 27.1,33.2 (cyclohexyl GHg), 53.1 (cyclohexyl GH), 63.1 
(3-G), 65.9 (2-G), 73.4 (Jp g 7.7 Hz 1-G) and 74.5 (4-G); ôp (121.5 MHz; G^HGIg) 
2.96; m/z(GI) (derivatised as the dimethyl ester) 232 ( [M + NH^]+, 65%), 215 
(100, [M+ H]+), 183 (5, [M-OMe]+) and 153 (7, [M -2 0Me]+).
BnO. ,0 .^ P — OBnIIO
5-O-benzyl pentane 1,5-dlol 1-bis benzyl phosphate (148); This was 
prepared in an identical manner to compound (147) from pentanel ,5-diol
(144) (0.62 g, 28%); (Found: [M ^ H]"^  455.1990. G2 6 H3 2 O5 P requires
135
455.1987); D^ax (neat)/ crrr'* 2900 s (C-H), 1270 s (P=0), 1050 s (0-0), 750 s
and 700 s; Ôh (200 MHz; C^HCIg) 1.30-1.66 (6 H, m, 2-Hg, 3-Hg and 4-Hg), 3.45 
(2H, t, J4 5 6 .2  Hz, 5-Hg), 4.00 (2 H, dt, 2 6  3 Hz, J^  p 6 .6  Hz, 5 -H2), 4.50 (2H, 
s. Benzyl ether CH2), 5.05 (4H, d, ^Benzyl H2 ,P 6.2 Hz, Benzyl ester CH2) and
7.30 (15H, m, Ar-H); Ôq (50.5 MHz, C^HCIg) 22.7 (3-0), 29.7 (4-0), 30.5 (2-0), 
68.3, 69.6, 70.5, 73.4 (1-0 , 5-0 and benzyl OHg), 128.0, 128.1, 128.4, 128.9,
129.1 (Ar-0) and 136.4,138.5 (Ar-0 quaternary); ôp (121.5 MHz; O^HOIg) -1.90; 
m/z (01) 472 (5%, [M+ NH^n, 455 (100, [M+ H]+), 275 (5, [M(free acid) 4- H]+), 
257 (2 0 , [M + H - 2  BnO]+) 195 (5, [ M + H -  P0(0Bn)2)]+), 108 (85, BnOH) and 
91 (55, Bn+);tlc Rf = 0.51 (60% ethyl acetate/ petroleum ether).
NH:.0HO. O
Pentane 1,5-dlo l m onophosphate b is cyclohexy iam m onium  sa lt
(150); This was prepared in an identical manner to compound (121 ) from 5-O- 
benzyl pentane 1,5-diol 1-bis benzyl phosphate (148) (0.31 g, 83%); m.pt. 149- 
151 °C m/z ((derivatised as the dimethyl ester); Found: [M + H]+ 213.0890. 
OyHfgOgP requires 213.0892); 'o^ax (nujol)/ cm"  ^3300 bs (O-H), 2850 bs (N-H), 
1200 m (P=0), 1050 s (0-0), 770 m and 700 m; Ôh (200 MHz; 2 H2O) 1.00-2.00 
(26H, m, cyclohexyl OHg, 2-0, 3-0 & 4-0), 3.00 (2H, m, cyclohexyl OHg), 3.45
(2 H, m, 5 -OH2) and 3.65 (2H, m, 1-Hg); 0  ^(50.5 MHz, ^HgO) 24.3 (5-0), 26.6,
33.1 (cyclohexyl OHg), 27.0, 32.6 (2-0 & 4-0), 27.1 (cyclohexyl OHg), 53.1 
(cyclohexyl OH), 64.5 (5-0) and 67.3 (Jp cS.O Hz, 1-0); ôp (121.5 MHz; ^HgO) 
3.57; m/z (01) (derivatised as the dimethyl ester) 230 {[M + NHJ^, 35%), 213 
(100, [M+ H]+) and 181 (3, [M- OMe]+).
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OBn
Diethylene glycol cyclic phosphate benzyl ester (155); This was 
prepared in an identical manner to compound (116) from diethylene glycol and 
N,N'-diisopropyl dichloro phosphoramidite (115) followed by transestérification 
with benzyl alcohol, and oxidation with m-CPBA in an identical manner to 
compound (120) to give the desired compound as a colourless oil (0.75 g,
46%); m/z (Found, [M + H]+ 259.0735. CiiHigOgP requires 259.0735); o^ax 
(nujol)/ cm-l2900 bs (C-H ) 1485 s, 1250 (P=0), 1100 s, 1050 s, 900 s and 720 
s; ÔH (200 MHz, C^HCy 3.60 (2H, m, 2 -H and 4-H), 4.00 (4H, m, 1H, 2 -H, 3-H 
and 4-H), 4.40 (2H, m, 1-H and 4-H), 5.10 (2 H, d, Jp |_| 7.2 Hz, Benzyl CHg) and
7.35 (5H, m, Ar-H); Ôq (50.5 MHz, C^HCIg) 69.5, 69.7 (1-C, 5-C and Benzyl 
CHg), 73.1 (2-C and 4-C), 128.2, 128.5 (Ar-C) and 139.5 (Ar-C quaternary) ôp 
(121.5 MHz, C^HCy -0.79; m/z (Cl) 517 {[2M + H]+, 5%), 276 (3, [M+ NH^M, 
259 (100, [M+ H]+), 108 (4, BnOH) and 91(5, PhCHg^).
Diethylene glycol cyclic phosphate diester cyclohexyiammonium 
salt (157); This was prepared in an identical manner to compound (1 2 1  ) from 
diethylene glycol cyclic phosphate benzyl ester (155) to give the desired 
compound as a white solid (0.52 g, 8 6 %); m.pt. 190-193 °C; m/z (Found: [M
(free acid) + H]"^  169.0266. C^H^oOgP requires 169.0266); (nujol)/ cm'f 
2900 s (C-H), 1270 (P=0), 1100 s, 1050 s and 750 s;0h (200 MHz; ^HgO) 1.00-
2 .0 0  (1 0 H, m, cyclohexyl CHg), 3.00 (1 H, m, cyclohexyl CHg), 3.75 (4H, m, 2 -H2
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and 4 -H2), 3.95 (4H, m, 1-Hg and S-Hg); Sq (50.5 MHz, ^HgO) 26.6, 27.1, 33.1 
(cyclohexyl GHg), 53.1 (cyclohexyl CH), 69.5 (Jp ^ CH2OP), 73.7 (CH2OGH2);
6 p (121.5 MHz,G2HGI3) -0.25; m/z (Gl) 337 ([2M f  H]+, 5%), 186 (1 0 0 , [M +
N H ^n  and 169 (100, [M+ H]+).
Pentane 1,5 d io l cyclic  phosphate monobenzyl ester (156); This was 
prepared in an identical manner to compound (155) from pentane 1,5-diol 
(144) to give the desired compound as a colourless oil (0.35 g, 34%); m/z
(Found: A / f 256.0864. G12H17O4P requires 256.0864); o^ax (neat)/ cm'^ 2860 
bs (N-H and H-bonding), 1220 (P=0), 1050 s, 900 s, 760 m and 750 m; 0^ (200 
MHz, G^HGIg) 1.60-2.10 (6 H, m, 2-Hg, O-Hg and 4-Hg), 4.20 (4H, m, GHgOP), 
5.15 (2 H, d, Jp q8.5 Hz, Benzyi GHg); Sq (50.5 MHz, G^HGIg) 24.2, 29.6 (2-G, 3 - 
G and 4-G), 69.4, 69.6 (1-G, 5-G and Benzyl GHg), 128.4, 129.0 (Ar-G) and
137.5 (Ar-G quaternary); ôp (121.5 MHz,G2 hG13) -0.80; m/z (Gl) 274 ([A4-f 
NH41+. 15%), 257 (1 0 0 , [M+ H]+), 184 (5 , [A4- PhGHg+HM, 167 (5, [A4- PhGHg 
+ NH4M , 108 (10, BnOH) and 91 (5, PhGHg^).
Pentane 1,5 d io l cyclic  phosphate cyclohexy iammonium salt (158); 
This was prepared in an identicai manner to compound (121 ) from pentane 1 ,5 
dioi cyciic phosphate benzyl ester (156) to give the desired compound as a
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white solid (0.41 g, 85 %); m.pt. 160-162 °C; m/z (Found: [A4 (free acid) + NHJ'*' 
184.0739. C5 H15NO4 P requires 184.0738); (nujol)/ cm’ "* 2850 bs (N-H 
and H-bonding), 1210 (P=0), 1050 s, 950 s and 790 s; Ôh (200 MHz, ^HgO) 1.0-
2.0 (16H, m, cyciohexyi CHg, 2 -H2 , 3 -H2 and 4 -H2), 3.00 (1H, m, cyclohexyl 
CH), 3.85 (4H, m, OHgOP); Ôq (50.5 MHz; ^HgO) 26.1, 26.6, 27.0, 31.4, 33.1 (2- 
0, 3-0, 4-0 and cyclohexyl CH2), 53.1 (cyclohexyl CH2) and 70.3 (Jpc^.l Hz, 
POCH2); ôp (121.5 MHz, C^HCIg) 0.70; m/z (01) 333 ([2  A4+ H]+, 15%), (100, 
[A4 + NH4M  and 167 (30, [A4 + H]+).
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Inositol as a substrate for inositol monophosphatase
50 pi Assay buffer (150 mM Tris HCI, pH 8 , RT, 100 mM KI-^PO^).
25 pi 30 mM aqueous inositol solution (for control, use 25pl distilled water).
25 pi 20mM MgCl2 .
100 pi enzyme solution, 0.44 mg/ ml bovine inositol monophosphatase, 1 mg/ 
ml BSA, S.Â. = 34,400 nmol/ min/ mg.
The above samples were incubated at 37 °G for 30 minutes to achieve 
steady state conditions, and [‘•®0]-water (60% atom excess, 50 pi) added to 
each. Samples were quenched in liquid nitrogen at t = 0 , 40 and 80 minutes, 
and the controi (containing no inositol) quenched at t = 80 minutes. The water 
removed by lyophilisation, and the residues extracted with HCI in methanol 
(100 pi, 0.2 M) by vortexing for 30 seconds. Excess ethereal diazomethane was 
added to each sample until the yellow colouration persisted. Excess 
diazomethane was removed by bubbling nitrogen gas through the soiution, and 
the supernatant separated from the residue by decanting after centrifugation. 
The derivatised trimethyl phosphate samples were analysed by GC/MS.
Adenosine as a substrate for Inositol monophosphatase.
a) The above experiment was repeated using adenosine (30 mM, 25 pi / 
sample) in place of inositol.
b) The above experiment was repeated using adenosine (30 mM, 25 pi / 
sample) inplace of inositol, in addition to a greater overall concentration 
of [‘•®0]-water (45 atom %) and greater incubation periods (t^ pgx = 24 hrs).
(All incubations containing adenosine were run in parallel with incubations 
containing inositol under identical conditions)
Colorimetrlo Assay.^^^
C o io rim etrle  Assay reagent: Malachite green (1.5 g) was dissolved in 
hydrochloric acid (25 ml, 5 M) and diluted with water (750 ml). To this solution 
was added ammonium molybdate (10.5 g) in hydrochloric acid (225 ml, 5 M), 
and the solution stirred at room temperature for 10 minutes. The solution was
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filtered by gravity, and stored in the dark for periods of up to one month.
Assay:
Assay buffer A: 200 mM KCI, 2 mM MgClg, 50 mM Tris.HCI, pH 7.8
Assay buffer B; 200 mM KCi, 2 mM MgClg, 150 mM LiCI, 150 mM Tris.HCI,
pH 7.8
Incubation samples comprised of the following:
1 ). -assay buffer A - 210 pi
-substrate in assay buffer - 30 pi
-inhibitor in assay buffer - 30 pi (In the absence of an inhibitor, this 
addition was substituted with plain assay buffer (30 pi))
-enzyme solution - 30 pi
Parallel incubations were performed in the presence of Li+ to account for any 
background phosphate present as follows:
2). -assay buffer B - 210 pi
-substrate in assay buffer - 30 pi
-inhibitor in assay buffer - 30 pi (in the absence of an inhibitor, this 
addition was substituted with plain assay buffer (30 pi))
-enzyme solution - 30 pi
The assay samples were incubated at 37 °C and the reaction quenched by the 
addition of colorimetric assay reagent (2.0 ml) at the required time (relative to 
the addition of the enzyme solution). The colour was allowed to develop over a 
period of approximately 30 minutes, and the optical density measured at 660 
nm. In addition, known concentrations of inorganic phosphate 0-200 pM were 
prepared in triplicate, and treated with the colorimetric assay reagent (2.0 ml) to 
give a standard phosphate concentration curve from which accurate 
concentrations of product phosphate could be calculated .
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Radiochemical Âssay.^5
[U^^C]-D-myO"inositol 1-phosphate stock solution (50 pi, 1.25 pCi) was diluted 
with assay buffer A (200 mM KCI, 2 mM MgCl2 '6 H2 0 , 50 mM Tris HCI, pH 7.8) 
(450 pi).
Incubation samples comprised of the following:
-assay buffer A - 270 pi
-unlabelled inositol 1-phosphate in assay buffer - 30 pi 
-labelled inositol 1-phosphate (diluted form) - 60 pi 
-inhibitor in assay buffer - 60 pi 
A 70 pi aliquot was removed and added to sodium hydroxide solution (50 pi, 1.0 
M) (to act as a t = 0 quench). The relevant enzyme solution (150 pi) was added, 
and the sample incubated at 37 °C. At regular time intervals, aliquots (100 pi) 
were removed, and quenched by addition to sodium hydroxide soiution (50 pi,
1.0 M). The quenched assay solutions were diluted with water (1.0 ml) and 
applied to a 0.5 ml column of Dowex-1 (1 x 8 , 400 mesh) formate form. The 
[^^C] inositol was washed off the columns with water (1 ml), and the elutant 
emulsified with 10 mi scintillation fluid. Disintegrations were measured in a 
Packard Tri-Carb 4330 scintillation counter.
Reaction course of synthetic substrates:
assay buffer C 20 mM NH4 HCO3 , 2  mM MgCi2 , pH 8.0 in D2O
enzyme solution 50 pi (0.44 mg/ ml bovine inositol
monophosphatase, 1 mg/ ml BSA, S.A. = 34,400 
nmol/ min/ mg) lyophilised and redissolved in 
assay buffer C (100  pi).
The substrate was dissolved in assay buffer C (500 pi) to a concentration of 60
mM. The ^H NMR spectrum was recorded, and the enzyme solution (100 pi) 
added. The ^H NMR spectrum was recorded immediately to account for any 
signals arising from the enzyme buffer system. The samples were incubated at 
37 °C, and the H NMR and P spectra recorded at regular time intervals.
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Reaction course of uridine 2 ’°monophosphate hydrolysis:
Uridine 2 '-monophosphate was dissolved in assay buffer C (300 pi) and 
HgO (2 0 0  pi) added, and the reaction was incubated at 37 °C for 24 hours. Half 
of the reaction mixture was lyophilised, and the resuiting uridine analysed my Cl 
mass spectroscopy. The remainder of the solution was analysed by high 
resolution P NMR spectroscopy.
Inhibition studies.
Synthetic substrates/ inhibitors were tested using the colorimetric and/ or 
radiochemical assays, over a range of substrate and inhibitor concentrations.
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4. Appendix 1.
Publications.
1 . Andrew G. Cole and David Gani.
‘Active’ Conformation of the Inositol Monophosphatase Substrate, 
Adenosine 2’-Phosphate: Role of the Ribofuranosyl 0-atoms in Chelating 
Magnesium Ion.
J. Chem. Soc., Chem.Comm., Submitted for publication.
2 . Andrew G. Cole and David Gani.
Structure of the Catalytic Complex of Substrate, Magnesium Ion and 
Enzyme in inositol Monophosphatase and Mechanism of the Hydrolytic 
Process.
J. Chem. Soc., Chem.Comm., Submitted for publication.
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